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ABSTRACT 
Healthcare is one of the sectors in which Indonesia’s spending is yearly 
increasing towards Gross Domestic Product. Its highest contributor, pharmaceutical 
spending, is known also to increase up to 2017, showing +10.2% growth in IDR 
currency terms. In addition, it shows an increase in forecast trend projected up to 2021 
according to Business Monitor International (BMI) Research. The fact that 
pharmaceutical spending contributes high to total hospital expenditure in specific and 
has to hold critically vital products, urged the pharmacy to continuously provide 
excellent service to the patient. Blambangan Banyuwangi Public Hospital (RSUD 
Blambangan) is one of regional public service hospital or BLUD (Badan Layanan 
Umum Daerah) since 2009. This hospital had just received B-class certification on 
February 2017. Looking at its hospital pharmacy which contributes up to around 60% 
of the total hospital revenue, observation and evaluation are worth taking place on its 
pharmaceutical inventory management. 
This research is aimed to evaluate current inventory management and to 
observe the impact of delay in payment using joint order policy and periodic review to 
some of the A-class pharmaceutical products, from the ABC classification, in RSUD 
Blambangan. This aim is obtained from the finding that the hospital has a tendency to 
postpone the order payment to the supplier and it is permitted by the supplier. In 
addition, the pharmacy depot intuitively determined its review period in its inventory. 
The ignored permissible delay in payment is the key consideration of this research to 
be compared to the current inventory management by modifying general total inventory 
cost equation as well as proposing the periodic review policy. The expected results are 
a recommendation on Economic Order Interval (EOI) for each scenario (initial 
condition, consider EOI only, and consider both EOI and delay in payment). It will also 
analyze each scenario performance gap to know when and which to apply. The current 
best scenario seen from financial aspects in regards to the least total inventory cost is 
considering EOI only without the delay in payment. However, the gap towards that of 
considering both factors is very little depicted by one and two-way sensitivity analysis. 
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ABSTRAK 
Healthcare adalah salah satu sektor dengan tingkat belanja tahunan yang 
meningkat dalam Produk Domestik Bruto. Kontributor tertingginya, belanja farmasi, 
diketahui juga meningkat hingga 2017, menunjukkan pertumbuhan + 10.2% dalam 
mata uang Rupiah. Selain itu, tren ramalannya pun diproyeksikan meningkat hingga 
2021 oleh Business Monitor International (BMI) Research. Fakta bahwa farmasi 
berkontribusi tinggi terhadap total pengeluaran rumah sakit dan memiliki otoritas 
mengatur alat serta obat sebagai produk yang sangat penting availabilitasnya, 
mendesak apotek untuk terus memberikan pelayanan yang terbaik kepada pasien. 
Rumah Sakit Umum Blambangan Banyuwangi (RSUD Blambangan) adalah salah satu 
Badan Layanan Umum Daerah (BLUD) sejak tahun 2009. Rumah sakit ini baru saja 
menerima sertifikasi kelas B pada Februari 2017. Observasi dan evaluasi layak 
dilakukan pada manajemen inventori farmasi melihat depo farmasi rumah sakit yang 
berkontribusi hingga sekitar 60% terhadap total pendapatan rumah sakit. 
Penelitian ini bertujuan untuk mengevaluasi manajemen persediaan aktual dan 
untuk mengamati dampak keterlambatan pembayaran (delay in payment) 
menggunakan kebijakan pesanan bersama (joint order) dan peninjauan periodik untuk 
beberapa produk farmasi kelas A, dari klasifikasi ABC, di RSUD Blambangan. Tujuan 
ini diperoleh dari temuan bahwa rumah sakit memiliki kecenderungan menunda 
pembayaran pesanan kepada pemasok dan hal tersebut diizinkan. Selain itu, depo 
farmasi secara intuitif menentukan periode review dalam inventarisnya. Penundaan 
pembayaran yang diabaikan adalah fokus utama penelitian ini untuk dibandingkan 
dengan manajemen inventaris actual dengan memodifikasi persamaan total biaya 
persediaan serta mengusulkan kebijakan peninjauan periodik. Hasil yang diharapkan 
adalah rekomendasi pada Economic Order Interval (EOI) untuk setiap skenario 
(kondisi aktual, mempertimbangkan EOI, dan mempertimbangkan EOI serta 
penundaan pembayaran). Gap kinerja antar skenario juga akan dianalisis untuk 
mengetahui kapan dan skenario mana yang akan diterapkan. Skenario terbaik dari 
aspek keuangan terkait biaya persediaan paling kecil adalah mempertimbangkan EOI 
tanpa penundaan pembayaran. Namun, selisih dengan skenario yang 
mempertimbangkan dua faktor cukup sedikit, digambarkan oleh analisis sensitivitas 
satu dan dua-arah. 
Kata Kunci: Delay in Payment, Economic Order Interval, Joint Order, Periodic 
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CHAPTER 1  
INTRODUCTION 
 
This chapter explained the background, problem formulation, and research objectives, 
benefits, scope, and outline of the research.  
 
1.1 Background 
Healthcare is one of the sectors in which Indonesia’s spending is yearly 
increasing towards Gross Domestic Product (GDP). Business Monitor International 
(BMI, 2018) said that around 2.9% of Indonesia’s GDP is healthcare spending. Though 
it seems quite a small percentage, surprisingly, the spending from 2009 to 2015 is 
known to be growing at 14% Compounded Annual Growth Rate (CAGR). Healthcare 
spending is increasing from IDR363.7T in 2016 to IDR403.1T in 2017. It is +10.9% 
growth in IDR currency terms. Meanwhile, pharmaceutical spending is increasing from 
IDR85.6T in 2016 to IDR94.2T in 2017, showing +10.2% growth in IDR currency 
terms. The table below shows the pharmaceutical sales towards GDP and healthcare 
expenditure year 2015 and 2016 together with its forecast (f = BMI Forecast) 2017-
2021. 
 
Table 1.1 Headline Pharmaceutical and Healthcare Forecast (Indonesia 2015-2021) 
 2015 2016 2017f 2018f 2019f 2020f 2021f 
Pharmaceutical sales USD billion 5.79 6.43 7.04 7.61 8.20 8.89 9.63 
Pharmaceutical sales, % of GDP 0.67 0.69 0.70 0.69 0.69 0.68 0.68 
Pharmaceutical sales, % of 
healthcare expenditure 
23.6 23.5 23.4 23.2 22.9 22.6 22.3 
Health spending, USD billion 24.58 27.33 30.13 32.85 35.83 39.34 43.27 
 (BMI, 2018) 
 
Even though pharmaceutical sales contribution to GDP lies around 0.7% in 
stagnant, the USD billion sales show an increase in forecast trend. Taking a further 
look, pharmaceutical sales contribute around 23% of healthcare expenditure in total, 
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but pharmaceutical sales in the hospital are appointed to be a high contributor to total 
hospital expenditure. It is shown by Sari (2017), almost 80% of total hospital 
expenditures is used to fulfill pharmaceutical products and consumable medical 
supplies, while 20% of the remaining is spent for another expense like human 
resources. Based on DBS Vickers Securities Indonesia 2015 report, here is the graphic 
showing increasing trend of Indonesia’s healthcare spending.  
 
 
Figure 1.1 Indonesia's Healthcare Spending in IDR Trillion (DBS Vickers Securities 
Indonesia, 2015) 
 
The fact that pharmaceutical expenses contributes high to total hospital 
expenditure and has to hold critically vital products, urges the pharmacy to 
continuously provide excellent service to the patient. This is a high responsibility as it 
is said by Daniel P. O’Neil, et al. (2014), hospital pharmacy has high responsibility for 
“purchasing, storing, handling, and distributing the correct medicines, in the correct 
dosage, to the correct patient, at the correct time, and through the correct step”. Another 
statement arises that ‘good’ service of the achieved service level must be accompanied 
by a decrease in total expenditure. However, there is no such perfect world and 
therefore, the pharmacy should struggle to cope with it. 
3 
 
By procuring the right amount of medicines and consumable medical supplies 
then holding them in inventory for the upcoming demand efficiently, pharmacy is 
known to strive well in handling the inventory management. “Inventory management 
seeks to maximize the net benefit minus cost of the inventory” (Chambers & Lacey, 
2010). In general, inventory is said to be the largest single part investment. It is 
commonly composed of 20%-30% of the total assets, that is why effectively managed 
becomes important to maintain and strive for better financial performance (Shardeo, 
2015). 
According to the official portal of Government of Banyuwangi (2017), 
Blambangan Banyuwangi Public Hospital (RSUD Blambangan) has been included into 
a regional public service or BLUD (Badan Layanan Umum Daerah) since 2009, as one 
of two public hospitals in Banyuwangi, out of 15 hospitals in total: public and private. 
RSUD Blambangan is known to be one of the hospitals with highest market coverage 
in Banyuwangi. Moreover, according to the information from Ministry of Health, 
RSUD Blambangan had just received B class-type certified hospital on February 2017 
after having a massive progress to develop its facilities, services, and resources. Thus, 
RSUD Blambangan must be ready to be a reference hospital from neighborhood 
regency, as it is said by Abdullah Azwar Anas, the Regent of Banyuwangi on some 
news portal. 
However, RSUD Blambangan needs to always improve its services to get A-
certification and to increase its service level. Redirecting to one of the biggest 
contributors to the hospital expenditure: the pharmaceutical expense takes place. 
Moreover, pharmaceutical expenses of this hospital in terms of purchasing 
pharmaceutical products and consumable medical supplies is said to be around 40% of 
the total hospital expenditures. While the revenue gained by the hospital pharmacy 
contributes up to around 60% of the total hospital gain, according to the latest data 
taken by direct dialog, 2017. Based on 2017 data presented by the Head of Pharmacy 
Depot, hospital expenditures lie around IDR79T, while the pharmaceutical expense is 
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IDR24.5T. Additionally, the pharmaceutical income ranges around IDR33T towards 
IDR45T of total income. It is clear that the common sense of hospital as a service 
institution is to save a life as the main goal and to maintain the pharmaceutical products 
available to be 100% whenever it is needed. However, there is another statement to be 
highlighted. It is, said the Head of Pharmacy Depot, the hospital pharmacy is the 
“revenue-center” for the hospital and no wonder the hospital is a profit-oriented 
business, without neglecting the social values and aims. Below are figures of RSUD 




Figure 1.2 Blambangan Banyuwangi Public Hospital and its Pharmaceutical 
Warehouse. Source: direct capture and Government of Banyuwangi (2017). 
 
RSUD Blambangan, therefore, struggles to manage its inventory well. There 
are five pharmacy depots: three outpatient depots and two inpatient depots. There are 
three warehouses to keep medical devices, infusion solution, and pharmaceutical 
products. In this hospital, in order to determine the number of products ordered to the 
5 
 
supplier from the Pharmaceutical Warehouse, the hospital takes the previous year 
demand pattern to project the forecast for the current year by adding or reducing some 
percentages due to some concerns such as voluminous product, epidemiology, etc. 
Voluminous products are said as products which consume more spaces in inventory. 
In this case, the space availability is the constraint. Thus, the hospital can only hold 
several amounts and not much of this product. Then, the hospital decides intuitively to 
order this type of product weekly, without considering daily demand or a structured 
review policy. Another concern is to revisit current year epidemiology. Hence, those 
products used as the medicines of the epidemic diseases must be ordered several 
percentages higher than usual. The Head of Pharmacy Depot added, it is not surprising 
also to count up its order frequency. The rest of the pharmaceutical products are 
managed and analyzed by the ABC classification or the Always, Better, Control 
classification in which already calculated regarding 2016 demand data. However, the 
Pharmaceutical Warehouse did not utilize what is already calculated and reviewing 
back to validate the accuracy. This can be considered as this hospital is improving but 
the awareness to optimize its inventory management is not high enough. From this 
point, this work attempts to re-structure the inventory management using the suitable 
control technique. 
Another finding is that one factor which, not only lately, becomes habitual in 
Pharmacy Depot viewpoint that is to postpone the purchasing payment to the 
distributor only if the budget runs low especially at the end of the year. The 2017 and 
2016 delay in payment was not an offer from the supplier. It was proposed by the 
Pharmaceutical Warehouse through a letter with its subjectively determined delay 
period. However, it is permissible. If the management could be more sensitive to this 
pattern, it would actually be an opportunity for the hospital to re-project its order 
interval and review period adapting to this permissible delay parameter setting. This 
yearly funding from the government and the permissible delay in payment by the 
distributor can make the hospital keeps the postponement as habitual or tends to 
postpone to keep the cash safe and probable to earn a profit. Otherwise, if the one who 
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firstly aware to this pattern was the supplier side, it would be a threat for the hospital 
that the supplier can set an amount that is receivable for the supplier whenever the 
hospital attempt to delay the payment. In short, there might be a payable amount by the 
hospital. This point becomes the main consideration in this research, to seek the 
optimum order interval to understand the impact of the permissible delay.  
This is quite a novel research that there has never been a research in RSUD 
Blambangan’s pharmaceutical inventory management. The previous research was to 
implement Balance Score Card (BSC) to measure the service quality, analyzed 
patient’s satisfaction, evaluate the environmental health, information system, etc. None 
of them focused on inventory management. This research gap will be discussed later in 
the following chapter. Moreover, from this work’s humble references, there has not 
been any research or international journal discussed the impact of permissible delay in 
payment to a Pharmaceutical Supply Chain (PSC) practices. However, this is 
considered feasible from the theoretical viewpoint as the previous joint order 
deterministic inventory model research existed, the gap shows that it is applied to other 
types of business. The output of this work is intended to be beneficial for the hospital 
to manage its inventory with the Economic Order Interval (EOI) considering the 
permissible delay in payment for cost minimization. 
 
1.2 Problem Formulation 
Based on the aforementioned background, the problem formulation going to be 
discussed and solved in this research is to evaluate the current inventory management 
and to observe the impact of permissible delay in payment using joint order policy and 
periodic review to the A class pharmaceutical products in RSUD Blambangan. The 
expected results are a recommendation on Economic Order Interval (EOI) for each 





1.3 Objectives of Research 
The objectives that are going to be achieved in this research are as follows:  
1. To evaluate the current inventory management without Economic Order 
Interval (EOI) and without considering the permissible delay in payment. 
2. To find out the inventory decision recommendation while considering the EOI 
but without considering the permissible delay in payment. 
3. To find out the inventory decision recommendation while considering both the 
EOI and the permissible delay in payment. 
4. To find out a more comprehensive inventory decision recommendation 
regarding when to apply each of the scenarios and how far each scenario yields 
a different result in total inventory cost to each other. 
 
1.4 Intended Benefit of Research 
The benefit intended to be obtained in this research is that the hospital will be 
able to understand the current inventory management performance and evaluate 
compared to the proposed scenarios. The hospital will also be able to understand and 
differ the decision regarding certain conditions due to the structured control techniques 
practices mainly the review period (Economic Order Interval or EOI) as an approach 
desiring cost minimization. 
 
1.5 Scope of Research 
The scope used to describe the boundaries of this research is explained in the 
limitations and assumptions as follows:  
 
1.5.1 Limitations  
The limitation used in this research are as follows: 
1. The research focuses on joint order of only pharmaceutical products of A class 
from the resulted ABC classification by the hospital (consumable medical 
supplies are excluded). 
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2. The demand data used is the Pharmaceutical Warehouse data (Medical Devices 
and Infusion Solution Warehouse data are excluded). The demand data used is 
the total demand from 3 Outpatient Depot and 2 Inpatient Depot). 
3. The research data (stock, demand, price, and related measures) is ranged 
limitedly from January 1st to December 31st, 2017. 
4. The term pharmaceutical products are defined as medicines or drugs prescribed 
and consumed rationally used for patients by the medical forces. 
5. The delay period considered is not more than the period in which inventory 
level is positive. 
 
1.5.2 Assumptions 
The assumption used in this research are as follows:  
1. Demand rate is known, constant, and continuous during the time horizon. The 
same as the lead time of delivery, it is known and constant. 
2. No quantity discounts. Hence, cost structure is fixed (holding cost is linear 
function based on average inventory, purchase cost is constant, order cost is 
calculated both on the joint order and on each item).  
3. No lost sale, backorder, special sale price, and known price increase. Products 
are always available when it is needed. 
4. There is sufficient space, capacity, and capital to procure the desired lot size. 
5. Entire lot size is added to inventory at the same time. 
6. No inspection errors, so the rejected units are discarded prior to storage. 
Rejected units are never added to warehouse. No defective products put on 
warehouse. 
7. Holding cost is assumed to be 25% of the purchase cost, as the average 






1.6 Research Outline 
This subchapter explained the research outline used in this research report, 
which is explained as follows:  
CHAPTER 1 INTRODUCTION 
In introduction, will be explained about the background of the research, the 
problem formulation aimed to be solved, the objectives planned to be accomplished, 
the benefits expected to be obtained, the scope broken down to the limitation and 
assumption used as the system under discussion, and the research outline as the report 
systematically brief-described in order per chapter. 
CHAPTER II LITERATURE REVIEW 
In literature review, will be explained about the theory used to assess the 
research. This will be used as the basis to solve the problem formulation with the detail 
explanation about the conceptual thinking. The theory is usually taken from research 
journal, paper, books, previous researches, and other qualified resources. 
CHAPTER III RESEARCH METHODOLOGY 
In research methodology, will be explained about the systematical thinking 
regarding the steps to do the research starting from the problem formulation until the 
end. It provides thorough comprehension about the research procedure. 
CHAPTER IV DATA COLLECTING & PROCESSING 
In data collecting and processing will be explained the data collected regarding 
the completion of research. The data can be either or both the primary or/and secondary 
data. As it becomes the input for the research after being collected, the data is then 




CHAPTER V ANALYSIS & INTERPRETATION 
In analysis and interpretation will be explained in detailed analysis, elaboration, 
and further explanation regarding the result obtained. The content follows the data that 
has been processed previously. 
CHAPTER VI CLOSURE 
In the closure, will be explained the conclusion and suggestion. The conclusion 
is usually obtained from the result of data processing and analysis regarding the 
problem formulation. The suggestion is usually proposed for the upcoming research 
regarding the absence, points outside focus of the research, and related topics to 




CHAPTER 2  
LITERATURE REVIEW 
 
This chapter explained the study from the literature related to the research. It is 
about Healthcare Supply Chain (HSC) and Pharmaceutical Supply Chain (PSC) 
regarding to its inventory management, inventory control techniques (replenishment 
policy both continuous and periodic review policy are compared, Economic Order 
Interval (EOI) or T-method compared to Economic Order Quantity (EOQ) or Q-
method, Safety Stock (SS), Average Inventory Level (AIL), and ABC classification), 
permissible delay in payment, and the corresponding approach with the research gap.  
 
2.1  Healthcare and Pharmaceutical Supply Chain Management 
Supply chain is an emerging and growing concerned-sector in which the growth 
is considerably fast in many kinds of industry. In healthcare institution, based on 
Simchi-Levi, et al. (2004), supply chain management practice on its early existence 
was focusing more on supplier side to reduce cost as the desired objective. However, 
the study brings proof that focusing more on supplier side is not enough (Simchi-Levi, 
et al., 2004). Healthcare institution, which considerably more complex and immature 
compared to another type of businesses, needs also to concern on another side of supply 
chain to gain more revenue and reduce more costs. Matter of fact in practical, common 
problems arise on HSC that previous researchers attempted to deal with: (1) internal or 
external system missed-coordination,  (2) problems on order quantity, stock level, 
availability, and stock review, (3) demand information, (4) human resource 
dependencies, (5) procurement management including planning, ordering, etc., (6) 
avoiding shortage, (7) expiration and deterioration, (8) warehousing, (9) temperature 
controlling, and also (10) delivery visibility including transit, postponement, and 
arrival visibility. Based on those 10 common problems, some of those are inventory 
cases, suit what this work attempted to cope with. Moreover, inventory could probably 
be the case on each of the three major roles in its supply chain (up to healthcare 
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provider). Explained by Burns (2002), HSC management has four major roles. Figure 
2.1 below shows the general model of HSC. 
 
 
Figure 2.1 General Model of Healthcare Supply Chain Role (Burns, 2002) 
 
 Healthcare Supply Chain which focuses on drugs or medicines is commonly 
named as Pharmaceutical Supply Chain (PSC). PSC is truly important to handle the 
availability, stock level, and performance of the hospital inventory management 
dealing with both pharmaceutical products and consumable medical supplies. 
Pharmaceutical products are critical in usage for disease prevention program or 
treatment plan (International Pharmaceutical Federation, 2012). Therefore, it is 
expected that the practice could significantly contribute to improving healthcare 
service. Must be noticed that the prescribed pharmaceutical products are timely manner 
distributed (Pedersen, et al., 2009). PSC cope with demand, inventory management, 
and distribution commonly to achieve the minimum total inventory cost which also 
satisfies the targeted service level. Below is the figure of the pharmacy care unit in this 
work’s object as the overview of distribution system flow (pharmacy depot order to 



























Figure 2.2 Overview of Pharmaceutical Order Flow in Blambangan Banyuwangi 
Public Hospital 
 
2.2 Pharmaceutical Inventory Management 
Pharmaceuticals already become the largest investment in any healthcare 
delivery system. The total hospital pharmacy cost is all the acquisition costs through 
all purchased pharmaceutical products including one which is still in stock, plus costs 
required to convert drugs or medicines into patient doses, and another cost related to 
typically this consumable inventory – such as spoilage, expiration, shrinkage, and 
recalls (Federal Accounting Standards Advisory Board, 2006). 
Explained by Gebicki, et al. (2013), there are constraints in any pharmaceutical 
inventory management activities related. First, each pharmaceutical products and 
consumable medical supplies need customer service level, the performance as the 
consequences of stock out, that is dependent on its criticality and also the life of a 
patient. Second, drugs and medicines are perishable products meaning that they have a 
specific time length of when to use. If it exceeds the expiry date, it is a waste causing 
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a negative impact to finance. According to the Regulation of Health Ministry of 
Indonesian Republic No. 58/2014: “Every pharmaceutical products and consumable 
medical supplies are said to be deadstock or expired whenever its demand is zero for 
three months respectively”. Third, pharmacy order is not always fully granted by the 
supplier. It is due to the limited availability of products from the supplier, meaning the 
lead time for each product may also considerably vary. 
However, operational costs in pharmaceutical inventory obviously contribute 
to hospital expenses. There are lots of factors influencing the management level to set 
its inventory system strategy. Some factors included here are the order interval/review 
period, order frequency, order quantity, unit price and other hidden costs. To have 
efficient inventory management, as the number of stock will yield to an increase in 
carrying/holding cost, thus it must be handled by adding the order frequency in the 
aims of to reduce the cost of carrying. However, order frequency stimulates the 
purchasing and ordering cost increase. Hence, there are several methods especially in 
pharmaceutical inventory management commonly used. 
 
2.2.1 ABC Classification 
One of the common method used to control the stock is by conducting the ABC 
(Always, Better, Control) classification. It is a basic technique of inventory control as 
the classification of stores according to value: high, medium, and low. It is also known 
as Selective Inventory Control (SIC) or Pareto Analysis (Datta, 1984). This ABC 
classification is beneficial in stating the strategy of pharmaceutical products selection, 
procurement, distribution, and to give rational ranged consumption of products. ABC 
classification helps to determine various decision making such as the ordering 
frequency, supplier selection for each class of category, review policy to maintain 
service level and avoid sudden purchase, priority control to procure pharmaceutical 
products and day-to-day control implementation. One common sense is the higher 
order frequency together with a smaller lot size for A class category usually preferable 
and capable to reduce the carrying cost. According to Ravinder & Misra (2014), “ABC 
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Inventory Analysis divides inventory into three classes based on its annual dollar 
volume”. Each of items will be categorized as A, B, or C class.   
 Class A are items with high value but constitute a very small percentage of 
total number of items. In example, class A represent around 10% - 15% of 
the total inventory items, but they represent 60% - 80% of the total dollar 
usage.  
 Class B are items with average movement and thus constitutes a quite good 
percentage in value. Those items carry medium annual dollar volume. This 
class represent around 30% of the total inventory items and spend 15% - 
25% of the total dollar usage.  
 Class C are those who carry low annual dollar volume. This class may 
represent around 55% of the total inventory items, but only spent 5% of the 
total dollar usage. 
Here is the table showing the percentage of total inventory items and values for each 
class.  
 
Table 2.1 Percentage of ABC Classification to Total Item and Value of Inventory 
Class 
Items in Inventory, % to total 
inventory items 
Value of item, % to total 
inventory value 
A 10 - 15 % 60 - 65 % 
B 30 % 30 % 
C 55 - 60 % 5 - 10 % 
(Datta, 1984) 
 
2.2.2 VEN and Therapy Analysis 
Another method to evaluate the inventory management performance is by the 
VEN method and therapy analysis. The VEN method is an abbreviation for vital, 
essential, and non-essential. It categorizes pharmaceutical products into three 
categories: vital, essential, or non-essential. This categorization is granted by global 
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health institution in which usually referred to the VEN Classification Guide by WHO 
or from the published list by the Ministry of Health of Indonesia. Beside the VEN, 
therapy method, in which is alike, also helps the pharmaceutical manager in hospital to 
control the spread of the product together with the usage of the therapy. Also, this 
analysis can give recommendation on which pharmaceutical product yield to the best 
therapy effect together with having the low price. If the company can manage its 
inventory system effectively and efficiently, it can considerably reduce operating costs.  
 
2.3  Control Techniques in Inventory Management  
Inventory management focuses on balancing the order and holding cost with 
service level (Gebicki, et al., 2013). The order cost consists of the cost for time and 
energy on order placement, transporting materials, receiving cost, and other related 
cost. The holding cost consists of the opportunity cost or the money tied up in 
inventory, space requirement cost, condition settings such as the temperature, lighting, 
etc., spoilage cost, and other costs. The service level is represented by the probability 
or percentage of not having stock out sales (Gebicki, et al., 2013). The higher the 
inventory level, the higher the holding cost will be. However, increase in inventory 
level will deny the probability of sales stock out due to the inadequate inventory, hence 
it increases the service level for the company (Sari, 2017). 
Therefore, to make sure there are enough stocks available, some techniques are 
used to control the inventory level, such as safety stock, reorder point, replenishment 
policy, economic order quantity, economic order interval, and average inventory level 
(Hafnika, et al., 2016). Each of those techniques will be explained below. 
 
2.3.1 Replenishment Policy (SS, ROP, EOQ, EOI, AIL) 
One of the techniques used to control inventory level is the replenishment 
policy. According to Chopra & Meindl (2013), replenishment policy includes the 
decision about when and how much to reorder. There are two types of replenishment 
policy, those are continuous and periodic review policy. These inventory system 
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policies sufficiently provide solutions, as the nearest approach representing the real-
world practices to problems concerning on the inventory management system. Figure 
below are each graph of continuous and periodic review policy, with the OH inventory 
projected towards time. 
 
 
Figure 2.3 Continuous Review Policy and Periodic Review Policy (Jungfeng Ma & 
Gul E., 2013) 
 
Here is the above figure notation explanation: 
Q = quantity 
P = protection 
TBOx = time between order 
Lx = lead time 
 
2.3.1.1 Continuous Review Policy 
In the continuous review policy, according to Chopra & Meindl (2013), 
inventory is simultaneously tracked. An order is placed when inventory depletes up to 
the reorder point (ROP). In this scenario, order size does not change between orders, 
but time between orders probably fluctuates up based on the demand variability. By 
using continuous review policy, company may retain positive impacts such as real time 
update of stock level which makes the company easier to predict when to reorder in 
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future. Some said that it also eases the accounting calculation because of the real time 
Cost of Goods Sold (COGS) provision. It can also address when the product has high 
demand. However, some disadvantages are higher in implementation cost since it 
requires more personnel to track stocks and needs high reliability information system 
to review (Jungfeng Ma & Gul E., 2013). 
 
2.3.1.2 Periodic Review Policy 
Differ from continuous review, in the periodic review policy according to 
Chopra & Meindl (2013), stock is checked at constant periodic interval. An order is 
placed to raise the stock level. In this case, size of an order is not constant as it signs 
the demand variability. However, order interval remains the same. By using periodic 
review policy, company can get positive impact such as time reduction to analyze stock 
level, and very practical and feasible for joint order or for multiple items. Meanwhile, 
the disadvantage is the inaccuracies in tracking, moreover if it is a high-sales volume 
business (Jungfeng Ma & Gul E., 2013). The application of periodic review policy 
somewhat was simpler to implement than the continuous review policy, since it did not 
require real time tracking, thus the implementation cost is lower, and fewer resources 
used (Chopra & Meindl, 2013). Table 2.2 below summarizes the differences between 





Table 2.2 Differences between Continuous Review Policy and Periodic Review Policy 
 
(Jungfeng Ma & Gul E., 2013) 
  
2.3.2 Safety Stock and Reorder Point 
Other control techniques commonly used to control inventory level alongside 
the continuous review policy are safety stock and reorder point (ROP). Chopra & 
Meindl (2013) defined safety stock as “A number of inventory that is held by company 
to fulfill demand that exceeds the amount forecasted for a given period”. Safety stock 
is held as an awareness to uncertain demand or uncertain lead time, and shortage 
probably occur if actual demand exceeds forecasted demand. Customer service level 
becomes the input in calculating safety stock. Chopra & Meindl (2013) explained that 
customer service level is obtained from the stock out sales probability.  
Meanwhile, Chen, et al. (1998) defined reorder point as “The minimum 
inventory level that triggers the placement of orders for additional units”. Reorder point 
is presented by the consequence of lead time. Reorder point is affected by daily demand 
and lead time only if there is no any variable demand and lead time. However, when 
demand or lead time are uncertain, reorder point will be also affected by safety stock 
(Ravinder & Misra, 2014). The equation for both safety stock and reorder point remain 
actually the same to various model implementation. However, there is no reorder point 
in periodic review policy. It can be seen in the table below. 
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Table 2.3 Safety Stock and Reorder Point Equation 
 Source Safety Stock (SS) 
Reorder Point 
(ROP) 










𝑆𝑆 = 𝐹𝑆−1(𝐶𝑆𝐿) 𝑥 𝜎𝑇+𝐿 
 
- 
(Hani, et al., 2013)  
 
Here is the notation explanation: 
z = standard deviation of demand 
𝜎 = service level constant 
L = lead time 
d = average demand during lead time 
SS = safety stock  
CSL = cycle service level  
FS-1 = normsinv  
𝜎𝑇+𝐿 = demand standard deviation during T+L  
T  = review interval  
L  = average lead time for replenishment  
 
2.3.3 Average Inventory Level 
Average inventory level, also known as cycle inventory, explained in definition 
by Chopra & Meindl (2013) as the average number of stock in warehouse due to 
company purchase or production in lots which are usually larger than demanded by 
customers. Average inventory level is simply the result from dividing lot size (Q) by 
two if there is no any uncertainty both in demand and lead time. However, when 
demand and lead time is uncertain, average inventory level is also increased by safety 




 𝐴𝐼𝐿 =  
𝑄
2
+ 𝑆𝑆       (2.1) 
 
2.3.4 Economic Order Quantity 
This control technique used by companies along with continuous review policy 
is Economic Order Quantity (EOQ). It was first developed by Haris in 1913, then the 
following improvement was contributed from Wilson due to his in-depth analysis about 
this traditional control technique (Shardeo, 2015). The goal of EOQ is to find the 
optimal quantity to order each time that can minimize the total inventory cost, consists 
of purchasing cost, order cost, and holding cost (Chambers & Lacey, 2010). 
According to Chopra & Meindl (2013), EOQ model uses tradeoff between 
order cost and holding cost to determine the optimal order quantity. The larger the 
quantity, the lower the ordering frequency and the lower the total order cost will be. 
However, a larger quantity leads to higher holding cost. Otherwise, a lower quantity 
will decrease average stock level and holding cost, but will increase ordering frequency 
and total order cost.  
Optimal order quantity occurs when the order and holding cost graph intersect 
each other. There are some assumptions while using this model, such as constant 
holding cost, constant lead time, instantaneous replenishment, no stocks out are 
allowed, and no discount is allowed. Matter of fact, those assumption makes EOQ 
model cannot be feasible to all situation, such as for the joint order of multiple items, 
therefore this model must be compositely modified in the real inventory system 
analysis (Rachmania & Basri, 2013). Below is the Economic Order Quantity equation 
(Tersine, 1994): 
 𝑄∗ = √
2𝐶𝑅
𝐻
        (2.2) 
 
Here is the notation explanation of the equation: 
Q* = Economic Order Quantity 
R = annual demand in units 
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C = order cost per order 
P = purchase cost of an item 
F = annual fraction of holding cost per unit 
H = annual holding cost per unit (PF) 
 
2.3.5 Economic Order Interval (EOI) – Multiple Item 
This control technique differs from the Q-method. It is used for the fixed order 
interval in periodic review policy, can be both the EOI for single item and multiple 
item inventory management. This part explained about the EOI for multiple item. In 
EOI, common sense is that order must be rarely placed separately, moreover in a 
hospital pharmacy with many type of products. It is more economical to place joint 
order. When it is joint, the inventory level review can be coordinated and maintenance 
are kept to minimum. Furthermore, there is adjustment in review period thus it will not 
be too frequent and easy to adapt to another business activities. There may also be 
logistics cost savings, moreover transporting cost, due to the smaller material handling 
costs and weight breaks (Tersine, 1994). 
In preparing joint order, the quantity of each item to order depends on the time 
interval between orders for the entire group. The point in this model is to find the time 
interval T which will minimize inventory costs for the group as a whole. Once the 
optimum time to order interval is established, the desired maximum inventory level Ei 
for each item can be determined. From that maximum stock level, the individual order 
quantities can be calculated as well, by calculating the difference between each item’s 
maximum inventory level and its stock position at the time of the order review. 
The economic order interval can be obtained by deriving the total annual cost. 
Neglecting stockout cost, the formulation by Tersine (1994) is shown below. 
 
Total annual cost = purchase cost + order cost + holding cost 














Here is the notation explanation: 
Ri = annual requirement for item i 
Pi = purchase cost of item i 
n = total number of joint order items 
C = order cost for the joint order 
c = order cost to each individual item 
T = order interval in years 
F = annual holding cost as a fraction of purchase cost 
By taking its derivative with respect to T, the EOI (Tersine, 1994)  results in: 





       (2.4) 
 
The maximum inventory level for each item must be large enough to satisfy 
demand during the respective order interval and also during the lead time L. The 
amount to order each individual item is simply obtained by the maximum inventory 
level (Ei) minus the inventory position (Tersine, 1994). The maximum inventory level 
is determined (when the order interval (T) and lead time (L) expressed in days and there 










      (2.5) 
 
The minimum total cost per year (Tersine, 1994) is obtained by replacing the T 
with the EOI in the annual cost equation: 
 𝑇𝐶 (𝑇∗) = (1 + 𝐹𝑇∗) ∑ 𝑃𝑖𝑅𝑖
𝑛
𝑖=1      (2.6) 
 
2.4  Permissible Delay in Payment 
In receiving the payment, suppliers usually received a request of payment 
postponement from customer. Moreover, on some companies the credit period is 
confidently provided by the supplier. The benefits of this permissible payment delay 
not only attract new customer who claimed it an opportunity to reduce the purchasing 
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cost, but also to provide a competitive strategy for suppliers—not cutting down the 
wholesale price only. In this case from the hospital point of view as the customer, it is 
critical to determine the optimal inventory cycle time in procurement process when 
they face permissible delay in payment. 
Delay in payment can be either provided by supplier or proposed by the retailer. 
In the way that it is proposed by the retailer, the supplier can optionally refuse the 
proposal and cut the chain or permit the delayed payment under a considerable delay 
period. It is said as permissible based on the retailer’s allowance to pay back the dues 
without paying any interest to the supplier. The retailer can pay the supplier either at 
the end of the delay period or later incurring interest charges on the unpaid balance for 
the overdue period. This is the principle of permissible delay in payment.  
Now let’s say the hospital is the retailer. As it is mentioned in background, if 
the retailer could capture this opportunity of permissible delay, there probably be some 
receivable amount or can be called as the interest earned. It is also in relation to 
constraints, that is the delay period (M) faced to the period in which inventory is still 
positive (t1). Interest earned can be obtained if the retailer can pay before the delay 
period reaches to an end. That case is where the M > t1. Otherwise, if it is the supplier 
who already captured this pattern of payment delay, it could be a threat for the retailer 
because there will be an interest charged. This can be applied if the M < t1, thus the 
retailer probably pay exceeds the delay period and yield to an interest charged 
consequently. 
The retailer is expected to settle the account at a time before the end of the 
inventory cycle time because the payable interest rate is generally higher than the 
earned interest rate. However, recently, Cheng et al. (2012) discussed an economic 
order quantity model with trade credit policy in different financial environments. They 
discussed and found that the interest earned rate can be higher than the interest charged 
rate.  
The saving in cost as a result of permissible delay in settling the replenishment 
account largely comes from the ability to delay payment without paying any interest 
25 
 
(that payment period before the end of M). As a result of increased order quantity under 
conditions of permissible delay in payments, retailer needs to order less often. All of 
the interest formulas will be used further in this work (charged and earned) are based 
on the International Journal of Statistics and Systems (Behera & Tripathy, 2017) 
There are two conditions may arise: 
1. When the retailer earned interest but the payment is done exceeding the 
delay period because the positive-stock period is longer than the delay 
period. It is represented by (0 < M ≤ t1) 
2. When the retailer earned interest with no payable interest because the 
positive stock period is shorter than the delay period thus retailer has to pay 
under the delay period. It is represented by (M > t1) 
Here is the notation explanation: 
P = purchasing cost per unit 
S = selling price per unit 
T = the length of the order cycle (order interval) 
t = the respective time to trace inventory level 
Ie = interest earned per IDR per year, where Ie < Ic 
Ic = interest charged in stock by the supplier 
M = delay period 
t1 = length of positive-stock period (represent actual payment time) 
 
The scenario will be discussed in the following chapter. However, this is the 
formulation for Condition 1. (0 < M ≤ t1): 
 Interest Earned (IE1) (Ie) during the length of delay in payment (0, M) is: 



















    (2.7) 
 Interest Charged (IC1) (IC) during the (M, t1) is: 
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⌋   (2.8) 
 
Meanwhile, this is the formulation for Condition 2. (M> t1): 
 Interest Earned during time period (0, T): 

















]  (2.9) 
 Interest Charged = 0 thus IC2 = 0 
 
2.5 Corresponding Approach 
This subchapter explained about previous research based on the international 
journal and other related references to determine the position of this research. 
Explained also the tools used in this work according to the aforementioned literature 
review. 
This work is no wonder to have previous research in working on this scope and 
problem. Here is the table showing the related international journal and research about 
joint order inventory management with permissible delay in payment: 
 
Table 2.4 Related International Journal and Previous Research 
Research Method Output 
(Behera & Tripathy, 2017) An 
Optimal Replenishment Policy for 
Deteriorating Items with Power 




period with Power 
Pattern 
Effect of delay 
period, tradeoff 
between delay 




Research Method Output 
(Kumar & Kumar, 2016) An 
Inventory Model for Deteriorating 
Items Under Inflation and 






(Huang, 2003) Retailer’s 
Replenishment Policies Under 
Conditions of Permissible Delay in 
Payments 
EOQ, trade credit, 
Goyal’s model 
modification 
Optimal cycle time 
(Tian, 2014) Joint Order of Multi-
Item Inventory Model 
ABC classification, 




(Hafnika, et al., 2016) Improvement 
of Inventory Control Using 
Continuous Review Policy in A 






(Musa & Sani, 2012) Inventory 
Ordering Policies of Delayed 
Deteriorating Items Under 
Permissible Delay in payment 
Inventory control 
techniques 
Cycle period, total 
cost saving 
(Present Work) A Joint Order 
Inventory Model with Permissible 
Delay in payment in Pharmaceutical 
Supply Chain (Case Study: 











Meanwhile, here is the table showing some of the previous research done on 
Blambangan Banyuwangi Public Hospital:  
 
Table 2.5 Some Previous Research on Blambangan Banyuwangi Public Hospital on 
Various Topics 
Research Method Output 
(Nurul, 2017) Influence of 
Organization Support, Work 
Discipline, Motivation, and Training 











Research Method Output 
Blanbangan Banyuwangi (Dr. 
Soetomo University) 
(Wicaksono, 2014) Balanced Score 
Card (BSC) in Blambangan 






(Purwanto, et al., 2015) Factors 
Causing the Length of Waiting Time 
in Outpatient Pharmacy Installation 
Service of RSUD Blambangan 
(Brawijaya University) 
Fishbone diagram, 
FGD, USG (Urgency, 
Serious, and Growth), 
Mc. Namara 





(Suyanto, et al., 2015) Factors 
Inhibiting the Implementation of 
Hospital Management Information 
System at RSUD Blambangan 
Banyuwangi (Brawijaya University) 
Interview, fishbone 
diagram 
Roots of problem, 
solution alternative 
(Sigit, S., 2009) The Influence of the 
Function of Head Direction and 
Team Leader on Job Satisfaction of 
Nurses in RSUD Blambangan 








Beside the previous research and international journals, this work needs to 
summarize the corresponding approach. Thus, below is the elaboration of tools that are 
going to be used in this work in sequence based on the aforementioned literature review 
are: 
1. ABC Classification Data 
Based on the previous literature review, it is known that there are more than 
two methods in pharmaceutical inventory management. Always, Better, Control is 
chosen to be used because it represents the real condition in inventory based on the 
SKUs and by initially projecting the Pareto law (80-20%). With around 1200 
pharmaceutical products, this ABC classification can result in the very high value 
product with the small inventory items (A class category). The advantage is that the 
number and types of items relatively small but the contribution to the total inventory 
29 
 
cost is high. In this case, the supporting background of choosing ABC classification is 
that the hospital pharmacy management is currently projecting its ABC classification. 
 
2. Calculating Economic Order Interval – Joint Order Policy 
Based on the aforementioned literature, joint order policy is more suitable than 
that of the Q-method or Economic Order Quantity method. EOQ is more applicable to 
individual item inventory management. However, in this case, the A class category 
pharmaceutical products as the object of research are multiple-items. Hence, joint order 
policy is chosen. In the real world, the hospital pharmacy is very seldom to place 
individual order. They tend to always have joint order. However, it is done without the 
structured calculation of order interval/review period. The practice is done intuitively. 
Thus, this work will deliver the problem solution by first calculating the EOI to each 
proposed scenario. Scenario will be discussed in the following chapter. After the T* is 
obtained on each scenario, the maximum inventory level (Ei) is calculated to further 
calculate the order quantity of each item. Then the minimum total cost can be 
calculated.  
The initial total cost equation is used and taken by granted for the scenario 
without permissible delay in payment (Scenario 1). Later, the total cost equation will 
expand after having the permissible delay equation for the second scenario (considering 
the permissible delay in payment). Here is the formula used from the initial total cost 
equation: 
 
Total annual cost = purchase cost + order cost + holding cost 










𝑖=1    (2.3)  















      (2.5) 
 𝑇𝐶 (𝑇∗) = (1 + 𝐹𝑇∗) ∑ 𝑃𝑖𝑅𝑖
𝑛




3. Periodic Review Policy (T-method) 
Periodic review policy is chosen compared to continuous review policy because 
continuous review policy tends to cope with individual order in the inventory 
management. While in periodic review, the order interval is fixed for some products 
(joint order) and this clearly represents the practice in real world. Not only the T* and 
order quantity that are calculated, another control techniques can be used in order to 
have the solution more comprehensive and add points to compare to each other’s 
proposed scenario and to the base condition. It is by calculating the Safety Stock (SS) 
and Average Inventory Level (AIL). By knowing the safety stock, the hospital can have 
the anticipation stock for the future uncertainty, also AIL is intended to be useful to 
control how much the current inventory level towards the average inventory level. 
Below is the formula that will be used under periodic review policy (T-method): 




+ 𝑆𝑆       (2.1) 
 
This is the notation explanation:  
SS = safety stock  
CSL = cycle service level  
FS-1 = normsinv  
𝜎𝑇+𝐿= standard deviation of demand during T+L  
T   = review interval  
L   = average lead time for replenishment  
D   = average demand per period  
AIL = average inventory level  
 
4. Permissible Delay in Payment Setting 
Permissible delay in payment clearly states both opportunity and threat for the 
hospital. Opportunity is represented by the interest earned: it is, if the hospital can be 
more sensitive to capture the opportunity, the hospital can re-project the payment 
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period to obtain minimum cost. While threat is represented by the interest payable or 
interest charged to the supplier if the supplier capable of to be aware first to this 
permissible delay condition.  This tool is used to optimize hospital’s opportunity. The 
setting is the delay period is compared to the period with positive inventory. The 
scenario will be discussed in the following chapter.  
However, the condition used in this research will be the Condition 1 (based on 
the previous literature review) that is the case with (0<M≤t1). In order to consider both 
joint order policy and the permissible delay in payment for this case, the initial total 
annual cost of periodic review will be modified and added with the interest charged 
and interest earned.  
Furthermore, since this work deals with no significant demand variability, the 
n in both IC and IE formula will be set to 1 (n = 1) because it is assumed to be constant. 
While the deterioration rate will be set to 0. Here is the modified total annual cost that 
will be used for Scenario 3 (will be further explained on the following chapter): 
Total annual cost = purchase cost + order cost + holding cost + interest charged – 
interest earned 










𝑖=1 + 𝐼𝐶1 − 𝐼𝐸1  (2.11) 
 
While the EOI equation will be conducted on the following chapter in data 
processing. However, the modified total inventory cost has been determined. The 
formulation results in: 





























CHAPTER 3  
RESEARCH METHODOLOGY 
 
This chapter explains about the methodology used in this research. The 
explanations are structured based on the step of the process.  
 
3.1 Variable Identification and Conceptual Modelling 
The initial stage is conducting the variable identification and conceptual 
modelling. In this subchapter, will be explained the summary and the data requirements 
to study the system and identify the variable. 
 
3.1.1 Variable Identification 
In this part will be mentioned the variable addressed to work with the problem 
formulation. The variables used are based on the corresponding approach in literature 
review, as the tool techniques in procedure to obtain the solution. The variables will be 
such as EOI or T* as the optimum order interval, Ei as the maximum inventory level 
for joint order, Service Level, Safety Stock (SS), the interest charged, etc. The detailed 
list and explanation will be conducted in the following chapter. 
 
3.1.2 Study of the System under Discussion 
This part will explain about the scope of Blambangan Banyuwangi Public 
Hospital inventory management, which consists of five pharmacy depots: three 
outpatient depots and two inpatient depots. There are three warehouses to keep medical 
devices, infusion solution, and pharmaceutical products. The outpatient depot consists 
of polyclinic department, emergency unit department, and Obgyn and surgery 
polyclinic. While the inpatient depot consists of surgery room (OK/HD) and inpatient 
room. Detailed explanation about the order and supply flow, together with the 
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composition of role for each manager in the unit regarding to inventory management 
decision making will be explained in the following chapter. 
Conceptual model will also be built to have a more comprehensive 
understanding regarding to the problem formulation from the real system. The 
identified variable will exhibit at this point subjected to the corresponding Pharmacy 
Depot or unit. There will also be the explanation as the elaboration of the model. 
 
3.2 Data Collection 
This subchapter explained about the data required to complete this work. It is 
to collect data regarding to the ABC classification A-class category result, periodic 
review policy, Economic Order Interval. In this stage, the data required will be 
collected. 
 
3.2.1 ABC Classification and Periodic Review Policy Component  
The data required from the ABC classification is the resulted and classified A-
class category of pharmaceutical products (consumable medical supplies excluded). It 
is no need to process the ABC classification since it is confidential for the management 
to process the whole (around 1200 types) pharmaceutical products data. While for the 
periodic review policy, the data required is like the lead time constant, service level, 
demand data, etc. Further explanation will be conducted on the following chapter. 
 
3.2.2 Economic Order Interval and Joint Order Cost Component 
In this part, data that should be gathered is regarding to the order cost, purchase 
cost, and holding cost. It is like procurement taxes, administrative expenses, for the 
order cost. Sale price of the item for the purchase cost and its demand data. Holding 
cost can be obtained by either using fraction as assumption or manually calculating in 
the real practice to gather primary data. After all, the detailed explanation will be 




3.3  Data Processing 
This subchapter explained about the data processing based on the input from 
the data collection, modify the initial total annual cost and project it to the scenario 
generation. After that, the what—if analysis is conducted based on the numerical 
experiment by changing the parameter settings. 
 
3.3.1 Total Inventory Cost Modification 
In this part will be explained about the additional parameter which is interest 
charged and earned. Firstly, the initial total annual cost is taken. It only consists of three 
cost components: purchase cost, order cost, and holding cost. Second, interest charged 
and earned are referred and revisited. Both of the interest variables will be simplified 
under validation to the real practice. Third, the interest factor is added to the total 
inventory cost equation. Lastly, the T* equation is obtained by taking the modified total 
cost first derivative with respect to T. 
 
3.3.2 Scenario Generation 
The scenario generation is formulated based on the problem formulation and 
objectives, thus it needs an input from the data collection stage. It will be tested then 
to certain scenarios: with/without the review policy considering the delay in payment 
variable. It has 3 conditions. The first one is the initial condition, the real condition 
from the field. The second is only joint order. The third is joint order with the 
permissible delay in payment and thus it is broken down into two detail scenarios. 
Detailed explanation will be discussed on the following chapter. 
 
3.3.3 Numerical Experiment and What-If Analysis 
The numerical experiment is used as the sensitivity analysis by testing the total 
cost difference using parameter changes. It is then constructed into a rule sentences or 
the what-if analysis, based on the numerical experiment. The resulting interpretation 
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will be brought to discussion, conclusion, and recommendation. The more 
comprehensive detail will be conducted on the following chapter. 
 
3.4  Discussion, Conclusion, and Recommendation 
This stage consists of the analysis on the scenario chosen and the interpretation 
of the experiment result. Based on the previous numerical experiment, what-if analysis, 
and the discussion, conclusion and recommendation are made. 
 
3.4.1 Discussion 
This sub-stage compares the chosen scenario to another scenarios, analyze its 
performance gap, and the interpretation on real activity for the supply chain.  
 
3.4.2 Conclusion and Recommendation 
This sub-stage consists the conclusion for the research based on the problem 
formulation and revisit the research objectives, while the recommendation is made for 
the future research. 
After all, based on the whole brief description above, the research methodology is 





Variable identification used to visualize the system concept.
Collecting ABC Classification, Demand, and Review Period 
Data
Data collection regarding to the demand per product period in 
2017, the class category for ABC classification including its 
percentage and value contribution, and the actual review period
Studying the System Under Discussion
Graphical illustration of System Under Discussion: 
Pharmaceutical Warehouse by the demand of Outpatient Depot 
and Inpatient Depot.
Collecting Periodic Review Policy and Permissible Delay in 
Payment Settling Data
Data collection of the review policy component (lead time, 
joint order cost, current review period), and he permissible 
delay in settling the accounts (interests and delay component).
Variable Identification and 
Conceptual Modelling
Data Collection
Modifying Total Inventory Cost
1. To revisit initial total inventory cost
2. Referring to interest charged and earned equation
3. Adding the interest charged and earned to modify total 
inventory cost equation
4. Taking first derivative of modified total inventory cost to 





Scenario generation is done to explain the condition and the 
formula used for each calculation: 
- Scenario 1 (initial condition): inventory model without 
considering both EOI and delay in payment
- Scenario 2: inventory model considering EOI, without delay 
in payment




Assessing Numerical Experiment and Analysis
Experiment on each scenario based on specified variables and 
parameters. Sensitivity analysis is done one-way and two-way.
Generating Discussion and Interpretation
Interpretation is made about: the best scenario seen from 
financial aspect, when to apply each of the scenarios and its 
performance gap, behavior/reaction of the output based on the 
parameter setting on sensitivity analysis, and so forth.
Making Conclusion and Recommendation
Conclusion is made based on problem formulation and research 
objectives, while recommendation is made for the upcoming 
research.
Discussion, Conclusion and 
Recommendation
 




CHAPTER 4  
MODEL BUILDING 
 
In this chapter will be explained about the system under discussion including 
the variable identification, conceptual modelling, data collection, and data processing. 
 
4.1 Conceptual Modelling 
In formulating conceptual model, identified variable in the system will be the 
components that build the order interval model. Below is the figure of order flow in 






















This figure explains about the order flow of consumable medical supplies in 
Blambangan Banyuwangi Public Hospital inventory management. It consists of five 
pharmacy depots: three outpatient depots and two inpatient depots. There are three 
warehouses to keep medical devices, infusion solution, and pharmaceutical products. 
The outpatient depot consists of polyclinic department, emergency unit department, 
and obgyn and surgery polyclinic. While the inpatient depot consists of surgery room 
(OK/HD) and inpatient room. In parallel, three outpatient depots and two inpatient 
depots order the medical supplies and pharmaceutical products to pharmaceutical 
warehouse, as one of the three warehouses in the hospital. This amount of demand 
becomes the total demand ordered to the distributor, by the pharmaceutical warehouse. 
Based on the total demand from five depots, here is the conceptual model of the 





































Figure 4.2 Conceptual Model: Fixed Order Interval System of Pharmaceutical 
Warehouse Demand 
 
In the figure above, it is known that the T (order interval) remains the same on 
each cycle, said as constant. Meanwhile, the quantity on order each cycle whenever an 
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order is placed is variable. Initially, inventory level drops until certain time reaches the 
review period. At this review period, the warehouse placed an order, with the quantity 
to order that is variable. After the lead time, order is received and is ready to deplete 
until it reaches the next review period. 
In order to work with the fixed order interval system of pharmaceutical 
warehouse demand above, variables need to be mentioned. The variables used are 
based on the corresponding approach in literature review, as the tool techniques in 
procedure to obtain the solution. Here is the list of variables will be used: 
Pi = purchasing cost of item i 
T = the length of the order cycle (order interval) 
Ie = interest earned per IDR per year, where Ie < Ic 
Ic = interest charged in stock by the supplier 
M = delay period 
t1 = the length of positive-stock period (represent actual payment time) 
C = order cost for the joint order 
n = total number of joint order items 
c = order cost associated with each individual item 
F = annual holding cost as a fraction of purchase cost 
Ri = annual requirement for item i 
 
Conceptual model above is built to have a more comprehensive understanding 
regarding to the problem formulation from the real system. It gives connection to ease 
the work to identify relevant factors, and it is usually visualized to give comprehensive 
approach to that fixed order interval system in Blambangan Banyuwangi Public 
Hospital pharmaceutical warehouse. This model will be used as guidance for the 




4.2 Data Collection 
This subchapter explained about the data required to complete this work. It is 
to collect data regarding to the ABC classification result, demand data, review data 
such as lead time constant, service level, etc. In this stage, the data required will be 
collected and presented in following. 
 
4.2.1 ABC Classification 
The ABC classification is generally processed by dividing items into three 
different classes regarding to its value contribution. Based on the theory, it is known 
that small percentage of number of items will likely contribute the highest in percentage 
of value. In this case, the value is the annual expense of pharmaceutical products and 
is compared to the number of items. 
After the demand data of each medical supplies and pharmaceutical products 
are collected and reviewed monthly in a year, the total actual expense is obtained. The 
total purchasing cost of pharmaceutical products, 58% to the total annual 
pharmaceutical expenditure including medical supplies, is IDR 14.278.806.493 in 
2017. It consists of 1397 items out of 1521 items in total. While the remaining medical 
supplies data is then excluded. As the remaining data, pharmaceutical products demand 
will be processed. The classification result is used to make clear of which products are 
classified into A-category to be taken further as the object of observation. Based on the 
2017 data, starting from January 1st to December 31st, here is the resulted ABC Classes: 
 
Table 4.1 ABC Classification Result 
Class Value Contribution 
Percentage 
Value (IDR) Number 
of Items 
Number of Item 
Percentage 
A 75.02% 10,711,464,693 161 11.52% 
B 20.65% 2,948,976,369 445 31.85% 
C 4.33% 618,365,431 791 56.63% 




Table 4.1 clearly shows the result according to the ABC classification principle. 
Large percentage of number of items usually contributes the smallest towards 
percentage of value, vice versa. In this case, the C-class items contributes 4.33% in 
value with a high percentage: 56.63% number of items. While the B-class items 
contributes 20.65% in value with only 31.85% number of items. Lastly, the A-class 
items contributes the highest in value which is 75.02% with only 11.52% items.  
The ABC classification result shown on Table 4.1 above is assessed based on 
its financial aspect, which is the value contribution to the total expense. However, it 
does not put aside the criticality factor. The Head of the Pharmacy Depot said that 
pharmaceutical product is said to be critical based on its usage frequency. The more 
frequent the product demanded, the higher the criticality. Furthermore, frequency of 
usage is linear towards the total expense. Thus, if it is seen from the A-class product, it 
is not only a set of products with high product price, but also high frequency of usage 
(in example: compare Koate 970 IU-1060 IU (BLB) to Clopidogel). On that way 
criticality factor is included, without decreasing the sense of classifying products to 
ABC classes. Because at last, in integration, the sum of all A-class products’ value 
contribution is 75.02% composed of only 11.52% number of items. 
In addition, the hospital pharmacy annually ranks their ten highest contributors 
to the total pharmaceutical products’ values. Based on 2017 data, the total expense of 
the ten highest contributors is still higher than that of B and C class total expenses. As 
the highest value contributor in terms of cost including criticality factor, these products 
becomes the object of observation. Here is the ten biggest pharmaceutical products 








Unit Price Total Expenditure 
Koate 970 IU-1060 IU (BLB) 252 3,600,000 907,154,046 
Micardis 80 mg Tablet 88,583 5,409 531,485,081 
Clopidogel 222,681 1,650 397,687,100 
Anbacin Inj 10,319 36,960 381,447,780 
Ceftriaxon 33,806 8,003 353,465,657 
Inviclot 7,586.6 43,995 329,129,362 
Nimotop Tab 67,229 3,520 233,096,223 
Micardis 40mg 59,704 3,045 209,581,050 
Ferriprox Tab 6,062 33,000 200,045,800 
Asering Infus 21,374 9,275 198,247,528 
 
4.2.2 Demand Data and Review Period 
Detailed demand data of each products going to be observed is also critical to 
note. Currently, it is reviewed monthly or if conversed to days, it is due to the amount 
of days in a month. This data will be used to determine the Average Inventory Level 
(AIL) and the Safety Stock (SS) next in the following data processing. Based on the 
appointed pharmaceutical products observed, here is the annual demand data of Koate 
970 IU-1060 IU (BLB) reviewed monthly: 
 




Monthly Purchase Cost 
(IDR) 
31/01/2017 21 75,593,479.5 
28/02/2017 29 104,390,995.5 
31/03/2017 13 46,795,963.5 
30/04/2017 21 75,593,479.5 
31/05/2017 19 68,395,653 
30/06/2017 17 61,199,379 
31/07/2017 28 100,794,411 
31/08/2017 17 61,200,000 
30/09/2017 19 68,400,000 
31/10/2017 26 93,599,379 






Monthly Purchase Cost 
(IDR) 
31/12/2017 23 82,796,895 
Total 252 907,154,046 
 
Koate 970 IU-1060 IU (BLB) is known to have the biggest contribution to total 
expenditure to the hospital which is IDR 907,154,046 with only 252 units of annual 
demand. This product is composed of antihemopilic factor VIII for those with 
hemophilia type A given through intra-veins and must be safely stored in room 
temperature. Compared to another ten biggest contributor of pharmaceutical products 
class A in which the annual demands are in thousands, this product has the least annual 
demand which is below a thousand unit. It is followed by the second ranked contributor 
which demand data is shown in the table below, Micardis 80 mg Tablet: 
 
Table 4.4 Micardis 80mg Tablet Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 6,227 40,475,500 
28/02/2017 5,760 37,440,000 
31/03/2017 6,949 45,168,500 
30/04/2017 6,989 45,428,500 
31/05/2017 7,431 48,301,500 
30/06/2017 7,084 46,046,000 
31/07/2017 8,683 55,185,941 
31/08/2017 8,463 45,776,367 
30/09/2017 7,926 42,871,734 
31/10/2017 8,217 44,445,753 
30/11/2017 7,896 42,709,464 
31/12/2017 6,958 37,635,822 
Total 88,583 531,485,081 
 
 Micardis 80 mg Tablet is significantly higher in amount of annual demand 
(88,583 units) compared to the first ranked pharmaceutical products (Koate IU-1060 
IU (BLB) which is 252 units). This product is saved in room temperature, used to treat 
high blood pressure patient (patient with hypertension). Since it is quite frequent to be 
46 
 
issued and depleted, it has another type of dosage included into ten biggest product, 
which is Micardis 40 mg Tablet. Meanwhile, the third ranked pharmaceutical products 
is Clopidogel as it is shown below: 
 
Table 4.5 Clopidogel Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 17,532 35,064,000 
28/02/2017 16,234 32,468,000 
31/03/2017 17,642 35,284,000 
30/04/2017 17,225 34,450,000 
31/05/2017 18,565 36,874,150 
30/06/2017 15,368 25,357,200 
31/07/2017 18,963 31,288,950 
31/08/2017 18,815 31,044,750 
30/09/2017 18,908 31,198,200 
31/10/2017 20,239 33,394,350 
30/11/2017 21,296 35,138,400 
31/12/2017 21,894 36,125,100 
Total 222,681 397,687,100 
 
Clopidogel, a tablet used to prevent heart attacks, strokes, or peripheral vascular 
diseases, has the highest annual demand compared to another ten biggest 
pharmaceutical products. It reaches hundred-thousand while other products stayed on 
thousands units per annum. However, the value contribution is still below Koate IU-
1060 IU (BLB) with only 252 units in demand per annum. Clopidogel is not 
significantly different in value contribution to the following product, Anbacin Inj. The 
following pharmaceutical product is shown below with the demand data in 2017: 
 
Table 4.6 Anbacin Inj Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 844 31,229,722 
28/02/2017 935 34,583,933 
31/03/2017 1,202 44,425,319 
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Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
30/04/2017 942 34,815,849 
31/05/2017 958 35,407,201 
30/06/2017 717 26,499,960 
31/07/2017 783 28,939,287 
31/08/2017 807 29,826,316 
30/09/2017 886 32,746,117 
31/10/2017 786 29,050,167 
30/11/2017 625 23,099,688 
31/12/2017 834 30,824,222 
Total 10,319 381,447,780 
 
 Anbacin Inj is a pharmaceutical product used to cure patient with bacteria 
infection as an antibiotic. It is quite fast in depletion knowing that the demand reaches 
more than ten thousands units per annum. Meanwhile, the value contribution is not 
much different with the following product which is Ceftriaxon. The demand data is 
shown in the table below: 
 
Table 4.7 Ceftriaxon Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 3,104 61,239,654 
28/02/2017 3,112 36,725,714 
31/03/2017 3,057 30,577,031 
30/04/2017 3,084 30,848,268 
31/05/2017 2,686 27,332,571 
30/06/2017 2,356 25,916,000 
31/07/2017 2,659 27,630,987 
31/08/2017 2,693 24,726,873 
30/09/2017 2,557 20,464,080 
31/10/2017 3,069 24,561,698 
30/11/2017 2,465 19,727,789 
31/12/2017 2,964 23,714,991 




Ceftriaxon is a pharmaceutical product which needs special handling in the 
inventory. It is an antibacterial product to cure patient with infections on the respiratory 
tract, urinary tract, skin structure, bone, and joint, etc. It must be sterilized in 
refrigerator and protected from light. However, it is quite frequent to be used and 
depleted. This product is followed by the sixth ranked, Inviclot, as it is shown in the 
table below: 
 
Table 4.8 Inviclot Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 614,6 26,362,284 
28/02/2017 579.8 24,869,593 
31/03/2017 623.2 26,731,167 
30/04/2017 617 26,465,228 
31/05/2017 638 27,365,989 
30/06/2017 598.2 25,658,832 
31/07/2017 665.4 28,674,921 
31/08/2017 677.7 29,815,412 
30/09/2017 643.9 28,328,381 
31/10/2017 669.4 29,450,253 
30/11/2017 640.2 28,165,599 
31/12/2017 619.2 27,241,704 
Total 7586.6 329,129,362 
 
 Inviclot is an anticoagulant for venous thrombosis and embolism treatment. It 
has quite smaller amount of annual demand compared to the previous mentioned ten 
biggest products. It is below ten thousands, but with three hundred million IDR in value 
contribution per annum, not much different with the previous product. However, it is 
significant from the following product, Nimotop Tab, which reaches two hundred 




Table 4.9 Nimotop Tab Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 5,576 18,817,980 
28/02/2017 5,392 18,197,016 
31/03/2017 6,257 21,116,236 
30/04/2017 5,773 19,483,011 
31/05/2017 6,417 21,657,375 
30/06/2017 6,003 20,759,505 
31/07/2017 5,470 19,254,400 
31/08/2017 6,534 22,999,680 
30/09/2017 6,411 22,566,720 
31/10/2017 6,265 22,052,800 
30/11/2017 6,786 23,886,720 
31/12/2017 345 2,304,780 
Total 67,229 233,096,223 
 
 Nimotop Tab, product to cure patient with bleeding, has more significant 
amount in annual demand compared to Inviclot. It reaches almost seventy thousand 
units per annum. However, the value contribution is below Inviclot (with only below 
ten thousand units in annual demand). It is followed by the second type of Micardis as 
it is shown below: 
 
Table 4.10 Micardis 40mg Tablet Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 4,236 16,520,400 
28/02/2017 3,971 15,486,900 
31/03/2017 4,459 17,390,100 
30/04/2017 4,641 18,099,900 
31/05/2017 5,228 20,389,200 
30/06/2017 3,882 15,139,800 
31/07/2017 5,471 21,336,900 
31/08/2017 5,276 16,583,550 
30/09/2017 5,832 17,758,440 
31/10/2017 5,415 16,488,675 
30/11/2017 5,539 16,866,255 
31/12/2017 5,754 17,520,930 
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Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
Total 59,704 209,581,050 
 
 Micardis 40 mg Tablet is the other dosage type of the second ranked 
pharmaceutical products. It has the same characteristics with the 80 mg dosage of 
tablet, which is typically high in value contribution by being large in amount (units 
demanded per annum). Micardis is followed by Ferriprox Tab, as shown in the table 
below: 
 
Table 4.11 Ferriprox Tab Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 540 17,819,982 
28/02/2017 210 6,929,993.1 
31/03/2017 406 13,397,987 
30/04/2017 495 16,334,984 
31/05/2017 511 16,862,983 
30/06/2017 403 13,298,987 
31/07/2017 435 14354,986 
31/08/2017 765 25,244,975 
30/09/2017 482 15,905,984 
31/10/2017 420 13,859,986 
30/11/2017 765 25,244,975 
31/12/2017 630 20,789,979 
Total 6,062 200,045,800 
 
 Ferriprox Tab, tablet for thalassemia major patient with overload iron, is the 
second least in annual demand compared to another ten biggest pharmaceutical 
products, after Koate IU-1060 IU (BLB). It is only 6,062 units demanded in 2017. 
However, the unit purchase cost is 120 times lower than the first ranked products. Thus, 
the annual value is also the second least, but it is toward Asering Infus, as the lowest in 




Table 4.12 Asering Infus Monthly Demand Data in 2017 
Review Date Monthly Demand 
Monthly Purchase 
Cost (in IDR) 
31/01/2017 2,257 20,934,126 
28/02/2017 1,940 17,993,888 
31/03/2017 1,991 18,466,923 
30/04/2017 1,843 17,094,194 
31/05/2017 1,721 15,962,351 
30/06/2017 1,159 10,749,829 
31/07/2017 1,464 13,578,892 
31/08/2017 1,664 15,433,932 
30/09/2017 1,516 14,061,052 
31/10/2017 2,078 19,273,817 
30/11/2017 1,924 17,845,485 
31/12/2017 1,817 16,853,038 
Total 21,374 198,247,528 
 
 Asering Infus is the tenth product, with 21,374 annual demand yielding to IDR 
198,247,528 in total. It is to cure patient with dehydration through the solution and to 
treat the loosing blood patient. The annual demand is quite high, however, the unit 
purchase cost is not enough supporting the value contribution. 
 
4.2.3  Periodic Review Policy and Permissible Delay Component 
After the pharmaceutical products for further observation is sorted and 
determined, secondary data regarding to make complete of periodic review policy and 
permissible delay component is obtained. In periodic review policy, in this case to 
calculate the Economic Order Interval (EOI) of multiple items, the components are: 
annual requirement of each item, purchase cost of each item, order cost for joint order, 
order cost associated with each individual item, order interval in year, lead time 
constant, service level, and annual holding cost. While the permissible delay 
components are the delay period, actual payment period, interest charged, and interest 
earned. Those are the data required to make complete of this review policy. 
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This secondary data is obtained based on 2017 historical data and the 
assumption is only put on the holding cost. Here is the data gathered and the 
explanation will be after the following: 
 
Table 4.13 Secondary Data Recap of Periodic Review Policy and Delay Component 
Component Value Unit 
Periodic Review Policy Component 
Lead time constant 1 day 
Current review period 28/30/31 days (monthly) 
Service level (SL) 95 % 
Order cost 1 % 
Joint-order cost  950,000,000 IDR 
Holding cost 25 % 
Permissible Delay Component 
Interest earned around 5 % 
Interest charged around 6 % 
Delay period 60 days 
Actual payment period 76 days 
  
The lead time is known daily and constant. Once an order is placed on Tuesday 
morning, Wednesday morning the order has arrived. While the service level is said to 
be 95% in evaluation from 2016 known from the stock out sales probability. The order 
cost is 1% per unit in estimation by the Head of the Pharmacy Depot knowing the needs 
to pay on taxes: procurement taxes paid to the distributor. Holding cost is said to be 
25% stated from previous chapter as the research scope. Meanwhile, the joint-order 
cost is obtained from the administrative expenses such as document printing, and 
copying. However, it is mainly for the material handling cost accounted to worker in 
charge. It is for put-away process, from unboxing the order received up to the products 
is put on the shelf. It needs handling, specially, for Ceftriaxon and Koate that have 
special space in refrigerator. 
In permissible delay component, the delay period that has happened started 
from December 31st 2017 up to February 28th 2018. However, March 15th 2018 is the 
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actual payment. Due to this situation, the interest charged by the distributor as the cause 
of the lateness in payment is 6%. While the interest earned, obtained from the interest 
bearing account, is 5%. 
 
4.3 Data Processing 
In data processing will be explained about the total inventory cost modification, 
scenario generation, and numerical experiment. The total inventory cost modification 
is used as one of the input for scenario generation. While scenario generation is used 
as the input to process the numerical experiment as the sensitivity analysis. 
 
4.4.1 Total Inventory Cost Modification  
As it is explained in previous chapters, for the model building, total inventory 
cost in this permissible delay case needs to be modified. The result of this subchapter 
will be used in the following subchapter which is the scenario generation, specifically, 
for scenario considering both the Economic Order Interval (EOI) and delay in payment.  
The initial total inventory consists only purchase cost, order cost (plus joint 
order cost), and holding cost. This initial total inventory cost will be used for scenario 
in which delay in payment is not permissible, while the EOI is calculated. However, in 
the case where delay in payment is permissible, there will be two additional variables 
called interest charged and interest earned depending on delay period and actual 
payment time. In this part, initial total inventory cost formula needs to be modified. To 
clearly show the steps of the modification process, firstly, here is the initial total 
inventory cost formula: 
Total annual cost = purchase cost + order cost + holding cost 
 𝑇𝐶 (𝑇) =  ∑ 𝑃𝑖𝑅𝑖
𝑛












As it is known that the period considered is 0 < M ≤ t1, the interest earned as the 
amount the pharmaceutical warehouse can sale during (0,M) which interest rate is 𝐼𝑒 
in an interest bearing account is obtained by Formula 2.13 below.  





𝑀2       (2.13) 
 
While the interest charged, during (M,t1) is: 









2 − 𝑀)⌋   (2.14) 
 
Based on the interest charged and earned, it is known that the interest earned 
will decrease total inventory cost at some amount. While interest charged is the reverse. 
Hence, the modified total inventory cost is obtained by adding the initial total inventory 
cost by the interest charged and subtracting it with the interest earned. Hence, the 
modified total inventory cost is: 
























𝑀2      (2.15) 
 
Finally, taken its first derivative towards order interval (T) to obtain the economic order 
interval formula, here is the result: 




















Hence, by replacing T with T* in the modified total inventory cost, the obtained 
minimum total cost is:  
























𝑀2     (2.17) 
 
4.4.2 Scenario Generation 
After the total inventory cost modification is done, the scenario generation takes 
place. It consists of three scenarios, the objective is to find out the total annual cost and 
the behavior of the order interval, followed by the result of the sensitivity analysis in 
numerical experiment as the following subchapter. Besides finding out the total annual 
cost and another variables behavior, there are additional factors to consider as the input 
for the analysis (safety stock and average inventory level). Value of these two variables 
will also vary regarding to the order interval. These scenarios will be compared in terms 
of costs, practicality, and economic. The following subchapter will explain one by one 
the scenario plus the additional factors to analyze. 
 
4.4.2.1 Scenario 1 (Initial Condition) – Without EOI and Delay in Payment 
Scenario 1 describes the real condition where the current inventory management 
takes place. EOI is not considered here. Hence, no calculation on economic order 
interval, rather, using the current review period. No holding cost considered and 
calculated. Delay in payment is also considered as permissible but ignored. Therefore, 
here is the formula used to process scenario 1: 
Total annual cost = purchase cost + order cost 









4.4.2.2 Scenario 2 – With EOI, Without Delay in Payment 
Scenario 2 describes the proposed scenario using periodic review policy 
calculating Economic Order Interval (EOI) on multiple items without considering 
delay in payment. Here is the formula used to process scenario 2: 
1. Calculating the EOI (T*) 





       (2.4) 
2. Calculating the minimum total cost per year 
Insert T* to this formula: 
Total annual cost = purchase cost + order cost + holding cost 










𝑖=1    (2.3) 
 
so that the minimum total cost per year is: 
 𝑇𝐶 (𝑇∗) = (1 + 𝐹𝑇∗) ∑ 𝑃𝑖𝑅𝑖
𝑛
𝑖=1      (2.6) 
 
4.4.2.3 Scenario 3 – With both EOI and Delay in Payment 
Scenario 3 describes the condition where all possible variables are considered. 
It is the condition with both EOI and delay in payment. The total inventory cost used 
is the modified formula, the same with the EOI formula and the minimum total 
inventory cost formula. Here are the formula used for scenario 3: 
1. Calculating the EOI 
Basically, the order cost is attached as the numerator with the interest 
component. Meanwhile, the de-numerator is the holding cost. Here is the obtained 
formula used to calculate the EOI in Scenario 3: 
















   (2.16) 
2. Calculating the minimum total annual cost 
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By replacing T with T* in the modified total inventory cost, the obtained 
minimum total cost is:  
























𝑀2      (2.17) 
 
4.4.2.4 Safety Stock and Average Inventory Level 
As it is already explained previously in this subchapter headings (Subchapter 
4.4.2), safety stock is calculated to anticipate future uncertainty, also AIL is intended 
to be beneficial to control how much is the current inventory level towards the average 
inventory level. It needs information around demand data (the average and standard 
deviation), service level, and order interval/review period. So here is the formula of 
safety stock and average inventory level that will be used: 




+ 𝑆𝑆       (2.1) 
 
This is the notation explanation:  
SS = safety stock  
CSL = cycle service level  
FS-1 = normsinv  
𝜎𝑇+𝐿= standard deviation of demand during T+L  
T   = review interval  
L   = average lead time for replenishment  
D   = average demand per period  




4.4.3 Numerical Experiment 
Numerical experiment explains the result of the calculation and sensitivity 
analysis on each scenario. Here is the result of the numerical experiment. 
4.4.3.1 Scenario 1 (Initial Condition) – Without EOI and Delay in Payment 
Stated in scenario generation, total cost of Scenario 1 is composed of purchase 
and joint order cost with the current or actual review period. Thus, without calculating 
the economic review period, the initial condition evaluation is done directly by the sum 
of the total annual purchase cost and total annual order cost. Here is the result of the 
calculation shown step by step regarding to the component: 
1. Total Purchase Cost 
It is obtained that the total purchase cost is IDR 3,741,339,700. Here is the table 
showing the count up calculation of purchase cost: 
Table 4.14 Total Annual Purchase Cost per Product Based on 2017 Data 
Item Ri Pi PiRi Total Cost 
Koate IU-1060 IIU 
(BLB) 
252 3,600,000 907,154,046 907,154,053.3 
Micardis 80 mg Tablet 88583 5,409 531,485,081 531,485,088.3 
Clopidogel 222681 1,650 397,687,100 397,687,107.3 
Anbacin Inj 10319 36,960 381,447,780 381,447,787.3 
Ceftriaxon 33806 8,003 353465,657 353,465,664.3 
Inviclot 7586.6 43,995 329,129,362 329,129,369.3 
Nimotop Tab 67229 3,520 233,096,223 233,096,230.3 
Micardis 40mg Tablet 59704 3,045 209,581,050 209,581,057.3 
Ferriprox Tab 6062 33,000 200,045,800 200,045,807.3 
Asering Infus 21374 9,275 198,247,528 198,247,535.3 
Total 3,741,339,700 
 
2. Total Order Cost 
The order cost, the overhead cost related to the purchasing process, is attached 
to both the lot (joint-order) and the unit ordered. Based on the secondary data obtained, 
here is the summary of order cost component: 
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 Joint-order cost per period, the cost component is: 
1. Labor or material handling cost 
The worker obliged to handle the order receipt, shipping, and transporting up 
to the storage is only one person. However, the job is not only on pharmaceutical 
warehouse, but also on the other 2 warehouses (solution and medical devices 
warehouse). Based on the secondary data, it is known that the workload is 25%-25%-
50% towards pharmaceutical-solution-medical devices warehouse. Medical devices 
warehouse takes the greatest workload since the shipping takes more time and energy, 
the procedure is more complicated since the partner to work with and the destination is 
various. Differ from the other two warehouses, the flow is only warehouse-depot, vice 
versa. 
 The cost associated to this component is calculated to the proportion of the 
worker’s wages. It is IDR 3,000,000 per month. Thus, the material handling cost is 
25% of the wages, equals to IDR 750,000 per month (the same period with the 
review/order interval).  
 
2. Administrative expenses 
This component is composed of document printing, photocopy, administrative 
files transferred, meeting files, telephone bill to order monthly, etc. It is monthly 
estimated to be IDR 500,000. 
Thus, the joint-order cost per period is the sum of administrative expense and 
material handling cost which is IDR 1,250,000 in total per order. 
 
 Order cost per unit 
Order cost per unit is attached to each unit purchase cost and the order quantity. 





Based on two components of order costs mentioned previously, here is the 
summary of order cost calculation based on 2017 data: 
 
Table 4.15 Total Annual Joint Order Cost 
Order Date Total Purchase Cost per Order Order Cost 
31/01/2017 IDR 344,057,127  IDR 4,690,571  
28/02/2017 IDR 329,086,033  IDR 4,540,860  
31/03/2017 IDR 299,353,227  IDR 4,243,532  
30/04/2017 IDR 318,613,412  IDR 4,436,134  
31/05/2017 IDR 318,548,973  IDR 4,435,490  
30/06/2017 IDR 270,625,491  IDR 3,956,255  
31/07/2017 IDR 341,039,675  IDR 4,660,397  
31/08/2017 IDR 302,651,854  IDR 4,276,519  
30/09/2017 IDR 294,300,708  IDR 4,193,007  
31/10/2017 IDR 326,176,878  IDR 4,511,769  
30/11/2017 IDR 301,078,785  IDR 4,260,788  
31/12/2017 IDR 295,807,462  IDR 4,208,075  
Total IDR 3,741,339,627  IDR 52,413,396  
 
By having the complete information regarding to annual purchase and order 
cost, the result of Scenario 1 is obtained: 
1. The order interval (T) is 0.082 in years, or 30 days. 
2. The total annual cost is: 
Total annual cost = Total purchase cost + total order cost 
Total annual cost = 3,741,339,700 + (52,413,396/0.082) 
Total annual cost = IDR 4,379,035,948 
 
4.4.3.2 Scenario 2 – With EOI, Without Delay in Payment 
Based on the scenario generation, total cost of Scenario 2 is composed of 
purchase, joint-order, and holding cost with the Economic Order Interval (EOI). Thus, 
by calculating the EOI, the minimum total inventory cost (TC(T*)) will be obtained. 
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However, the total purchase and order cost remains the same. Here is the result of the 
calculation shown step by step regarding to the component: 
 
1. Economic Order Interval (T*) 
Knowing that the annual fraction of holding cost is 25%, total order cost is IDR 
52,413,396, and total purchase cost is IDR 3,741,339,700, here is the result of the 
calculation:  





       (2.4) 
 𝑇∗ = √
2(52,413,396)
0,25 𝑥 3,741,339,700  
 
T* = 0.3348 year (4 months or 122 days) 
 
2. Minimum Total Inventory Cost, TC (T*) 
Based on the obtained T*, here is the result of minimum total inventory cost 
calculation: 
 𝑇𝐶 (𝑇∗) = (1 + 𝐹𝑇∗) ∑ 𝑃𝑖𝑅𝑖
𝑛
𝑖=1      (2.6) 
𝑇𝐶 (𝑇∗) = (1 + 0,25 𝑥 0,3348)𝑥 3,741,339,700 
TC (T*) = 4,054,466,052 
 
Based on two steps of calculation above, Scenario 2 obtained: 
1. The Economic Order Interval is 0.3448 year, or 4 months, or 122 days. 
2. The minimum total inventory cost is IDR 4,054,466,052 
 
4.4.3.3 Scenario 3 – With both EOI and Delay in Payment 
Scenario 3 has some additional components differ from the previous scenario. 
In this model, besides considering EOI, as it is stated in scenario generation, the delay 
in payment is permissible. Thus, there are two interest components: interest charged 
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and interest earned. Based on the secondary data obtained, the interest charged is 6% 
while the interest earned is 5%. 
 The total inventory cost component is the same as Scenario 2, which is 
purchase, joint-order, and holding cost with the Economic Order Interval (EOI) and the 
permissible delay in payment. Here is the result of the calculation shown step by step 
regarding to the component: 
1. Economic Order Interval (T*)  
Initially on previous data processing, Subchapter 4.4.1, the Economic Order 
Interval equation has been modified in order to fit the delay in payment parameter 
setting. It is resulted from the first derivation of total inventory cost equation. Thus, the 
calculation can be obtained. Knowing that the annual fraction of holding cost is 25%, 
total order cost is IDR 52,413,396, total purchase cost is IDR 3,741,339,700, actual 
payment time is 76 days (0,2082 year), and the delay period is 60 days (0,1644 year), 
here is the result of the calculation:  
















   (2.16) 
T* = 0,3356 year (4 months or 122 days) 
 
2. Minimum Total Inventory Cost, TC (T*) 
Based on the obtained T*, here is the result of minimum total inventory cost 
calculation: 
 𝑇𝐶 (𝑇∗) =  ∑ 𝑃𝑖𝑅𝐼
𝑛






















𝑀2      (2.17) 
TC (T*) = 4,093,518,931 
 
Based on two steps of calculation above, Scenario 2 obtained: 
1. The Economic Order Interval is 0.3448 year, or 4 months, or 122 days. 
2. The minimum total inventory cost is IDR 4,093,518,931 
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4.4.3.4 Safety Stock and Average Inventory Level 
Based on the scenario generation, the additional evaluation needed to do the 
performance analysis is the calculation of Safety Stock (SS) and Average Inventory 
Level (AIL). The amount of SS per unit will be the same for all scenario. However, the 
AIL depends on the review period (T*). Here is the result of the calculation on SS and 
AIL: 
1. Safety Stock 
By using this following formula, SS is obtained. Knowing that the Service 
Level is 95% based on the secondary data, the formula is followed by the summary 
table of all ten pharmaceutical products SS calculation: 
𝑆𝑆 = 𝐹𝑆−1(𝐶𝑆𝐿) 𝑥 𝜎𝑇+𝐿       (2.10) 
 
Table 4.16 Safety Stock (SS) Calculation Recapitulation 
Item Demand Standard Deviation SS 
Koate IU-1060 IU (BLB) 5 8 
Micardis 80 mg Tablet 889 1,462 
Clopidogel 1,932 3,177 
Anbacin Inj 145 238 
Ceftriaxon 277 456 
Inviclot 29 48 
Nimotop Tab 1,715 2,821 
Micardis 40mg 699 1,150 
Ferriprox Tab 157 259 
Asering Infus 299 492 
 
2. Average Inventory Level of Scenario 1 
AIL is composed of SS, demand, and order interval. Known that the order 





+ 𝑆𝑆       (2.1) 
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Table 4.17 Average Inventory Level of Scenario 1 
Item Annual Demand SS AIL 
Koate IU-1060 IU (BLB) 252 8 18 
Micardis 80 mg Tablet 88,583 1462 5,103 
Clopidogel 222,681 3177 13,239 
Anbacin Inj 10,319 238 662 
Ceftriaxon 33,806 456 1,845 
Inviclot 7,586.6 48 360 
Nimotop Tab 67,229 2821 5,583 
Micardis 40mg 59,704 1150 3,603 
Ferriprox Tab 6,062 259 508 
Asering Infus 21,374 492 1,371 
 
3. Average Inventory Level of Scenario 2 
AIL of Scenario 2 will yield different value to those in Scenario 1, it is 
influenced by the order interval. Known that the EOI (T*) of Scenario 2 is 0.3348 year, 
here is the obtained AIL of Scenario 2: 
 
Table 4.18 Average Inventory Level of Scenario 2 
Item Annual Demand SS AIL 
Koate IU-1060 IU (BLB) 252 8 50 
Micardis 80 mg Tablet 88,583 1,462 16,290 
Clopidogel 222,681 3,177 40,451 
Anbacin Inj 10,319 238 1,965 
Ceftriaxon 33,806 456 6,115 
Inviclot 7,586.6 48 1,318 
Nimotop Tab 67,229 2,821 14,074 
Micardis 40mg 59,704 1,150 11,144 
Ferriprox Tab 6,062 259 1,273 






4. Average Inventory Level of Scenario 3 
The same towards what is stated in Scenario 2, AIL of Scenario 3 will yield 
different value by the influence of the order interval. Known that the EOI (T*) of 
Scenario 2 is 0.3356 year, here is the obtained AIL of Scenario 3: 
 
Table 4.19 Average Inventory Level of Scenario 3 
Item Annual Demand SS AIL 
Koate IU-1060 IU (BLB) 252 8 50 
Micardis 80 mg Tablet 88,583 1,462 16,327 
Clopidogel 222,681 3,177 40,543 
Anbacin Inj 10,319 238 1,970 
Ceftriaxon 33,806 456 6,128 
Inviclot 7,586.6 48 1,321 
Nimotop Tab 67,229 2,821 14,101 
Micardis 40mg 59,704 1,150 11,169 
Ferriprox Tab 6,062 259 1,276 
Asering Infus 21,374 492 4,079 
 
 
4.4.3.5 Sensitivity Analysis 
After conducting the complete data processing, sensitivity analysis is done to 
enhance the assessment and be able to obtain accurate evaluation of comparison on 
scenario. The sensitivity analysis is done on Scenario 3 setting. It is done on two 
parameter settings (delay period and interest charged) and two conditions (one-way 
and two-way analysis). The output is to know how the order interval moves together 
with the reaction of total inventory cost. Here is the result of the sensitivity analysis: 
4.4.3.5.1 One-Way Sensitivity Analysis 
One-way sensitivity analysis is assessed to test the behavior of a single 
parameter setting. Here will be explained the result (sensitivity analysis is done only 
on Scenario 3): 
a. Sensitivity Analysis on Delay Period 
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The delay period is 0.1644 year (60 days) in actual. In this calculation, 
the delay period will be changed in ±5, 10, 15, 20, 25, 50, 75, 80, and 100 in 
percentage of M value. The table below shows the summary of the result: 
 
Table 4.20 One-Way Sensitivity Analysis on Total Inventory Cost and EOI with Delay 
Period as the Parameter Setting 
% change Parameter Setting (M) T* Reaction TC(T*) Reaction 
100 0.3288 0.3206 4,105,575,167 
80 0.2959 0.3236 4,104,261,603 
75 0.2877 0.3244 4,103,844,731 
50 0.2466 0.3282 4,101,240,746 
25 0.2055 0.3319 4,097,790,342 
20 0.1973 0.3326 4,097,000,956 
15 0.1890 0.3334 4,096,178,930 
10 0.1808 0.3341 4,095,324,457 
5 0.1726 0.3349 4,094,437,728 
0 0.1644 0.3356 4,093,518,931 
-5 0.1562 0.3363 4,092,568,252 
-10 0.1479 0.3371 4,091,585,875 
-15 0.1397 0.3378 4,090,571,980 
-20 0.1315 0.3385 4,089,526,748 
-25 0.1233 0.3392 4,088,450,355 
-50 0.0822 0.3429 4,082,607,019 
-75 0.0411 0.3464 4,076,010,013 
-80 0.0329 0.3471 4,074,601,942 
-100 0.0000 0.3500 4,068,679,220 
 
b. Sensitivity Analysis on Interest Charged 
The interest charged is 6% in actual. In this calculation, the interest 
charged will be changed the same as the previous assessment of sensitivity 
analysis on delay period which is ±5, 10, 15, 20, 25, 50, 75, 80, and 100 in 
percentage of Ic value. 
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However, there is one factor differs from the previous sensitivity 
analysis. Initially, the total cost of Scenario 2 (IDR 4,054,466,052) is lower than 
that of Scenario 3 (IDR 4,093,518,931). In the middle of running the sensitivity 
calculation, it is known that when the interest charged is set to 0 (decreased by 
100%), the total cost (Scenario 3) becomes lower than Scenario 2. In fact, if it 
is decreased by 80%, the total cost is still above the Scenario 2. This becomes 
the additional analysis to assess at what percentage does Scenario 3 will 
approximately be the same total cost to that Scenario 2 with interest charged as 
the parameter changing between 80-100% decreased in value. The table below 
shows the summary of the result: 
 
Table 4.21 One-Way Sensitivity Analysis on Total Inventory Cost and EOI with 
Interest Charged as the Parameter Setting 
% Change Parameter Setting (Ic) T* Reaction TC(T*) Reaction 
100 0.1200 0,3822 4,132,414,185 
80 0.1080 0,3733 4,124,933,979 
75 0.1050 0,3711 4,123,042,101 
50 0.0900 0,3596 4,113,445,945 
25 0.0750 0,3478 4,103,610,445 
20 0.0720 0,3454 4,101,613,182 
15 0.0690 0,3430 4,099,605,542 
10 0.0660 0,3405 4,097,587,384 
5 0.0630 0,3381 4,095,558,563 
0 0.0600 0,3356 4,093,518,931 
-5 0.0570 0,3331 4,091,468,340 
-10 0.0540 0,3306 4,089,406,638 
-15 0.0510 0,3280 4,087,333,673 
-20 0.0480 0,3255 4,085,249,289 
-25 0.0450 0,3229 4,083,153,330 
-50 0.0300 0,3097 4,072,494,310 
-75 0.0150 0,2959 4,061,521,721 
-80 0.0120 0,2931 4,059,287,798 
-90,69 0.0056 0,2869 4,054,466,193 
-100 0.0000 0,2814 4,050,215,639 
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4.4.3.5.2 Two-Way Sensitivity Analysis 
Two-way sensitivity analysis is assessed to test the behavior of two parameter 
settings simultaneously. In this case, the parameter setting is the same to the one-way: 
delay period and interest charged. The output is also the same. What differs the analysis 
is the calculation process. It is started with Random Number Generation. 
Because there are two parameter setting assessed simultaneously, there are four 
probabilities of conditions to capture the whole behavior of M and Ic together with the 
reaction of T* and TC(T*). Delay period is limited from 1 (0.0027 year) up to 365 (1 
year) days. Meanwhile, interest charged is limited from 0.05 (the interest earned, as it 
is stated in literature review that interest charged is higher than the interest earned) up 
to 1. Here is the summary table of the four conditions, range of M and Ic, together with 
the behavior to capture to have a complete analysis: 
 
Table 4.22 Conditions to Capture on Two-Way Sensitivity Analysis 
Condition Range Characteristic to Capture 
M and Ic are above the 
actual value 
M: 0.1644 < M < 1 
Ic: 0.06 < Ic < 1 
M > Ic and M < Ic 
M and Ic are below the 
actual value 
M: 0.0027 < M < 0.1644 
Ic: 0.05 < Ic < 0.06 
M > Ic and M < Ic 
M is above the actual 
value while Ic is below 
M: 0.1644 < M < 1 
Ic: 0.05 < Ic < 0.06 
M > Ic 
M is below the actual 
value while Ic is above 
M: 0.0027 < M < 0.1644 
Ic: 0.06 < Ic < 1 
M > Ic and M < Ic 
 
Based on those conditions, random number is generated. There are 30-50 
random numbers per conditions generated. Thing to note is that all the generated 
numbers must occupy all characteristics to capture within the range. The output will be 
about to analyze behavior and reaction of T* and TC (T*).  
There are 55 random numbers of M and Ic generated in form of column and is 
converted to matrix to fill the minimum total inventory cost. The random number 
generation table together with the result of two-way sensitivity analysis will be 
provided in Attachment.  
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CHAPTER 5  
ANALYSIS 
 
In this chapter will be explained about the numerical experiment analysis 
related to each performance of scenario generated, Safety Stock and Average Inventory 
Level, and sensitivity analysis. 
 
5.1 Performance Gap on Each Scenario 
Based on previous calculation that has been done in data processing, it can be 
concluded that the result and the performance gap of each scenario is shown in the table 
below: 
Table 5.1 Total Inventory Cost Recapitulation of Each Scenario Generated 






1 0.0822 (30) 12 4,379,035,948 - 
2 0.3348 (122) 3 4,054,466,052 7.41% 
3 0.3356 (122) 3 4,093,518,931 6.52% 
 
It is known that scenario 2 is most preferable seen from financial aspect as the 
lowest in total inventory cost. The gap is 7.41% from the initial condition (Scenario 1, 
as the highest in total inventory cost). However, the performance is not significantly 
different from that of Scenario 3. Scenario 3 yield 6.52% decreased in percentage 
compared to Scenario 1. It only differ IDR 39,052,879 from Scenario 2, thus it gives 
0.89% difference in total inventory cost. 
Scenario 1, the actual condition, considered no holding cost in calculator. It 
may decrease the total cost in calculation but not in reality. In fact, by ignoring holding 
cost, the calculated total cost is still far beyond that of Scenario 2 and 3. Moreover, the 
total order cost is only 1.5% to the total annual purchase cost. It is, again, not 
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considering interest as the delay component. Still, the actual condition yields the 
highest total cost, even if the difference is below 10%. This evaluation will be seen in 
enhance in the following sensitivity analysis subchapter. 
Meanwhile, Scenario 2 has the least total inventory cost. This is the most 
preferable condition due to 2017 data. However, the result may vary, regarding to the 
components’ behavior. Scenario 2 has the same EOI with Scenario 3 which is 122 days 
or 4 months long, it is shown in Scenario 3 T* equation: 
















   (2.16) 
 
What differs 3rd T* to 2nd Scenario is starting from variable Ic up to Ie, which 
are multiplied by purchase cost and combination operation of delay period and actual 
payment time. In fact, that side yields only IDR 257,801 difference in the numerator. 
This behavior can be predicted, the higher the value (moreover, the interest charged as 
the component with the plus sign), the higher the T* will be. IDR 257,801 is only 
0.0002 of the annual holding cost as the de-numerator. Thus, the T* in year is not 
significantly different, and the review period is in the same day-length. 
Scenario 3 has the second least total inventory cost. What affects the count up 
is the interest charged. 
 
5.2 Average Inventory Level Analysis 
AIL is affected by SS, annual demand, and order interval. It varies on each 




Table 5.2 Average Inventory Level Recapitulation on Each Scenario 
Item AIL Scenario 1 Ail Scenario 2 AIL Scenario 3 
Koate IU-1060 IU (BLB) 18 50 50 
Micardis 80 mg Tablet 5,103 16,290 16,327 
Clopidogel 13,239 40,451 40,543 
Anbacin Inj 662 1,965 1,970 
Ceftriaxon 1,845 6,115 6,128 
Inviclot 360 1,318 1,321 
Nimotop Tab 5,583 14,074 14,101 
Micardis 40mg 3,603 11,144 11,169 
Ferriprox Tab 508 1,273 1,276 
Asering Infus 1,371 4,070 4,079 
 
It is known that the AIL of Scenario 1 is the least on all products in 2017 
compared to Scenario 2 and 3. On the other hand, Scenario 2 and 3 have no significant 
difference or they have relatively the same AIL. It can be concluded that the behavior 
of AIL follows the order interval behavior linearly. Since the order interval is the 
numerator, beside annual demand and SS which affect the value, AIL increases by the 
increase of order interval.  
AIL is used to estimate the average space required at a period of time. If the 
AIL keep on increasing, it is no wonder yielding to an increase in future holding cost. 
The probability of insufficient space and capacity may also raise. Right or wrong in 
determining review period will critically determine the sufficiency of space and 
capacity in inventory. This urges the hospital to carefully calculate the EOI with highly 
confident on demand data accuracy and service level fulfillment (avoiding stockout). 
 
5.3 One-Way Sensitivity Analysis 
The one-way sensitivity analysis has been done on each of delay period and 
interest charged. To comprehend the behavior and reaction of the EOI and the 




Figure 5.1 Sensitivity Analysis on the Economic Order Interval (T*) Graph with 
Delay Period as the Parameter Setting 
 
 
Figure 5.2 Sensitivity Analysis on the Minimum Total Inventory Cost or TC (T*) 



















Delay Period (M, in year)
Sensitivity Analysis on Economic Order Interval 































































































































Delay Period (M, in year)
Sensitivity Analysis on Minimum Total Inventory 




The figure above shows the result with delay period as the parameter setting, 
T* as the output. It can be concluded that: 
1. The shorter the delay period (M), the longer the EOI (T*), the lower the TC 
(T*). This has a meaning that: a strict tolerance on delay period will trigger 
the hospital to push down the total inventory cost by lengthening the review 
period. 
2. The longer the delay period (M), the shorter the EOI (T*) and the higher the 
total cost TC (T*) will be. Loose in delay period (high tolerance) will trigger 
the hospital wants more accuracy on its review policy by shortening the 
review period. It moves closer to continuous review policy hence the 
expense is getting bigger by inclining review frequency. 
 
After having the delay period as the parameter setting, interest charged is the 
next parameter assessed. Here is the resulted graph: 
 
 
Figure 5.3 Sensitivity Analysis on the Economic Order Interval (T*) Graph with 


















Sensitivity Analysis on economic Order Interval 





Figure 5.4 Sensitivity Analysis on the Minimum Total Inventory Cost or TC (T*) 
Graph with Interest Charged as the Parameter Setting 
The figure above shows the result with interest charged as the parameter setting, 
T* and TC (T*) as the output. It can be concluded that: 
1. The smaller the interest charged (Ic), the shorter the EOI (T*), and the lower 
the TC (T*). This has a meaning that the lesser the supplier charges the 
hospital, the hospital will be triggered to increase the review frequency. It 
becomes shorter (the EOI) move closer to continuous review policy and 
yield to lower total cost, supported  by the least interest charged. 
2. The higher the interest charged (Ic), the longer the EOI (T*), the higher the 
TC (T*) will be. This means, effect of adding Ic is bigger than lengthening 
the order interval. Because by the addition of interest charged, even if the 
review period is longer, total cost is still inclining affected by the charge. 
3. When interest charge drops reaching 90.69%, the resulted TC (T*) is the 
closest to that of Scenario 2. Total cost of Scenario 2 is IDR 4,054,466,052 
while IDR 4,054,466,193. Hence, Scenario 3 is more preferable when the 






































































































































Sensitivity Analysis on Minimum Total Inventory 




5.4 Two-Way Sensitivity Analysis 
The two-way sensitivity analysis is done simultaneously on the delay period 
and interest charged. Here is the result shown in 3D Surface graph after generating 
random number to capture all possibilities of conditions. Based on the graph in the 
following page, it can be concluded that: 
1. Total inventory cost will increase by the increase of both delay period and 
interest charged at an unknown different rate. 
2. Interest charged has higher effect in contribution of adding total inventory cost, 
known from the orange area (the second lowest category in total inventory cost 
shown in the legend). Whatever the delay period may vary (0.0062 year or 
0.9278 year), the inventory cost remains in range of IDR 4,000,000,000 up to 
IDR 4,100,000,000.  
3. Based on 55x55 matrix generated from random number of M and Ic , Scenario 
3 is more preferable due to total inventory cost when Ic and M are on this range: 
a. When M reaches (from below) 0.7015 and Ic reaches 0.0512 (from 
below) up to the Ic reaches 0.0543. 
b. When M reaches (from below) 0.7314 and Ic reaches 0.0551 (from 
below) up to the Ic reaches 0.0578. 
c. When M reaches (from below) 0.7514 and Ic reaches 0.0585 (from 
below) up to the Ic reaches 0.0590. 
d. When M reaches (from below) 0.8580 and Ic reaches 0.07 (from below). 
e. When M reaches (from below) 0.9906 and Ic reaches 0.0782 (from 
below). 
f. In summary, M is ranged on 0.7015 until 0.9993 and Ic is ranged on 
0.0512 until 0.0782. 
Below is shown both of the graph, two-way sensitivity analysis toward total inventory 





Figure 5.5 Two-Way Sensitivity Analysis Result: 3D Surface Graph between Delay Period, Interest Charged, and Minimum 


















































































































3D Surface Interaction Graph between Delay Period, Interest Charged, and 
Minimum Total Inventory Cost
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CHAPTER 6  
CLOSURE 
 
In this chapter will be explained about the conclusion obtained based on the objectives 
of research and recommendation for future research and the research object. 
 
6.1 Conclusion 
By modifying total inventory cost equation, as the theoretical contribution and 
a novel research, with the permissible delay in payment parameter, this research has 
come into conclusions. The conclusion obtained is explained in the following. 
1. Seen from financial aspect, Scenario 2 is the most preferable with only IDR 
4,054,466,052, a 7.41% decreased from the initial condition (Scenario 1) 
which is IDR 4,379,035,948. However, it is not significantly different from 
the second least total inventory cost, Scenario 3, which is IDR 
4,093,518,931. 6.52% decreased from the initial condition. In addition, the 
EOI for both (Scenario 2 and Scenario 3) is the same. The EOI is 122 days 
or 4 months, 3 times per annum as the order frequency. 
2. Based on one-way sensitivity analysis on delay period, it is concluded that: 
the shorter the delay period (M), the longer the EOI (T*), the lower the TC 
(T*). This has a meaning that: a strict tolerance on delay period will trigger 
the hospital to push down the total inventory cost by lengthening the review 
period. In reverse, the longer the delay period (M), the shorter the EOI (T*) 
and the higher the total cost TC (T*) will be. Loose in delay period (high 
tolerance) will trigger the hospital wants more accuracy on its review 
policy by shortening the review period. It moves closer to continuous 




3. Based on one-way sensitivity analysis on the interest charged, it can be 
concluded that the smaller the interest charged (Ic), the shorter the EOI 
(T*), and the lower the TC (T*). This has a meaning that the lesser the 
supplier charges the hospital, the hospital will be triggered to increase the 
review frequency. It becomes shorter (the EOI) move closer to continuous 
review policy and yield to lower total cost, supported  by the least interest 
charged. However, in reverse, the higher the interest charged (Ic), the longer 
the EOI (T*), the higher the TC (T*) will be. This means, effect of adding 
Ic is bigger than lengthening the order interval. Because by the addition of 
interest charged, even if the review period is longer, total cost is still 
inclining affected by the charge. 
4. Based on two-way sensitivity analysis, the total inventory cost will increase 
by the increase of both delay period and interest charged at an unknown 
different rate. However, interest charged has higher effect in contribution 
of adding total inventory cost. Whatever the delay period may vary, the 
inventory cost remains low as long as the interest charged from the supplier 
is low.  
5. Scenario 3 can be more preferable than Scenario 2 whenever these situation 
is occupied. It is when the interest charge drops reaching up to 90.69% and 
more. Total cost of Scenario 2 is IDR 4,054,466,052 while IDR 
4,054,466,193 at that point. Scenario 3 can also be more preferable 
whenever M is ranged on 0.7015 until 0.9993 simultaneously with Ic that 






The recommendation is made for future research and the research object. It is 
formulated as follows. 
1. Multiplayer decision making is needed to be considered, such as the application 
of game theory involving the supplier, and other type of warehouse inside the 
hospital. It is to know the behavior and the player reaction regarding to the 
hospital decision making, thus the hospital would be completely ready to 
implement this research method. Multi-supplier can also be considered toward 
wide variety of pharmaceutical products and its sources’ probability. 
2. In implementing the method or assessing future research, older data needs to be 
considered, besides calculating forecast that yields to inaccuracy of result 
(reality blurred). 
3. Scheme in which the delay period is higher than the period in which inventory 
level is positive is also needed to be considered. 
4. To raise accuracy, manual or actual calculation needs to be considered on 
holding cost regarding to the space requirement, capacity, overhead cost 
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Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,057,124,366.55   Rp 4,057,502,097.87   Rp 4,059,750,473.33   Rp 4,059,924,241.72   Rp 4,060,710,498.85  
0.0518  Rp 4,057,283,743.88   Rp 4,057,665,861.32   Rp 4,059,940,646.99   Rp 4,060,116,479.36   Rp 4,060,912,119.23  
0.0519  Rp 4,057,309,780.83   Rp 4,057,692,614.61   Rp 4,059,971,713.38   Rp 4,060,147,882.80   Rp 4,060,945,054.89  
0.0523  Rp 4,057,405,768.94   Rp 4,057,791,243.09   Rp 4,060,086,239.07   Rp 4,060,263,650.78   Rp 4,061,066,470.09  
0.0528  Rp 4,057,538,539.90   Rp 4,057,927,664.93   Rp 4,060,244,640.87   Rp 4,060,423,770.11   Rp 4,061,234,396.83  
0.0532  Rp 4,057,655,894.15   Rp 4,058,048,244.89   Rp 4,060,384,639.80   Rp 4,060,565,286.37   Rp 4,061,382,810.25  
0.0533  Rp 4,057,666,184.49   Rp 4,058,058,818.02   Rp 4,060,396,915.32   Rp 4,060,577,694.90   Rp 4,061,395,823.40  
0.0539  Rp 4,057,828,837.37   Rp 4,058,225,939.66   Rp 4,060,590,937.02   Rp 4,060,773,818.32   Rp 4,061,601,500.15  
0.0543  Rp 4,057,925,331.86   Rp 4,058,325,084.20   Rp 4,060,706,032.69   Rp 4,060,890,160.18   Rp 4,061,723,506.43  
0.0551  Rp 4,058,139,920.06   Rp 4,058,545,562.86   Rp 4,060,961,964.20   Rp 4,061,148,861.26   Rp 4,061,994,795.92  
0.0558  Rp 4,058,316,835.95   Rp 4,058,727,332.18   Rp 4,061,172,941.81   Rp 4,061,362,120.41   Rp 4,062,218,424.85  
0.0568  Rp 4,058,576,365.14   Rp 4,058,993,976.42   Rp 4,061,482,399.97   Rp 4,061,674,922.54   Rp 4,062,546,424.99  
0.0568  Rp 4,058,585,507.07   Rp 4,059,003,368.87   Rp 4,061,493,299.82   Rp 4,061,685,940.12   Rp 4,062,557,977.61  
0.0569  Rp 4,058,604,607.77   Rp 4,059,022,992.98   Rp 4,061,516,073.24   Rp 4,061,708,959.50   Rp 4,062,582,114.83  
0.0570  Rp 4,058,642,421.47   Rp 4,059,061,842.79   Rp 4,061,561,157.13   Rp 4,061,754,530.26   Rp 4,062,629,898.29  
0.0573  Rp 4,058,721,621.32   Rp 4,059,143,212.35   Rp 4,061,655,581.08   Rp 4,061,849,973.70   Rp 4,062,729,975.04  
0.0574  Rp 4,058,729,736.30   Rp 4,059,151,549.61   Rp 4,061,665,255.71   Rp 4,061,859,752.78   Rp 4,062,740,228.77  




Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,059,033,457.97   Rp 4,059,463,586.78   Rp 4,062,027,319.08   Rp 4,062,225,722.63   Rp 4,063,123,951.79  
0.0590  Rp 4,059,166,477.61   Rp 4,059,600,245.89   Rp 4,062,185,870.84   Rp 4,062,385,983.79   Rp 4,063,291,981.06  
0.0700  Rp 4,061,986,231.25   Rp 4,062,496,804.29   Rp 4,065,544,088.80   Rp 4,065,780,224.06   Rp 4,066,849,876.47  
0.0782  Rp 4,064,080,332.12   Rp 4,064,647,525.18   Rp 4,068,034,725.63   Rp 4,068,297,354.54   Rp 4,069,487,320.30  
0.1176  Rp 4,073,972,242.53   Rp 4,074,802,279.31   Rp 4,079,763,066.23   Rp 4,080,148,037.19   Rp 4,081,893,048.14  
0.1207  Rp 4,074,731,980.34   Rp 4,075,581,902.02   Rp 4,080,661,455.39   Rp 4,081,055,640.65   Rp 4,082,842,421.29  
0.1668  Rp 4,085,900,756.61   Rp 4,087,038,343.24   Rp 4,093,831,968.26   Rp 4,094,358,856.13   Rp 4,096,746,711.13  
0.2144  Rp 4,097,078,919.07   Rp 4,098,496,253.42   Rp 4,106,950,067.89   Rp 4,107,605,026.90   Rp 4,110,572,188.91  
0.2190  Rp 4,098,128,895.18   Rp 4,099,572,115.13   Rp 4,108,179,243.72   Rp 4,108,846,008.86   Rp 4,111,866,538.21  
0.2676  Rp 4,109,153,529.07   Rp 4,110,864,747.81   Rp 4,121,056,364.88   Rp 4,121,844,955.52   Rp 4,125,415,852.05  
0.3276  Rp 4,122,327,948.40   Rp 4,124,350,943.28   Rp 4,136,379,991.53   Rp 4,137,309,459.66   Rp 4,141,516,129.83  
0.3695  Rp 4,131,267,170.50   Rp 4,133,496,908.75   Rp 4,146,741,289.33   Rp 4,147,763,731.39   Rp 4,152,389,644.83  
0.4046  Rp 4,138,584,291.05   Rp 4,140,980,582.75   Rp 4,155,202,426.52   Rp 4,156,299,538.22   Rp 4,161,261,979.47  
0.4046  Rp      4,138,584,291   Rp      4,140,980,583   Rp      4,155,202,427   Rp      4,156,299,538   Rp      4,161,261,979  
0.4355  Rp      4,144,936,206   Rp      4,147,475,239   Rp      4,162,533,745   Rp      4,163,694,700   Rp      4,168,944,764  
0.4537  Rp      4,148,610,321   Rp      4,151,231,173   Rp      4,166,768,831   Rp      4,167,966,322   Rp      4,173,380,939  
0.4593  Rp      4,149,744,001   Rp      4,152,389,991   Rp      4,168,074,808   Rp      4,169,283,516   Rp      4,174,748,648  
0.4706  Rp      4,152,016,983   Rp      4,154,713,224   Rp      4,170,692,128   Rp      4,171,923,249   Rp      4,177,489,299  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp      4,162,089,801   Rp      4,165,006,399   Rp      4,182,273,717   Rp      4,183,602,945   Rp      4,189,610,643  
0.5730  Rp      4,172,017,417   Rp      4,175,147,665   Rp      4,193,662,462   Rp      4,195,086,569   Rp      4,201,521,197  
0.6114  Rp      4,179,278,478   Rp      4,182,562,911   Rp      4,201,977,018   Rp      4,203,469,462   Rp      4,210,211,486  
0.6138  Rp      4,179,730,506   Rp      4,183,024,482   Rp      4,202,494,224   Rp      4,203,990,894   Rp      4,210,751,925  
0.6531  Rp      4,187,026,475   Rp      4,190,473,606   Rp      4,210,835,876   Rp      4,212,400,316   Rp      4,219,466,122  
0.6739  Rp      4,190,859,399   Rp      4,194,386,348   Rp      4,215,213,500   Rp      4,216,813,222   Rp      4,224,037,668  
0.7477  Rp      4,204,139,795   Rp      4,207,940,067   Rp      4,230,357,834   Rp      4,232,078,194   Rp      4,239,844,937  
0.7562  Rp      4,205,648,408   Rp      4,209,479,424   Rp      4,232,075,991   Rp      4,233,809,904   Rp      4,241,637,562  
0.7781  Rp      4,209,506,851   Rp      4,213,416,226   Rp      4,236,468,417   Rp      4,238,236,861   Rp      4,246,219,704  
0.8532  Rp      4,222,520,398   Rp      4,226,691,294   Rp      4,251,263,132   Rp      4,253,146,686   Rp      4,261,646,752  
0.8723  Rp      4,225,773,784   Rp      4,230,009,421   Rp      4,254,957,245   Rp      4,256,869,265   Rp      4,265,497,219  
0.8781  Rp      4,226,752,446   Rp      4,231,007,509   Rp      4,256,068,139   Rp      4,257,988,699   Rp      4,266,655,016  
0.8873  Rp      4,228,295,743   Rp      4,232,581,397   Rp      4,257,819,641   Rp      4,259,753,646   Rp      4,268,480,363  
0.8907  Rp      4,228,875,989   Rp      4,233,173,130   Rp      4,258,478,067   Rp      4,260,417,120   Rp      4,269,166,515  
0.8956  Rp      4,229,695,540   Rp      4,234,008,892   Rp      4,259,407,948   Rp      4,261,354,126   Rp      4,270,135,522  
0.9226  Rp      4,234,230,544   Rp      4,238,633,332   Rp      4,264,551,530   Rp      4,266,536,997   Rp      4,275,494,877  
0.9483  Rp      4,238,489,045   Rp      4,242,975,404   Rp      4,269,378,576   Rp      4,271,400,738   Rp      4,280,523,440  
0.9752  Rp      4,242,920,471   Rp      4,247,493,382   Rp      4,274,398,707   Rp      4,276,458,857   Rp      4,285,752,173  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,062,307,855.66   Rp 4,063,481,408.30   Rp 4,064,487,751.17   Rp 4,064,824,994.09   Rp 4,067,781,196.02  
0.0518  Rp 4,062,528,771.47   Rp 4,063,716,716.18   Rp 4,064,735,559.67   Rp 4,065,077,026.71   Rp 4,068,071,096.18  
0.0519  Rp 4,062,564,857.98   Rp 4,063,755,152.73   Rp 4,064,776,037.33   Rp 4,065,118,194.08   Rp 4,068,118,446.16  
0.0523  Rp 4,062,697,885.75   Rp 4,063,896,841.40   Rp 4,064,925,248.23   Rp 4,065,269,946.73   Rp 4,068,292,982.82  
0.0528  Rp 4,062,881,866.33   Rp 4,064,092,794.58   Rp 4,065,131,599.45   Rp 4,065,479,811.37   Rp 4,068,534,339.26  
0.0532  Rp 4,063,044,461.10   Rp 4,064,265,964.82   Rp 4,065,313,953.90   Rp 4,065,665,268.99   Rp 4,068,747,609.78  
0.0533  Rp 4,063,058,717.39   Rp 4,064,281,148.11   Rp 4,065,329,942.23   Rp 4,065,681,529.33   Rp 4,068,766,307.93  
0.0539  Rp 4,063,284,035.53   Rp 4,064,521,112.31   Rp 4,065,582,624.98   Rp 4,065,938,509.30   Rp 4,069,061,799.58  
0.0543  Rp 4,063,417,687.01   Rp 4,064,663,446.74   Rp 4,065,732,499.27   Rp 4,066,090,931.00   Rp 4,069,237,049.64  
0.0551  Rp 4,063,714,854.60   Rp 4,064,979,908.13   Rp 4,066,065,713.48   Rp 4,066,429,805.11   Rp 4,069,626,640.13  
0.0558  Rp 4,063,959,798.92   Rp 4,065,240,742.91   Rp 4,066,340,344.88   Rp 4,066,709,097.47   Rp 4,069,947,693.35  
0.0568  Rp 4,064,319,035.94   Rp 4,065,623,264.20   Rp 4,066,743,080.72   Rp 4,067,118,662.10   Rp 4,070,418,435.00  
0.0568  Rp 4,064,331,688.19   Rp 4,065,636,736.07   Rp 4,066,757,264.11   Rp 4,067,133,085.85   Rp 4,070,435,011.89  
0.0569  Rp 4,064,358,122.76   Rp 4,065,664,882.98   Rp 4,066,786,897.53   Rp 4,067,163,221.42   Rp 4,070,469,645.71  
0.0570  Rp 4,064,410,453.71   Rp 4,065,720,603.36   Rp 4,066,845,560.29   Rp 4,067,222,878.12   Rp 4,070,538,206.00  
0.0573  Rp 4,064,520,052.42   Rp 4,065,837,299.00   Rp 4,066,968,416.66   Rp 4,067,347,815.58   Rp 4,070,681,784.94  
0.0574  Rp 4,064,531,281.59   Rp 4,065,849,255.17   Rp 4,066,981,003.92   Rp 4,067,360,616.02   Rp 4,070,696,494.90  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,064,951,486.13   Rp 4,066,296,647.46   Rp 4,067,451,995.71   Rp 4,067,839,579.31   Rp 4,071,246,856.09  
0.0590  Rp 4,065,135,476.76   Rp 4,066,492,531.96   Rp 4,067,658,203.48   Rp 4,068,049,273.93   Rp 4,071,487,777.60  
0.0700  Rp 4,069,029,423.72   Rp 4,070,636,712.71   Rp 4,072,019,455.69   Rp 4,072,483,821.64   Rp 4,076,578,235.40  
0.0782  Rp 4,071,913,663.08   Rp 4,073,704,508.19   Rp 4,075,246,340.50   Rp 4,075,764,395.49   Rp 4,080,338,673.24  
0.1176  Rp 4,085,455,278.06   Rp 4,088,088,736.66   Rp 4,090,359,424.26   Rp 4,091,123,160.70   Rp 4,097,887,256.64  
0.1207  Rp 4,086,489,963.80   Rp 4,089,186,569.03   Rp 4,091,511,787.42   Rp 4,092,293,886.77   Rp 4,099,221,276.64  
0.1668  Rp 4,101,619,533.44   Rp 4,105,221,104.81   Rp 4,108,326,545.06   Rp 4,109,371,124.68   Rp 4,118,627,370.30  
0.2144  Rp 4,116,622,065.48   Rp 4,121,089,841.10   Rp 4,124,940,062.95   Rp 4,126,234,795.68   Rp 4,137,702,191.10  
0.2190  Rp 4,118,024,675.36   Rp 4,122,571,980.74   Rp 4,126,490,494.43   Rp 4,127,808,146.76   Rp 4,139,477,766.34  
0.2676  Rp 4,132,688,911.00   Rp 4,138,054,006.88   Rp 4,142,673,961.31   Rp 4,144,226,868.51   Rp 4,157,968,981.29  
0.3276  Rp 4,150,073,940.50   Rp 4,156,378,851.67   Rp 4,161,803,305.25   Rp 4,163,625,713.97   Rp 4,179,735,589.27  
0.3695  Rp 4,161,793,013.66   Rp 4,168,715,167.70   Rp 4,174,667,181.78   Rp 4,176,666,159.77   Rp 4,194,324,119.63  
0.4046  Rp 4,171,343,244.56   Rp 4,178,759,594.09   Rp 4,185,133,591.27   Rp 4,187,273,722.73   Rp 4,206,167,663.68  
0.4046  Rp      4,171,343,245   Rp      4,178,759,594   Rp      4,185,133,591   Rp      4,187,273,723   Rp      4,206,167,664  
0.4355  Rp      4,179,604,872   Rp      4,187,442,785   Rp      4,194,176,485   Rp      4,196,436,887   Rp      4,216,382,939  
0.4537  Rp      4,184,372,003   Rp      4,192,450,784   Rp      4,199,389,908   Rp      4,201,718,975   Rp      4,222,265,324  
0.4593  Rp      4,185,841,280   Rp      4,193,993,958   Rp      4,200,996,092   Rp      4,203,346,218   Rp      4,224,076,621  
0.4706  Rp      4,188,784,804   Rp      4,197,085,057   Rp      4,204,213,002   Rp      4,206,605,173   Rp      4,227,702,970  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp      4,201,793,389   Rp      4,210,738,579   Rp      4,218,416,073   Rp      4,220,991,845   Rp      4,243,692,895  
0.5730  Rp      4,214,560,774   Rp      4,224,128,151   Rp      4,232,335,415   Rp      4,235,088,102   Rp      4,259,332,561  
0.6114  Rp      4,223,867,535   Rp      4,233,882,211   Rp      4,242,470,122   Rp      4,245,349,885   Rp      4,270,702,157  
0.6138  Rp      4,224,446,081   Rp      4,234,488,397   Rp      4,243,099,824   Rp      4,245,987,437   Rp      4,271,408,121  
0.6531  Rp      4,233,771,128   Rp      4,244,256,386   Rp      4,253,244,586   Rp      4,256,257,949   Rp      4,282,774,273  
0.6739  Rp      4,238,660,505   Rp      4,249,376,135   Rp      4,258,560,236   Rp      4,261,638,971   Rp      4,288,724,665  
0.7477  Rp      4,255,553,664   Rp      4,267,055,930   Rp      4,276,908,694   Rp      4,280,210,512   Rp      4,309,238,217  
0.7562  Rp      4,257,468,210   Rp      4,269,058,758   Rp      4,278,986,541   Rp      4,282,313,383   Rp      4,311,558,841  
0.7781  Rp      4,262,360,914   Rp      4,274,176,303   Rp      4,284,295,129   Rp      4,287,685,692   Rp      4,317,485,575  
0.8532  Rp      4,278,822,610   Rp      4,291,386,742   Rp      4,302,141,565   Rp      4,305,744,227   Rp      4,337,388,859  
0.8723  Rp      4,282,928,806   Rp      4,295,677,933   Rp      4,306,589,853   Rp      4,310,244,896   Rp      4,342,344,983  
0.8781  Rp      4,284,163,311   Rp      4,296,967,922   Rp      4,307,926,957   Rp      4,311,597,709   Rp      4,343,834,375  
0.8873  Rp      4,286,109,418   Rp      4,299,001,373   Rp      4,310,034,573   Rp      4,313,730,054   Rp      4,346,181,703  
0.8907  Rp      4,286,840,909   Rp      4,299,765,656   Rp      4,310,826,699   Rp      4,314,531,464   Rp      4,347,063,817  
0.8956  Rp      4,287,873,894   Rp      4,300,844,914   Rp      4,311,945,245   Rp      4,315,663,109   Rp      4,348,309,336  
0.9226  Rp      4,293,586,045   Rp      4,306,812,192   Rp      4,318,129,130   Rp      4,321,919,210   Rp      4,355,193,175  
0.9483  Rp      4,298,944,034   Rp      4,312,408,371   Rp      4,323,927,511   Rp      4,327,785,000   Rp      4,361,644,841  
0.9752  Rp      4,304,513,720   Rp      4,318,224,542   Rp      4,329,952,904   Rp      4,333,880,139   Rp      4,368,346,084  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp   4,068,258,976.93   Rp   4,069,768,717.36   Rp  4,069,870,669   Rp   4,071,837,340   Rp    4,072,227,399  
0.0518  Rp   4,068,555,153.99   Rp   4,070,085,058.89   Rp  4,070,188,392   Rp   4,072,182,237   Rp    4,072,577,817  
0.0519  Rp   4,068,603,528.75   Rp   4,070,136,725.66   Rp  4,070,240,284   Rp   4,072,238,565   Rp    4,072,635,047  
0.0523  Rp   4,068,781,841.77   Rp   4,070,327,169.71   Rp  4,070,431,559   Rp   4,072,446,187   Rp    4,072,845,990  
0.0528  Rp   4,069,028,417.56   Rp   4,070,590,511.39   Rp  4,070,696,048   Rp   4,072,733,269   Rp    4,073,137,662  
0.0532  Rp   4,069,246,297.40   Rp   4,070,823,197.06   Rp  4,070,929,748   Rp   4,072,986,918   Rp    4,073,395,364  
0.0533  Rp   4,069,265,399.55   Rp   4,070,843,596.88   Rp  4,070,950,237   Rp   4,073,009,155   Rp    4,073,417,956  
0.0539  Rp   4,069,567,273.10   Rp   4,071,165,969.23   Rp  4,071,274,013   Rp   4,073,360,550   Rp    4,073,774,962  
0.0543  Rp   4,069,746,305.87   Rp   4,071,357,151.74   Rp  4,071,466,027   Rp   4,073,568,933   Rp    4,073,986,671  
0.0551  Rp   4,070,144,299.51   Rp   4,071,782,134.47   Rp  4,071,892,858   Rp   4,074,032,123   Rp    4,074,457,246  
0.0558  Rp   4,070,472,271.36   Rp   4,072,132,326.30   Rp  4,072,244,571   Rp   4,074,413,768   Rp    4,074,844,971  
0.0568  Rp   4,070,953,147.25   Rp   4,072,645,747.58   Rp  4,072,760,221   Rp   4,074,973,254   Rp    4,075,413,361  
0.0568  Rp   4,070,970,080.78   Rp   4,072,663,826.43   Rp  4,072,778,378   Rp   4,074,992,953   Rp    4,075,433,374  
0.0569  Rp   4,071,005,459.71   Rp   4,072,701,598.09   Rp  4,072,816,314   Rp   4,075,034,112   Rp    4,075,475,187  
0.0570  Rp   4,071,075,494.79   Rp   4,072,776,369.13   Rp  4,072,891,409   Rp   4,075,115,585   Rp    4,075,557,956  
0.0573  Rp   4,071,222,161.40   Rp   4,072,932,950.96   Rp  4,073,048,670   Rp   4,075,286,200   Rp    4,075,731,283  
0.0574  Rp   4,071,237,187.63   Rp   4,072,948,992.81   Rp  4,073,064,781   Rp   4,075,303,679   Rp    4,075,749,040  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp   4,071,799,373.59   Rp   4,073,549,148.82   Rp  4,073,667,536   Rp   4,075,957,568   Rp    4,076,413,314  
0.0590  Rp   4,072,045,466.26   Rp   4,073,811,845.46   Rp  4,073,931,370   Rp   4,076,243,759   Rp    4,076,704,046  
0.0700  Rp   4,077,244,463.17   Rp   4,079,359,214.21   Rp  4,079,502,581   Rp   4,082,283,775   Rp    4,082,839,238  
0.0782  Rp   4,081,084,213.46   Rp   4,083,453,368.35   Rp  4,083,614,137   Rp   4,086,737,322   Rp    4,087,362,176  
0.1176  Rp   4,098,993,759.10   Rp   4,102,519,066.84   Rp  4,102,758,834   Rp   4,107,432,372   Rp    4,108,371,339  
0.1207  Rp   4,100,354,634.60   Rp   4,103,965,853.38   Rp  4,104,211,485   Rp   4,108,999,979   Rp    4,109,962,206  
0.1668  Rp   4,120,142,880.41   Rp   4,124,975,115.22   Rp  4,125,304,017   Rp   4,131,722,806   Rp    4,133,014,486  
0.2144  Rp   4,139,579,190.62   Rp   4,145,564,065.00   Rp  4,145,971,446   Rp   4,153,923,666   Rp    4,155,524,534  
0.2190  Rp   4,141,387,767.23   Rp   4,147,477,765.76   Rp  4,147,892,299   Rp   4,155,984,127   Rp    4,157,613,115  
0.2676  Rp   4,160,216,680.24   Rp   4,167,381,499.54   Rp  4,167,869,109   Rp   4,177,386,214   Rp    4,179,302,009  
0.3276  Rp   4,182,368,067.82   Rp   4,190,755,773.75   Rp  4,191,326,431   Rp   4,202,460,961   Rp    4,204,701,709  
0.3695  Rp   4,197,207,663.37   Rp   4,206,392,413.98   Rp  4,207,017,152   Rp   4,219,203,825   Rp    4,221,655,703  
0.4046  Rp   4,209,251,403.71   Rp   4,219,071,276.52   Rp  4,219,739,086   Rp   4,232,763,152   Rp    4,235,382,944  
0.4046  Rp       4,209,251,404   Rp       4,219,071,277   Rp  4,219,739,086   Rp   4,232,763,152   Rp    4,235,382,944  
0.4355  Rp       4,219,636,934   Rp       4,229,996,671   Rp  4,230,701,077   Rp   4,244,436,315   Rp    4,247,198,635  
0.4537  Rp       4,225,616,400   Rp       4,236,283,870   Rp  4,237,009,132   Rp   4,251,149,516   Rp    4,253,993,003  
0.4593  Rp       4,227,457,454   Rp       4,238,219,235   Rp  4,238,950,887   Rp   4,253,215,405   Rp    4,256,083,757  
0.4706  Rp       4,231,143,191   Rp       4,242,093,175   Rp  4,242,837,579   Rp   4,257,349,767   Rp    4,260,267,724  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp       4,247,392,109   Rp       4,259,162,578   Rp  4,259,962,562   Rp   4,275,553,844   Rp    4,278,687,852  
0.5730  Rp       4,263,280,869   Rp       4,275,840,080   Rp  4,276,693,473   Rp   4,293,321,222   Rp    4,296,662,640  
0.6114  Rp       4,274,829,135   Rp       4,287,953,890   Rp  4,288,845,567   Rp   4,306,216,019   Rp    4,309,706,006  
0.6138  Rp       4,275,546,130   Rp       4,288,705,794   Rp  4,289,599,834   Rp   4,307,016,119   Rp    4,310,515,273  
0.6531  Rp       4,287,088,894   Rp       4,300,807,429   Rp  4,301,739,294   Rp   4,319,889,164   Rp    4,323,535,019  
0.6739  Rp       4,293,131,032   Rp       4,307,139,840   Rp  4,308,091,348   Rp   4,326,622,115   Rp    4,330,344,128  
0.7477  Rp       4,313,957,369   Rp       4,328,955,534   Rp  4,329,973,978   Rp   4,349,802,443   Rp    4,353,783,854  
0.7562  Rp       4,316,313,052   Rp       4,331,422,089   Rp  4,332,448,034   Rp   4,352,421,878   Rp    4,356,432,343  
0.7781  Rp       4,322,329,039   Rp       4,337,720,317   Rp  4,338,765,354   Rp   4,359,109,239   Rp    4,363,193,654  
0.8532  Rp       4,342,529,194   Rp       4,358,859,085   Rp  4,359,967,605   Rp   4,381,541,724   Rp    4,385,871,944  
0.8723  Rp       4,347,558,590   Rp       4,364,120,112   Rp  4,365,244,297   Rp   4,387,121,933   Rp    4,391,512,787  
0.8781  Rp       4,349,069,953   Rp       4,365,700,928   Rp  4,366,829,809   Rp   4,388,798,447   Rp    4,393,207,481  
0.8873  Rp       4,351,451,863   Rp       4,368,192,153   Rp  4,369,328,427   Rp   4,391,440,293   Rp    4,395,877,938  
0.8907  Rp       4,352,346,959   Rp       4,369,128,284   Rp  4,370,267,333   Rp   4,392,432,962   Rp    4,396,881,346  
0.8956  Rp       4,353,610,795   Rp       4,370,450,019   Rp  4,371,592,982   Rp   4,393,834,468   Rp    4,398,298,005  
0.9226  Rp       4,360,595,599   Rp       4,377,753,951   Rp  4,378,918,494   Rp   4,401,578,060   Rp    4,406,125,108  
0.9483  Rp       4,367,141,484   Rp       4,384,597,626   Rp  4,385,782,305   Rp   4,408,831,953   Rp    4,413,456,914  
0.9752  Rp       4,373,940,188   Rp       4,391,704,346   Rp  4,392,909,851   Rp   4,416,362,938   Rp    4,421,068,475  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,074,674,714   Rp 4,074,892,649   Rp 4,075,931,324   Rp  4,076,384,286   Rp  4,077,324,228  
0.0518  Rp 4,075,060,961   Rp 4,075,282,198   Rp 4,076,336,909   Rp  4,076,797,030   Rp  4,077,752,187  
0.0519  Rp 4,075,124,039   Rp 4,075,345,816   Rp 4,076,403,145   Rp  4,076,864,434   Rp  4,077,822,075  
0.0523  Rp 4,075,356,535   Rp 4,075,580,298   Rp 4,076,647,272   Rp  4,077,112,868   Rp  4,078,079,660  
0.0528  Rp 4,075,677,990   Rp 4,075,904,499   Rp 4,076,984,803   Rp  4,077,456,348   Rp  4,078,435,788  
0.0532  Rp 4,075,961,991   Rp 4,076,190,924   Rp 4,077,282,998   Rp  4,077,759,797   Rp  4,078,750,405  
0.0533  Rp 4,075,986,888   Rp 4,076,216,034   Rp 4,077,309,139   Rp  4,077,786,399   Rp  4,078,777,985  
0.0539  Rp 4,076,380,300   Rp 4,076,612,801   Rp 4,077,722,200   Rp  4,078,206,733   Rp  4,079,213,779  
0.0543  Rp 4,076,613,585   Rp 4,076,848,075   Rp 4,077,967,129   Rp  4,078,455,972   Rp  4,079,472,180  
0.0551  Rp 4,077,132,082   Rp 4,077,370,989   Rp 4,078,511,489   Rp  4,079,009,906   Rp  4,080,046,463  
0.0558  Rp 4,077,559,254   Rp 4,077,801,797   Rp 4,078,959,949   Rp  4,079,466,247   Rp  4,080,519,554  
0.0568  Rp 4,078,185,411   Rp 4,078,433,278   Rp 4,079,617,281   Rp  4,080,135,118   Rp  4,081,212,953  
0.0568  Rp 4,078,207,457   Rp 4,078,455,512   Rp 4,079,640,424   Rp  4,080,158,667   Rp  4,081,237,365  
0.0569  Rp 4,078,253,516   Rp 4,078,501,962   Rp 4,079,688,774   Rp  4,080,207,866   Rp  4,081,288,367  
0.0570  Rp 4,078,344,690   Rp 4,078,593,911   Rp 4,079,784,484   Rp  4,080,305,255   Rp  4,081,389,325  
0.0573  Rp 4,078,535,613   Rp 4,078,786,455   Rp 4,079,984,902   Rp  4,080,509,187   Rp  4,081,600,728  
0.0574  Rp 4,078,555,172   Rp 4,078,806,181   Rp 4,080,005,434   Rp  4,080,530,079   Rp  4,081,622,385  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,079,286,817   Rp 4,079,544,034   Rp 4,080,773,433   Rp  4,081,311,535   Rp  4,082,432,445  
0.0590  Rp 4,079,607,004   Rp 4,079,866,936   Rp 4,081,109,514   Rp  4,081,653,499   Rp  4,082,786,914  
0.0700  Rp 4,086,359,392   Rp 4,086,676,192   Rp 4,088,194,841   Rp  4,088,862,057   Rp  4,090,257,411  
0.0782  Rp 4,091,332,043   Rp 4,091,690,259   Rp 4,093,409,942   Rp  4,094,166,880   Rp  4,095,752,929  
0.1176  Rp 4,114,373,779   Rp 4,114,918,940   Rp 4,117,545,537   Rp  4,118,706,987   Rp  4,121,152,332  
0.1207  Rp 4,116,114,946   Rp 4,116,673,913   Rp 4,119,367,449   Rp  4,120,558,736   Rp  4,123,067,425  
0.1668  Rp 4,141,292,735   Rp 4,142,046,678   Rp 4,145,684,934   Rp  4,147,297,001   Rp  4,150,698,379  
0.2144  Rp 4,165,792,317   Rp 4,166,728,325   Rp 4,171,247,738   Rp  4,173,251,744   Rp  4,177,483,564  
0.2190  Rp 4,168,061,603   Rp 4,169,014,127   Rp 4,173,613,435   Rp  4,175,652,954   Rp  4,179,959,971  
0.2676  Rp 4,191,591,636   Rp 4,192,712,276   Rp 4,198,124,388   Rp  4,200,524,996   Rp  4,205,596,193  
0.3276  Rp 4,219,073,407   Rp 4,220,383,833   Rp 4,226,712,753   Rp  4,229,520,255   Rp  4,235,451,764  
0.3695  Rp 4,237,378,266   Rp 4,238,811,667   Rp 4,245,734,284   Rp  4,248,805,085   Rp  4,255,292,918  
0.4046  Rp 4,252,178,940   Rp 4,253,709,983   Rp 4,261,103,819   Rp  4,264,383,511   Rp  4,271,312,523  
0.4046  Rp 4,252,178,940   Rp 4,253,709,983   Rp 4,261,103,819   Rp  4,264,383,511   Rp  4,271,312,523  
0.4355  Rp 4,264,905,202   Rp 4,266,519,025   Rp 4,274,312,251   Rp  4,277,768,935   Rp  4,285,071,645  
0.4537  Rp 4,272,217,914   Rp 4,273,878,842   Rp 4,281,899,294   Rp  4,285,456,654   Rp  4,292,971,888  
0.4593  Rp 4,274,467,429   Rp 4,276,142,782   Rp 4,284,232,814   Rp  4,287,820,998   Rp  4,295,401,297  
0.4706  Rp 4,278,968,082   Rp 4,280,672,206   Rp 4,288,901,005   Rp  4,292,550,663   Rp  4,300,260,712  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,298,766,937   Rp 4,300,596,270   Rp 4,309,428,876   Rp  4,313,345,960   Rp  4,321,620,346  
0.5730  Rp 4,318,064,520   Rp 4,320,013,920   Rp 4,329,425,379   Rp  4,333,598,763   Rp  4,342,413,855  
0.6114  Rp 4,332,055,000   Rp 4,334,090,332   Rp 4,343,916,009   Rp  4,348,272,757   Rp  4,357,474,608  
0.6138  Rp 4,332,922,696   Rp 4,334,963,328   Rp 4,344,814,553   Rp  4,349,182,610   Rp  4,358,408,311  
0.6531  Rp 4,346,877,342   Rp 4,349,002,773   Rp 4,359,262,693   Rp  4,363,811,639   Rp  4,373,418,823  
0.6739  Rp 4,354,171,681   Rp 4,356,341,116   Rp 4,366,813,096   Rp  4,371,455,891   Rp  4,381,260,975  
0.7477  Rp 4,379,263,677   Rp 4,381,582,912   Rp 4,392,776,711   Rp  4,397,738,909   Rp  4,408,217,431  
0.7562  Rp 4,382,097,190   Rp 4,384,433,195   Rp 4,395,707,802   Rp  4,400,705,752   Rp  4,411,259,649  
0.7781  Rp 4,389,329,391   Rp 4,391,708,077   Rp 4,403,188,320   Rp  4,408,277,250   Rp  4,419,022,947  
0.8532  Rp 4,413,572,593   Rp 4,416,093,095   Rp 4,428,256,548   Rp  4,433,647,722   Rp  4,445,030,540  
0.8723  Rp 4,419,599,397   Rp 4,422,154,871   Rp 4,434,486,788   Rp  4,439,952,482   Rp  4,451,492,374  
0.8781  Rp 4,421,409,802   Rp 4,423,975,759   Rp 4,436,358,179   Rp  4,441,846,214   Rp  4,453,433,192  
0.8873  Rp 4,424,262,369   Rp 4,426,844,826   Rp 4,439,306,727   Rp  4,444,829,919   Rp  4,456,491,000  
0.8907  Rp 4,425,334,134   Rp 4,427,922,784   Rp 4,440,414,518   Rp  4,445,950,906   Rp  4,457,639,801  
0.8956  Rp 4,426,847,235   Rp 4,429,444,624   Rp 4,441,978,448   Rp  4,447,533,453   Rp  4,459,261,589  
0.9226  Rp 4,435,205,838   Rp 4,437,851,378   Rp 4,450,617,148   Rp  4,456,274,748   Rp  4,468,219,120  
0.9483  Rp 4,443,033,483   Rp 4,445,723,941   Rp 4,458,706,074   Rp  4,464,459,373   Rp  4,476,605,438  
0.9752  Rp 4,451,157,795   Rp 4,453,894,702   Rp 4,467,100,559   Rp  4,472,952,809   Rp  4,485,307,418  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,077,334,690   Rp 4,078,205,881   Rp 4,079,825,953   Rp  4,081,645,083   Rp  4,083,427,005  
0.0518  Rp 4,077,762,821   Rp 4,078,648,610   Rp 4,080,297,368   Rp  4,082,151,929   Rp  4,083,973,747  
0.0519  Rp 4,077,832,737   Rp 4,078,720,909   Rp 4,080,374,350   Rp  4,082,234,696   Rp  4,084,063,028  
0.0523  Rp 4,078,090,426   Rp 4,078,987,380   Rp 4,080,658,077   Rp  4,082,539,740   Rp  4,084,392,081  
0.0528  Rp 4,078,446,697   Rp 4,079,355,787   Rp 4,081,050,332   Rp  4,082,961,457   Rp  4,084,846,985  
0.0532  Rp 4,078,761,440   Rp 4,079,681,246   Rp 4,081,396,850   Rp  4,083,333,994   Rp  4,085,248,836  
0.0533  Rp 4,078,789,032   Rp 4,079,709,776   Rp 4,081,427,227   Rp  4,083,366,651   Rp  4,085,284,062  
0.0539  Rp 4,079,225,001   Rp 4,080,160,579   Rp 4,081,907,184   Rp  4,083,882,632   Rp  4,085,840,638  
0.0543  Rp 4,079,483,506   Rp 4,080,427,876   Rp 4,082,191,759   Rp  4,084,188,559   Rp  4,086,170,630  
0.0551  Rp 4,080,058,019   Rp 4,081,021,915   Rp 4,082,824,177   Rp  4,084,868,409   Rp  4,086,903,947  
0.0558  Rp 4,080,531,299   Rp 4,081,511,269   Rp 4,083,345,124   Rp  4,085,428,406   Rp  4,087,507,974  
0.0568  Rp 4,081,224,976   Rp 4,082,228,483   Rp 4,084,108,606   Rp  4,086,249,084   Rp  4,088,393,156  
0.0568  Rp 4,081,249,398   Rp 4,082,253,733   Rp 4,084,135,484   Rp  4,086,277,975   Rp  4,088,424,317  
0.0569  Rp 4,081,300,420   Rp 4,082,306,486   Rp 4,084,191,638   Rp  4,086,338,334   Rp  4,088,489,419  
0.0570  Rp 4,081,401,418   Rp 4,082,410,908   Rp 4,084,302,793   Rp  4,086,457,811   Rp  4,088,618,284  
0.0573  Rp 4,081,612,906   Rp 4,082,629,566   Rp 4,084,535,544   Rp  4,086,707,986   Rp  4,088,888,116  
0.0574  Rp 4,081,634,572   Rp 4,082,651,966   Rp 4,084,559,387   Rp  4,086,733,615   Rp  4,088,915,758  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,082,444,956   Rp 4,083,489,799   Rp 4,085,451,183   Rp  4,087,692,133   Rp  4,089,949,559  
0.0590  Rp 4,082,799,567   Rp 4,083,856,411   Rp 4,085,841,388   Rp  4,088,111,514   Rp  4,090,401,865  
0.0700  Rp 4,090,273,030   Rp 4,091,581,253   Rp 4,094,060,515   Rp  4,096,942,198   Rp  4,099,923,400  
0.0782  Rp 4,095,770,707   Rp 4,097,261,927   Rp 4,100,101,044   Rp  4,103,428,149   Rp  4,106,913,015  
0.1176  Rp 4,121,179,838   Rp 4,123,495,158   Rp 4,127,953,699   Rp  4,133,283,849   Rp  4,139,032,508  
0.1207  Rp 4,123,095,648   Rp 4,125,471,673   Rp 4,130,049,382   Rp  4,135,526,728   Rp  4,141,441,481  
0.1668  Rp 4,150,736,698   Rp 4,153,967,399   Rp 4,160,220,716   Rp  4,167,763,710   Rp  4,176,003,794  
0.2144  Rp 4,177,531,267   Rp 4,181,555,696   Rp 4,189,361,371   Rp  4,198,811,175   Rp  4,209,188,354  
0.2190  Rp 4,180,008,524   Rp 4,184,104,765   Rp 4,192,050,718   Rp  4,201,672,519   Rp  4,212,242,046  
0.2676  Rp 4,205,653,374   Rp 4,210,478,864   Rp 4,219,847,883   Rp  4,231,211,880   Rp  4,243,726,216  
0.3276  Rp 4,235,518,653   Rp 4,241,164,113   Rp 4,252,130,422   Rp  4,265,444,848   Rp  4,280,129,778  
0.3695  Rp 4,255,366,083   Rp 4,261,541,294   Rp 4,273,538,223   Rp  4,288,108,759   Rp  4,304,188,513  
0.4046  Rp 4,271,390,663   Rp 4,277,985,751   Rp 4,290,798,914   Rp  4,306,363,155   Rp  4,323,544,921  
0.4046  Rp 4,271,390,663   Rp 4,277,985,751   Rp 4,290,798,914   Rp  4,306,363,155   Rp  4,323,544,921  
0.4355  Rp 4,285,153,997   Rp 4,292,104,597   Rp 4,305,608,487   Rp  4,322,012,964   Rp  4,340,125,687  
0.4537  Rp 4,293,056,635   Rp 4,300,209,365   Rp 4,314,105,830   Rp  4,330,987,609   Rp  4,349,628,851  
0.4593  Rp 4,295,486,778   Rp 4,302,701,384   Rp 4,316,718,005   Rp  4,333,745,838   Rp  4,352,548,763  
0.4706  Rp 4,300,347,656   Rp 4,307,685,641   Rp 4,321,941,827   Rp  4,339,260,814   Rp  4,358,385,993  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,321,713,649   Rp 4,329,588,127   Rp 4,344,885,638   Rp  4,363,469,546   Rp  4,383,993,936  
0.5730  Rp 4,342,513,250   Rp 4,350,901,570   Rp 4,367,195,937   Rp  4,386,989,871   Rp  4,408,851,644  
0.6114  Rp 4,357,578,361   Rp 4,366,334,128   Rp 4,383,341,084   Rp  4,403,999,541   Rp  4,426,816,263  
0.6138  Rp 4,358,512,332   Rp 4,367,290,756   Rp 4,384,341,645   Rp  4,405,053,389   Rp  4,427,928,959  
0.6531  Rp 4,373,527,141   Rp 4,382,667,925   Rp 4,400,421,342   Rp  4,421,985,064   Rp  4,445,801,301  
0.6739  Rp 4,381,371,522   Rp 4,390,700,262   Rp 4,408,818,015   Rp  4,430,823,465   Rp  4,455,127,274  
0.7477  Rp 4,408,335,563   Rp 4,418,303,794   Rp 4,437,660,856   Rp  4,461,168,367   Rp  4,487,129,495  
0.7562  Rp 4,411,378,630   Rp 4,421,418,427   Rp 4,440,914,155   Rp  4,464,589,689   Rp  4,490,736,152  
0.7781  Rp 4,419,144,088   Rp 4,429,365,984   Rp 4,449,214,530   Rp  4,473,317,537   Rp  4,499,935,475  
0.8532  Rp 4,445,158,856   Rp 4,455,985,578   Rp 4,477,005,777   Rp  4,502,528,026   Rp  4,530,710,878  
0.8723  Rp 4,451,622,459   Rp 4,462,598,278   Rp 4,483,907,263   Rp  4,509,779,254   Rp  4,538,347,656  
0.8781  Rp 4,453,563,807   Rp 4,464,584,320   Rp 4,485,979,871   Rp  4,511,956,694   Rp  4,540,640,655  
0.8873  Rp 4,456,622,449   Rp 4,467,713,299   Rp 4,489,245,078   Rp  4,515,386,870   Rp  4,544,252,676  
0.8907  Rp 4,457,771,563   Rp 4,468,888,813   Rp 4,490,471,722   Rp  4,516,675,431   Rp  4,545,609,485  
0.8956  Rp 4,459,393,794   Rp 4,470,548,289   Rp 4,492,203,335   Rp  4,518,494,396   Rp  4,547,524,735  
0.9226  Rp 4,468,353,759   Rp 4,479,713,490   Rp 4,501,766,012   Rp  4,528,538,367   Rp  4,558,099,177  
0.9483  Rp 4,476,742,348   Rp 4,488,293,507   Rp 4,510,716,739   Rp  4,537,937,939   Rp  4,567,993,410  
0.9752  Rp 4,485,446,676   Rp 4,497,195,754   Rp 4,520,002,251   Rp  4,547,687,461   Rp  4,578,254,261  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,083,981,258   Rp 4,085,508,067   Rp  4,086,106,846   Rp 4,086,406,557   Rp 4,087,024,866  
0.0518  Rp 4,084,542,045   Rp 4,086,114,949   Rp  4,086,737,453   Rp 4,087,051,686   Rp 4,087,762,926  
0.0519  Rp 4,084,633,620   Rp 4,086,214,053   Rp  4,086,840,432   Rp 4,087,157,039   Rp 4,087,883,473  
0.0523  Rp 4,084,971,126   Rp 4,086,579,311   Rp  4,087,219,982   Rp 4,087,545,338   Rp 4,088,327,819  
0.0528  Rp 4,085,437,718   Rp 4,087,084,282   Rp  4,087,744,720   Rp 4,088,082,183   Rp 4,088,942,260  
0.0532  Rp 4,085,849,894   Rp 4,087,530,369   Rp  4,088,208,281   Rp 4,088,556,447   Rp 4,089,485,175  
0.0533  Rp 4,085,886,025   Rp 4,087,569,474   Rp  4,088,248,917   Rp 4,088,598,022   Rp 4,089,532,773  
0.0539  Rp 4,086,456,902   Rp 4,088,187,334   Rp  4,088,890,995   Rp 4,089,254,938   Rp 4,090,284,939  
0.0543  Rp 4,086,795,373   Rp 4,088,553,668   Rp  4,089,271,696   Rp 4,089,644,443   Rp 4,090,730,997  
0.0551  Rp 4,087,547,533   Rp 4,089,367,762   Rp  4,090,117,735   Rp 4,090,510,064   Rp 4,091,722,496  
0.0558  Rp 4,088,167,080   Rp 4,090,038,338   Rp  4,090,814,643   Rp 4,091,223,118   Rp 4,092,539,428  
0.0568  Rp 4,089,075,004   Rp 4,091,021,063   Rp  4,091,835,984   Rp 4,092,268,142   Rp 4,093,736,977  
0.0568  Rp 4,089,106,966   Rp 4,091,055,658   Rp  4,091,871,939   Rp 4,092,304,931   Rp 4,093,779,141  
0.0569  Rp 4,089,173,740   Rp 4,091,127,934   Rp  4,091,947,057   Rp 4,092,381,792   Rp 4,093,867,233  
0.0570  Rp 4,089,305,916   Rp 4,091,271,001   Rp  4,092,095,749   Rp 4,092,533,934   Rp 4,094,041,612  
0.0573  Rp 4,089,582,679   Rp 4,091,570,571   Rp  4,092,407,097   Rp 4,092,852,509   Rp 4,094,406,768  
0.0574  Rp 4,089,611,031   Rp 4,091,601,259   Rp  4,092,438,992   Rp 4,092,885,145   Rp 4,094,444,177  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,090,671,386   Rp 4,092,749,002   Rp  4,093,631,888   Rp 4,094,105,746   Rp 4,095,843,500  
0.0590  Rp 4,091,135,307   Rp 4,093,251,161   Rp  4,094,153,810   Rp 4,094,639,799   Rp 4,096,455,857  
0.0700  Rp 4,100,900,801   Rp 4,103,820,850   Rp  4,105,139,921   Rp 4,105,881,779   Rp 4,109,354,882  
0.0782  Rp 4,108,068,443   Rp 4,111,576,111   Rp  4,113,199,969   Rp 4,114,129,280   Rp 4,118,819,292  
0.1176  Rp 4,140,987,899   Rp 4,147,135,209   Rp  4,150,127,415   Rp 4,151,897,877   Rp 4,162,032,436  
0.1207  Rp 4,143,455,496   Rp 4,149,795,955   Rp  4,152,888,083   Rp 4,154,719,888   Rp 4,165,249,529  
0.1668  Rp 4,178,837,063   Rp 4,187,870,724   Rp  4,192,352,150   Rp 4,195,035,376   Rp 4,211,017,544  
0.2144  Rp 4,212,772,062   Rp 4,224,262,892   Rp  4,230,005,579   Rp 4,233,459,507   Rp 4,254,332,358  
0.2190  Rp 4,215,893,187   Rp 4,227,604,393   Rp  4,233,459,935   Rp 4,236,982,732   Rp 4,258,290,842  
0.2676  Rp 4,248,058,259   Rp 4,261,991,270   Rp  4,268,982,505   Rp 4,273,197,617   Rp 4,298,867,844  
0.3276  Rp 4,285,220,076   Rp 4,301,621,006   Rp  4,309,869,913   Rp 4,314,850,394   Rp 4,345,319,346  
0.3695  Rp 4,309,765,294   Rp 4,327,746,772   Rp  4,336,799,444   Rp 4,342,268,493   Rp 4,375,790,521  
0.4046  Rp 4,329,505,703   Rp 4,348,733,484   Rp  4,358,419,180   Rp 4,364,272,755   Rp 4,400,193,193  
0.4046  Rp 4,329,505,703   Rp 4,348,733,484   Rp  4,358,419,180   Rp 4,364,272,755   Rp 4,400,193,193  
0.4355  Rp 4,346,410,652   Rp 4,366,689,823   Rp  4,376,909,089   Rp 4,383,086,627   Rp 4,421,025,077  
0.4537  Rp 4,356,097,781   Rp 4,376,973,310   Rp  4,387,495,055   Rp 4,393,856,191   Rp 4,432,937,350  
0.4593  Rp 4,359,073,961   Rp 4,380,131,854   Rp  4,390,746,075   Rp 4,397,163,334   Rp 4,436,593,672  
0.4706  Rp 4,365,023,325   Rp 4,386,444,595   Rp  4,397,243,050   Rp 4,403,772,112   Rp 4,443,897,872  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,391,117,946   Rp 4,414,115,604   Rp  4,425,712,874   Rp 4,432,726,552   Rp 4,475,864,261  
0.5730  Rp 4,416,440,557   Rp 4,440,943,106   Rp  4,453,302,398   Rp 4,460,778,182   Rp 4,506,784,717  
0.6114  Rp 4,434,736,997   Rp 4,460,313,165   Rp  4,473,215,808   Rp 4,481,020,998   Rp 4,529,070,897  
0.6138  Rp 4,435,870,138   Rp 4,461,512,444   Rp  4,474,448,551   Rp 4,482,274,027   Rp 4,530,449,721  
0.6531  Rp 4,454,069,235   Rp 4,480,768,398   Rp  4,494,239,160   Rp 4,502,388,697   Rp 4,552,573,377  
0.6739  Rp 4,463,564,539   Rp 4,490,811,267   Rp  4,504,558,965   Rp 4,512,876,333   Rp 4,564,101,063  
0.7477  Rp 4,496,142,186   Rp 4,525,249,114   Rp  4,539,937,307   Rp 4,548,824,539   Rp 4,603,578,889  
0.7562  Rp 4,499,813,178   Rp 4,529,128,039   Rp  4,543,921,333   Rp 4,552,872,237   Rp 4,608,020,809  
0.7781  Rp 4,509,176,154   Rp 4,539,019,902   Rp  4,554,080,502   Rp 4,563,193,341   Rp 4,619,344,371  
0.8532  Rp 4,540,494,648   Rp 4,572,093,178   Rp  4,588,040,452   Rp 4,597,690,370   Rp 4,657,164,975  
0.8723  Rp 4,548,265,206   Rp 4,580,295,916   Rp  4,596,461,522   Rp 4,606,243,672   Rp 4,666,536,308  
0.8781  Rp 4,550,598,302   Rp 4,582,758,538   Rp  4,598,989,575   Rp 4,608,811,353   Rp 4,669,349,116  
0.8873  Rp 4,554,273,416   Rp 4,586,637,465   Rp  4,602,971,457   Rp 4,612,855,587   Rp 4,673,779,034  
0.8907  Rp 4,555,653,905   Rp 4,588,094,444   Rp  4,604,467,074   Rp 4,614,374,604   Rp 4,675,442,787  
0.8956  Rp 4,557,602,560   Rp 4,590,151,008   Rp  4,606,578,146   Rp 4,616,518,686   Rp 4,677,791,045  
0.9226  Rp 4,568,361,044   Rp 4,601,503,955   Rp  4,618,231,355   Rp 4,628,353,734   Rp 4,690,750,692  
0.9483  Rp 4,578,426,884   Rp 4,612,124,049   Rp  4,629,131,378   Rp 4,639,423,272   Rp 4,702,868,477  
0.9752  Rp 4,588,865,112   Rp 4,623,135,133   Rp  4,640,431,761   Rp 4,650,898,837   Rp 4,715,427,198  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,086,839,612   Rp 4,085,713,790   Rp 4,084,844,528   Rp 4,083,006,010   Rp 4,081,146,687  
0.0518  Rp 4,087,598,372   Rp 4,086,529,229   Rp 4,085,687,532   Rp 4,083,893,863   Rp 4,082,071,173  
0.0519  Rp 4,087,722,307   Rp 4,086,662,442   Rp 4,085,825,260   Rp 4,084,038,941   Rp 4,082,222,257  
0.0523  Rp 4,088,179,152   Rp 4,087,153,538   Rp 4,086,333,029   Rp 4,084,573,856   Rp 4,082,779,361  
0.0528  Rp 4,088,810,911   Rp 4,087,832,784   Rp 4,087,035,406   Rp 4,085,313,912   Rp 4,083,550,228  
0.0532  Rp 4,089,369,161   Rp 4,088,433,108   Rp 4,087,656,238   Rp 4,085,968,165   Rp 4,084,231,821  
0.0533  Rp 4,089,418,104   Rp 4,088,485,746   Rp 4,087,710,676   Rp 4,086,025,539   Rp 4,084,291,597  
0.0539  Rp 4,090,191,567   Rp 4,089,317,680   Rp 4,088,571,129   Rp 4,086,932,495   Rp 4,085,236,611  
0.0543  Rp 4,090,650,280   Rp 4,089,811,156   Rp 4,089,081,570   Rp 4,087,470,610   Rp 4,085,797,383  
0.0551  Rp 4,091,669,970   Rp 4,090,908,336   Rp 4,090,216,589   Rp 4,088,667,379   Rp 4,087,044,725  
0.0558  Rp 4,092,510,191   Rp 4,091,812,615   Rp 4,091,152,171   Rp 4,089,654,067   Rp 4,088,073,281  
0.0568  Rp 4,093,741,969   Rp 4,093,138,612   Rp 4,092,524,238   Rp 4,091,101,384   Rp 4,089,582,263  
0.0568  Rp 4,093,785,341   Rp 4,093,185,307   Rp 4,092,572,559   Rp 4,091,152,361   Rp 4,089,635,417  
0.0569  Rp 4,093,875,955   Rp 4,093,282,867   Rp 4,092,673,516   Rp 4,091,258,869   Rp 4,089,746,474  
0.0570  Rp 4,094,055,328   Rp 4,093,475,994   Rp 4,092,873,371   Rp 4,091,469,717   Rp 4,089,966,332  
0.0573  Rp 4,094,430,949   Rp 4,093,880,438   Rp 4,093,291,918   Rp 4,091,911,306   Rp 4,090,426,809  
0.0574  Rp 4,094,469,430   Rp 4,093,921,874   Rp 4,093,334,800   Rp 4,091,956,551   Rp 4,090,473,989  






Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,095,908,934   Rp 4,095,472,105   Rp 4,094,939,230   Rp 4,093,649,561   Rp 4,092,239,611  
0.0590  Rp 4,096,538,910   Rp 4,096,150,656   Rp 4,095,641,568   Rp 4,094,390,782   Rp 4,093,012,708  
0.0700  Rp 4,109,811,973   Rp 4,110,456,549   Rp 4,110,453,714   Rp 4,110,030,352   Rp 4,109,329,723  
0.0782  Rp 4,119,551,553   Rp 4,120,955,938   Rp 4,121,325,093   Rp 4,121,508,262   Rp 4,121,302,209  
0.1176  Rp 4,163,989,494   Rp 4,168,756,128   Rp 4,170,758,157   Rp 4,173,580,636   Rp 4,175,502,459  
0.1207  Rp 4,167,294,868   Rp 4,172,302,383   Rp 4,174,420,515   Rp 4,177,429,269   Rp 4,179,499,913  
0.1668  Rp 4,214,272,858   Rp 4,222,563,901   Rp 4,226,254,581   Rp 4,231,771,690   Rp 4,235,832,817  
0.2144  Rp 4,258,661,475   Rp 4,269,843,364   Rp 4,274,905,991   Rp 4,282,593,932   Rp 4,288,361,958  
0.2190  Rp 4,262,715,091   Rp 4,274,152,251   Rp 4,279,335,583   Rp 4,287,213,914   Rp 4,293,131,111  
0.2676  Rp 4,304,242,242   Rp 4,318,222,927   Rp 4,324,605,810   Rp 4,334,371,990   Rp 4,341,764,669  
0.3276  Rp 4,351,733,372   Rp 4,368,486,814   Rp 4,376,172,053   Rp 4,387,980,869   Rp 4,396,963,984  
0.3695  Rp 4,382,863,610   Rp 4,401,370,548   Rp 4,409,877,224   Rp 4,422,971,550   Rp 4,432,953,162  
0.4046  Rp 4,407,782,981   Rp 4,427,662,787   Rp 4,436,811,651   Rp 4,450,909,754   Rp 4,461,669,995  
0.4046  Rp 4,407,782,981   Rp 4,427,662,787   Rp 4,436,811,651   Rp 4,450,909,754   Rp 4,461,669,995  
0.4355  Rp 4,429,049,005   Rp 4,450,081,246   Rp 4,459,768,643   Rp 4,474,707,800   Rp 4,486,119,850  
0.4537  Rp 4,441,206,892   Rp 4,462,890,734   Rp 4,472,882,429   Rp 4,488,296,573   Rp 4,500,076,519  
0.4593  Rp 4,444,938,237   Rp 4,466,821,059   Rp 4,476,905,653   Rp 4,492,464,770   Rp 4,504,356,975  
0.4706  Rp 4,452,391,813   Rp 4,474,670,752   Rp 4,484,940,245   Rp 4,500,787,864   Rp 4,512,903,432  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,485,004,610   Rp 4,508,996,717   Rp 4,520,065,395   Rp 4,537,159,363   Rp 4,550,239,334  
0.5730  Rp 4,516,540,021   Rp 4,542,160,646   Rp 4,553,988,372   Rp 4,572,265,256   Rp 4,586,259,842  
0.6114  Rp 4,539,263,838   Rp 4,566,042,756   Rp 4,578,410,029   Rp 4,597,527,333   Rp 4,612,171,362  
0.6138  Rp 4,540,669,594   Rp 4,567,519,780   Rp 4,579,920,242   Rp 4,599,089,232   Rp 4,613,773,193  
0.6531  Rp 4,563,223,245   Rp 4,591,211,007   Rp 4,604,141,120   Rp 4,624,134,797   Rp 4,639,455,775  
0.6739  Rp 4,574,973,445   Rp 4,603,549,722   Rp 4,616,753,764   Rp 4,637,173,854   Rp 4,652,824,119  
0.7477  Rp 4,615,206,007   Rp 4,645,777,705   Rp 4,659,910,166   Rp 4,681,775,009   Rp 4,698,540,550  
0.7562  Rp 4,619,732,186   Rp 4,650,526,593   Rp 4,664,762,642   Rp 4,686,788,642   Rp 4,703,678,553  
0.7781  Rp 4,631,269,982   Rp 4,662,630,579   Rp 4,677,129,954   Rp 4,699,565,587   Rp 4,716,771,598  
0.8532  Rp 4,669,800,578   Rp 4,703,037,099   Rp 4,718,408,684   Rp 4,742,200,820   Rp 4,760,453,315  
0.8723  Rp 4,679,346,600   Rp 4,713,044,576   Rp 4,728,630,661   Rp 4,752,756,327   Rp 4,771,266,068  
0.8781  Rp 4,682,211,751   Rp 4,716,047,986   Rp 4,731,698,335   Rp 4,755,923,921   Rp 4,774,510,724  
0.8873  Rp 4,686,724,021   Rp 4,720,777,775   Rp 4,736,529,225   Rp 4,760,912,003   Rp 4,779,620,034  
0.8907  Rp 4,688,418,677   Rp 4,722,554,054   Rp 4,738,343,441   Rp 4,762,785,200   Rp 4,781,538,718  
0.8956  Rp 4,690,810,528   Rp 4,725,061,046   Rp 4,740,903,945   Rp 4,765,428,904   Rp 4,784,246,584  
0.9226  Rp 4,704,010,263   Rp 4,738,894,869   Rp 4,755,032,452   Rp 4,780,015,540   Rp 4,799,186,497  
0.9483  Rp 4,716,351,805   Rp 4,751,827,302   Rp 4,768,239,465   Rp 4,793,649,388   Rp 4,813,149,459  
0.9752  Rp 4,729,141,700   Rp 4,765,227,628   Rp 4,781,923,420   Rp 4,807,774,210   Rp 4,827,614,181  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,075,912,348   Rp4,070,288,865   Rp 4,068,215,213   Rp 4,065,590,735   Rp 4,060,455,752  
0.0518  Rp 4,076,920,445   Rp4,071,373,046   Rp 4,069,325,767   Rp 4,066,733,918   Rp 4,061,661,336  
0.0519  Rp 4,077,085,240   Rp4,071,550,319   Rp 4,069,507,365   Rp 4,066,920,864   Rp 4,061,858,505  
0.0523  Rp 4,077,693,015   Rp4,072,204,204   Rp 4,070,177,226   Rp 4,067,610,483   Rp 4,062,585,875  
0.0528  Rp 4,078,534,266   Rp4,073,109,498   Rp 4,071,104,701   Rp 4,068,565,380   Rp 4,063,593,133  
0.0532  Rp 4,079,278,336   Rp4,073,910,405   Rp 4,071,925,286   Rp 4,069,410,281   Rp 4,064,484,431  
0.0533  Rp 4,079,343,601   Rp4,073,980,664   Rp 4,071,997,273   Rp 4,069,484,403   Rp 4,064,562,627  
0.0539  Rp 4,080,375,609   Rp4,075,091,788   Rp 4,073,135,771   Rp 4,070,656,714   Rp 4,065,799,396  
0.0543  Rp 4,080,988,175   Rp4,075,751,444   Rp 4,073,811,712   Rp 4,071,352,761   Rp 4,066,533,742  
0.0551  Rp 4,082,351,142   Rp4,077,219,483   Rp 4,075,316,061   Rp 4,072,901,921   Rp 4,068,168,176  
0.0558  Rp 4,083,475,430   Rp4,078,430,699   Rp 4,076,557,293   Rp 4,074,180,170   Rp 4,069,516,782  
0.0568  Rp 4,085,125,393   Rp4,080,208,564   Rp 4,078,379,275   Rp 4,076,056,520   Rp 4,071,496,331  
0.0568  Rp 4,085,183,523   Rp4,080,271,207   Rp 4,078,443,473   Rp 4,076,122,633   Rp 4,071,566,078  
0.0569  Rp 4,085,304,980   Rp4,080,402,092   Rp 4,078,577,608   Rp 4,076,260,771   Rp 4,071,711,806  
0.0570  Rp 4,085,545,434   Rp4,080,661,216   Rp 4,078,843,166   Rp 4,076,534,254   Rp 4,072,000,315  
0.0573  Rp 4,086,049,082   Rp4,081,203,986   Rp 4,079,399,416   Rp 4,077,107,101   Rp 4,072,604,622  
0.0574  Rp 4,086,100,688   Rp4,081,259,603   Rp 4,079,456,413   Rp 4,077,165,799   Rp 4,072,666,542  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,088,032,234   Rp4,083,341,358   Rp 4,081,589,870   Rp 4,079,362,874   Rp 4,074,984,057  
0.0590  Rp 4,088,878,140   Rp4,084,253,101   Rp 4,082,524,248   Rp 4,080,325,085   Rp 4,075,998,890  
0.0700  Rp 4,106,735,980   Rp4,103,491,621   Rp 4,102,233,940   Rp 4,100,611,385   Rp 4,097,366,573  
0.0782  Rp 4,119,823,433   Rp4,117,562,856   Rp 4,116,637,049   Rp 4,115,417,792   Rp 4,112,920,613  
0.1176  Rp 4,178,728,826   Rp4,180,503,734   Rp 4,180,913,660   Rp 4,181,300,055   Rp 4,181,728,780  
0.1207  Rp 4,183,050,641   Rp4,185,098,233   Rp 4,185,597,258   Rp 4,186,089,986   Rp 4,186,710,316  
0.1668  Rp 4,243,678,528   Rp4,249,289,815   Rp 4,250,943,906   Rp 4,252,809,123   Rp 4,255,886,207  
0.2144  Rp 4,299,842,173   Rp4,308,418,288   Rp 4,311,023,473   Rp 4,314,012,583   Rp 4,319,084,705  
0.2190  Rp 4,304,927,372   Rp4,313,759,681   Rp 4,316,446,743   Rp 4,319,532,412   Rp 4,324,775,426  
0.2676  Rp 4,356,676,239   Rp4,368,023,112   Rp 4,371,511,760   Rp 4,375,541,502   Rp 4,382,452,014  
0.3276  Rp 4,415,216,063   Rp4,429,241,907   Rp 4,433,581,302   Rp 4,438,611,008   Rp 4,447,282,470  
0.3695  Rp 4,453,295,486   Rp4,468,990,779   Rp 4,473,859,056   Rp 4,479,509,624   Rp 4,489,272,379  
0.4046  Rp 4,483,639,332   Rp4,500,631,205   Rp 4,505,909,701   Rp 4,512,041,502   Rp 4,522,649,260  
0.4046  Rp 4,483,639,332   Rp4,500,631,205   Rp 4,505,909,701   Rp 4,512,041,502   Rp 4,522,649,260  
0.4355  Rp 4,509,449,503   Rp4,527,523,767   Rp 4,533,144,410   Rp 4,539,677,398   Rp 4,550,989,114  
0.4537  Rp 4,524,173,360   Rp4,542,857,476   Rp 4,548,670,785   Rp 4,555,429,618   Rp 4,567,137,448  
0.4593  Rp 4,528,687,832   Rp4,547,557,894   Rp 4,553,429,932   Rp 4,560,257,601   Rp 4,572,086,136  
0.4706  Rp 4,537,699,805   Rp4,556,939,652   Rp 4,562,928,466   Rp 4,569,892,990   Rp 4,581,961,480  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,577,044,132   Rp4,597,877,906   Rp 4,604,369,795   Rp 4,611,923,732   Rp 4,625,025,228  
0.5730  Rp 4,614,967,372   Rp4,637,309,242   Rp 4,644,276,753   Rp 4,652,387,719   Rp 4,666,464,886  
0.6114  Rp 4,642,228,951   Rp4,665,639,884   Rp 4,672,944,373   Rp 4,681,449,880   Rp 4,696,217,815  
0.6138  Rp 4,643,913,768   Rp4,667,390,390   Rp 4,674,715,580   Rp 4,683,245,322   Rp 4,698,055,681  
0.6531  Rp 4,670,919,820   Rp4,695,443,706   Rp 4,703,098,866   Rp 4,712,014,858   Rp 4,727,501,250  
0.6739  Rp 4,684,972,039   Rp4,710,036,831   Rp 4,717,862,372   Rp 4,726,977,779   Rp 4,742,813,123  
0.7477  Rp 4,733,003,580   Rp4,759,898,382   Rp 4,768,300,156   Rp 4,778,089,860   Rp 4,795,104,810  
0.7562  Rp 4,738,399,653   Rp4,765,498,353   Rp 4,773,964,311   Rp 4,783,829,113   Rp 4,800,975,407  
0.7781  Rp 4,752,148,523   Rp4,779,765,301   Rp 4,788,394,331   Rp 4,798,449,918   Rp 4,815,929,872  
0.8532  Rp 4,798,000,657   Rp4,827,331,218   Rp 4,836,499,538   Rp 4,847,185,980   Rp 4,865,768,989  
0.8723  Rp 4,809,346,769   Rp4,839,098,311   Rp 4,848,399,073   Rp 4,859,240,426   Rp 4,878,094,248  
0.8781  Rp 4,812,751,190   Rp4,842,628,823   Rp 4,851,969,251   Rp 4,862,856,999   Rp 4,881,791,923  
0.8873  Rp 4,818,111,818   Rp4,848,187,787   Rp 4,857,590,608   Rp 4,868,551,328   Rp 4,887,613,814  
0.8907  Rp 4,820,124,799   Rp4,850,275,180   Rp 4,859,701,409   Rp 4,870,689,507   Rp 4,889,799,848  
0.8956  Rp 4,822,965,669   Rp4,853,221,008   Rp 4,862,680,253   Rp 4,873,706,965   Rp 4,892,884,804  
0.9226  Rp 4,838,637,856   Rp4,869,470,985   Rp 4,879,111,970   Rp 4,890,351,230   Rp 4,909,900,587  
0.9483  Rp 4,853,282,907   Rp4,884,654,138   Rp 4,894,464,361   Rp 4,905,901,540   Rp 4,925,796,811  
0.9752  Rp 4,868,451,986   Rp4,900,378,796   Rp 4,910,363,737   Rp 4,922,005,232   Rp 4,942,257,573  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,046,360,818   Rp 4,038,185,757   Rp 4,032,213,029   Rp 4,029,119,317   Rp 4,020,996,261  
0.0518  Rp 4,047,736,258   Rp 4,039,662,644   Rp 4,033,766,477   Rp 4,030,713,379   Rp 4,022,700,443  
0.0519  Rp 4,047,961,206   Rp 4,039,904,144   Rp 4,034,020,449   Rp 4,030,973,958   Rp 4,022,978,914  
0.0523  Rp 4,048,791,041   Rp 4,040,794,936   Rp 4,034,957,118   Rp 4,031,934,920   Rp 4,024,005,589  
0.0528  Rp 4,049,940,116   Rp 4,042,028,136   Rp 4,036,253,507   Rp 4,033,264,724   Rp 4,025,425,635  
0.0532  Rp 4,050,956,789   Rp 4,043,118,952   Rp 4,037,399,894   Rp 4,034,440,458   Rp 4,026,680,484  
0.0533  Rp 4,051,045,977   Rp 4,043,214,630   Rp 4,037,500,433   Rp 4,034,543,561   Rp 4,026,790,494  
0.0539  Rp 4,052,456,443   Rp 4,044,727,443   Rp 4,039,089,768   Rp 4,036,173,241   Rp 4,028,528,717  
0.0543  Rp 4,053,293,752   Rp 4,045,625,233   Rp 4,040,032,685   Rp 4,037,139,919   Rp 4,029,559,209  
0.0551  Rp 4,055,156,795   Rp 4,047,622,081   Rp 4,042,129,130   Rp 4,039,288,721   Rp 4,031,848,356  
0.0558  Rp 4,056,693,370   Rp 4,049,268,189   Rp 4,043,856,530   Rp 4,041,058,774   Rp 4,033,732,469  
0.0568  Rp 4,058,947,585   Rp 4,051,681,697   Rp 4,046,387,892   Rp 4,043,651,848   Rp 4,036,490,158  
0.0568  Rp 4,059,026,980   Rp 4,051,766,673   Rp 4,046,476,988   Rp 4,043,743,099   Rp 4,036,587,148  
0.0569  Rp 4,059,192,862   Rp 4,051,944,205   Rp 4,046,663,122   Rp 4,043,933,732   Rp 4,036,789,760  
0.0570  Rp 4,059,521,242   Rp 4,052,295,622   Rp 4,047,031,541   Rp 4,044,311,040   Rp 4,037,190,733  
0.0573  Rp 4,060,208,945   Rp 4,053,031,452   Rp 4,047,802,863   Rp 4,045,100,908   Rp 4,038,029,944  
0.0574  Rp 4,060,279,402   Rp 4,053,106,831   Rp 4,047,881,869   Rp 4,045,181,809   Rp 4,038,115,883  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,062,915,144   Rp 4,055,925,476   Rp 4,050,835,048   Rp 4,048,205,171   Rp 4,041,325,587  
0.0590  Rp 4,064,068,524   Rp 4,057,158,146   Rp 4,052,125,878   Rp 4,049,526,288   Rp 4,042,726,944  
0.0700  Rp 4,088,225,347   Rp 4,082,873,120   Rp 4,078,966,777   Rp 4,076,948,011   Rp 4,071,669,923  
0.0782  Rp 4,105,653,942   Rp 4,101,315,673   Rp 4,098,127,805   Rp 4,096,475,172   Rp 4,092,142,050  
0.1176  Rp 4,181,518,355   Rp 4,180,840,030   Rp 4,180,183,771   Rp 4,179,802,467   Rp 4,178,694,744  
0.1207  Rp 4,186,950,646   Rp 4,186,500,008   Rp 4,185,998,899   Rp 4,185,694,806   Rp 4,184,780,917  
0.1668  Rp 4,261,825,197   Rp 4,264,211,541   Rp 4,265,628,322   Rp 4,266,274,174   Rp 4,267,732,264  
0.2144  Rp 4,329,570,809   Rp 4,334,180,386   Rp 4,337,085,505   Rp 4,338,464,273   Rp 4,341,740,363  
0.2190  Rp 4,335,648,609   Rp 4,340,446,243   Rp 4,343,476,827   Rp 4,344,917,255   Rp 4,348,345,940  
0.2676  Rp 4,397,086,672   Rp 4,403,704,151   Rp 4,407,946,163   Rp 4,409,981,156   Rp 4,414,879,094  
0.3276  Rp 4,465,865,023   Rp 4,474,380,643   Rp 4,479,881,989   Rp 4,482,533,845   Rp 4,488,952,740  
0.3695  Rp 4,510,292,077   Rp 4,519,974,882   Rp 4,526,248,983   Rp 4,529,278,892   Rp 4,536,628,622  
0.4046  Rp 4,545,552,123   Rp 4,556,134,886   Rp 4,563,004,144   Rp 4,566,325,024   Rp 4,574,390,636  
0.4046  Rp 4,545,552,123   Rp 4,556,134,886   Rp 4,563,004,144   Rp 4,566,325,024   Rp 4,574,390,636  
0.4355  Rp 4,575,458,562   Rp 4,586,788,899   Rp 4,594,152,154   Rp 4,597,714,438   Rp 4,606,373,669  
0.4537  Rp 4,592,487,600   Rp 4,604,237,820   Rp 4,611,878,396   Rp 4,615,576,160   Rp 4,624,568,430  
0.4593  Rp 4,597,704,557   Rp 4,609,582,624   Rp 4,617,307,621   Rp 4,621,046,622   Rp 4,630,140,246  
0.4706  Rp 4,608,113,052   Rp 4,620,245,131   Rp 4,628,137,836   Rp 4,631,958,749   Rp 4,641,253,682  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,653,470,019   Rp 4,666,693,695   Rp 4,675,306,763   Rp 4,679,479,422   Rp 4,689,638,535  
0.5730  Rp 4,697,072,974   Rp 4,711,325,119   Rp 4,720,616,439   Rp 4,725,120,149   Rp 4,736,092,235  
0.6114  Rp 4,728,356,164   Rp 4,743,335,168   Rp 4,753,105,605   Rp 4,757,843,102   Rp 4,769,389,122  
0.6138  Rp 4,730,287,976   Rp 4,745,311,589   Rp 4,755,111,424   Rp 4,759,863,265   Rp 4,771,444,492  
0.6531  Rp 4,761,230,154   Rp 4,776,964,151   Rp 4,787,232,069   Rp 4,792,212,264   Rp 4,804,353,944  
0.6739  Rp 4,777,314,202   Rp 4,793,414,559   Rp 4,803,923,819   Rp 4,809,021,735   Rp 4,821,452,296  
0.7477  Rp 4,832,214,660   Rp 4,849,552,014   Rp 4,860,875,892   Rp 4,866,371,085   Rp 4,879,776,323  
0.7562  Rp 4,838,375,600   Rp 4,855,850,560   Rp 4,867,265,034   Rp 4,872,804,403   Rp 4,886,318,004  
0.7781  Rp 4,854,067,521   Rp 4,871,891,940   Rp 4,883,536,471   Rp 4,889,188,013   Rp 4,902,976,754  
0.8532  Rp 4,906,343,569   Rp 4,925,322,262   Rp 4,937,726,492   Rp 4,943,748,401   Rp 4,958,445,443  
0.8723  Rp 4,919,266,892   Rp 4,938,528,753   Rp 4,951,119,313   Rp 4,957,232,050   Rp 4,972,151,808  
0.8781  Rp 4,923,143,658   Rp 4,942,490,305   Rp 4,955,136,654   Rp 4,961,276,584   Rp 4,976,263,020  
0.8873  Rp 4,929,247,216   Rp 4,948,727,205   Rp 4,961,461,289   Rp 4,967,643,983   Rp 4,982,735,277  
0.8907  Rp 4,931,538,918   Rp 4,951,068,926   Rp 4,963,835,921   Rp 4,970,034,657   Rp 4,985,165,283  
0.8956  Rp 4,934,772,903   Rp 4,954,373,457   Rp 4,967,186,867   Rp 4,973,408,227   Rp 4,988,594,323  
0.9226  Rp 4,952,608,881   Rp 4,972,597,644   Rp 4,985,666,457   Rp 4,992,012,301   Rp 5,007,503,604  
0.9483  Rp 4,969,268,649   Rp 4,989,618,745   Rp 5,002,925,257   Rp 5,009,386,949   Rp 5,025,162,268  
0.9752  Rp 4,986,517,455   Rp 5,007,240,415   Rp 5,020,792,190   Rp 5,027,373,411   Rp 5,043,441,752  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0512  Rp 4,000,617,392   Rp 4,000,543,860   Rp 3,992,099,994   Rp 3,973,291,865   Rp 3,956,854,226  
0.0518  Rp 4,002,623,413   Rp 4,002,551,042   Rp 3,994,244,373   Rp 3,975,770,298   Rp 3,959,659,544  
0.0519  Rp 4,002,950,743   Rp 4,002,878,560   Rp 3,994,594,016   Rp 3,976,173,610   Rp 3,960,115,121  
0.0523  Rp 4,004,156,444   Rp 4,004,084,948   Rp 3,995,881,276   Rp 3,977,656,593   Rp 3,961,788,129  
0.0528  Rp 4,005,821,273   Rp 4,005,750,712   Rp 3,997,657,134   Rp 3,979,697,758   Rp 3,964,085,466  
0.0532  Rp 4,007,289,736   Rp 4,007,219,988   Rp 3,999,222,042   Rp 3,981,492,094   Rp 3,966,100,059  
0.0533  Rp 4,007,418,355   Rp 4,007,348,679   Rp 3,999,359,044   Rp 3,981,648,992   Rp 3,966,276,004  
0.0539  Rp 4,009,448,102   Rp 4,009,379,531   Rp 4,001,519,717   Rp 3,984,119,524   Rp 3,969,042,071  
0.0543  Rp 4,010,649,235   Rp 4,010,581,311   Rp 4,002,797,151   Rp 3,985,576,774   Rp 3,970,669,902  
0.0551  Rp 4,013,311,777   Rp 4,013,245,260   Rp 4,005,625,817   Rp 3,988,795,071   Rp 3,974,255,583  
0.0558  Rp 4,015,497,517   Rp 4,015,432,132   Rp 4,007,944,942   Rp 3,991,425,252   Rp 3,977,176,940  
0.0568  Rp 4,018,687,746   Rp 4,018,623,977   Rp 4,011,325,246   Rp 3,995,246,183   Rp 3,981,407,262  
0.0568  Rp 4,018,799,761   Rp 4,018,736,048   Rp 4,011,443,839   Rp 3,995,379,970   Rp 3,981,555,104  
0.0569  Rp 4,019,033,719   Rp 4,018,970,123   Rp 4,011,691,514   Rp 3,995,659,323   Rp 3,981,863,744  
0.0570  Rp 4,019,496,563   Rp 4,019,433,198   Rp 4,012,181,415   Rp 3,996,211,657   Rp 3,982,473,753  
0.0573  Rp 4,020,464,582   Rp 4,020,401,697   Rp 4,013,205,673   Rp 3,997,365,502   Rp 3,983,747,088  
0.0574  Rp 4,020,563,660   Rp 4,020,500,823   Rp 4,013,310,481   Rp 3,997,483,498   Rp 3,983,877,228  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.0585  Rp 4,024,257,287   Rp 4,024,196,244   Rp 4,017,214,322   Rp 4,001,869,437   Rp 3,988,705,094  
0.0590  Rp 4,025,865,892   Rp 4,025,805,614   Rp 4,018,912,474   Rp 4,003,771,938   Rp 3,990,793,766  
0.0700  Rp 4,058,629,253   Rp 4,058,582,814   Rp 4,053,282,492   Rp 4,041,720,605   Rp 4,031,907,599  
0.0782  Rp 4,081,391,586   Rp 4,081,353,241   Rp 4,076,975,548   Rp 4,067,425,114   Rp 4,059,326,936  
0.1176  Rp 4,175,454,949   Rp 4,175,442,437   Rp 4,173,978,989   Rp 4,170,586,482   Rp 4,167,547,066  
0.1207  Rp 4,181,981,631   Rp 4,181,970,609   Rp 4,180,674,211   Rp 4,177,628,098   Rp 4,174,866,953  
0.1668  Rp 4,270,258,360   Rp 4,270,265,205   Rp 4,270,965,717   Rp 4,272,023,464   Rp 4,272,524,906  
0.2144  Rp 4,348,287,760   Rp 4,348,307,962   Rp 4,350,495,732   Rp 4,354,576,683   Rp 4,357,451,101  
0.2190  Rp 4,355,229,138   Rp 4,355,250,451   Rp 4,357,561,827   Rp 4,361,893,094   Rp 4,364,963,133  
0.2676  Rp 4,424,984,777   Rp 4,425,016,732   Rp 4,428,510,632   Rp 4,435,230,871   Rp 4,440,162,635  
0.3276  Rp 4,502,377,724   Rp 4,502,420,604   Rp 4,507,126,952   Rp 4,516,287,744   Rp 4,523,113,399  
0.3695  Rp 4,552,078,695   Rp 4,552,128,225   Rp 4,557,572,138   Rp 4,568,214,192   Rp 4,576,186,253  
0.4046  Rp 4,591,395,505   Rp 4,591,450,136   Rp 4,597,459,432   Rp 4,609,235,544   Rp 4,618,084,017  
0.4046  Rp 4,591,395,505   Rp 4,591,450,136   Rp 4,597,459,432   Rp 4,609,235,544   Rp 4,618,084,017  
0.4355  Rp 4,624,666,293   Rp 4,624,725,145   Rp 4,631,202,209   Rp 4,643,915,774   Rp 4,653,487,994  
0.4537  Rp 4,643,582,987   Rp 4,643,644,204   Rp 4,650,383,324   Rp 4,663,621,787   Rp 4,673,598,986  
0.4593  Rp 4,649,374,439   Rp 4,649,436,375   Rp 4,656,255,197   Rp 4,669,653,264   Rp 4,679,753,569  
0.4706  Rp 4,660,924,019   Rp 4,660,987,384   Rp 4,667,964,442   Rp 4,681,679,328   Rp 4,692,023,956  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
Dellay Period (M) 














0.5216  Rp 4,711,179,803   Rp 4,711,249,292   Rp 4,718,904,683   Rp 4,733,977,006   Rp 4,745,367,804  
0.5730  Rp 4,759,391,801   Rp 4,759,467,042   Rp 4,767,759,328   Rp 4,784,105,215   Rp 4,796,476,680  
0.6114  Rp 4,793,929,089   Rp 4,794,008,385   Rp 4,802,749,666   Rp 4,819,992,898   Rp 4,833,054,895  
0.6138  Rp 4,796,060,527   Rp 4,796,140,072   Rp 4,804,908,880   Rp 4,822,207,115   Rp 4,835,311,427  
0.6531  Rp 4,830,180,564   Rp 4,830,264,065   Rp 4,839,470,845   Rp 4,857,644,026   Rp 4,871,421,302  
0.6739  Rp 4,847,902,672   Rp 4,847,988,211   Rp 4,857,420,579   Rp 4,876,044,301   Rp 4,890,167,998  
0.7477  Rp 4,908,330,215   Rp 4,908,422,625   Rp 4,918,615,403   Rp 4,938,757,247   Rp 4,954,047,723  
0.7562  Rp 4,915,105,669   Rp 4,915,198,842   Rp 4,925,476,097   Rp 4,945,786,545   Rp 4,961,206,561  
0.7781  Rp 4,932,357,911   Rp 4,932,453,022   Rp 4,942,944,717   Rp 4,963,683,118   Rp 4,979,431,894  
0.8532  Rp 4,989,785,125   Rp 4,989,886,629   Rp 5,001,085,730   Rp 5,023,235,496   Rp 5,040,068,148  
0.8723  Rp 5,003,971,566   Rp 5,004,074,637   Rp 5,015,447,085   Rp 5,037,942,614   Rp 5,055,040,722  
0.8781  Rp 5,008,226,495   Rp 5,008,330,035   Rp 5,019,754,373   Rp 5,042,353,397   Rp 5,059,530,957  
0.8873  Rp 5,014,924,747   Rp 5,015,029,024   Rp 5,026,534,956   Rp 5,049,296,713   Rp 5,066,599,195  
0.8907  Rp 5,017,439,523   Rp 5,017,544,077   Rp 5,029,080,612   Rp 5,051,903,405   Rp 5,069,252,741  
0.8956  Rp 5,020,988,108   Rp 5,021,093,052   Rp 5,032,672,746   Rp 5,055,581,612   Rp 5,072,997,018  
0.9226  Rp 5,040,555,096   Rp 5,040,662,185   Rp 5,052,479,302   Rp 5,075,861,640   Rp 5,093,640,459  
0.9483  Rp 5,058,825,710   Rp 5,058,934,796   Rp 5,070,972,788   Rp 5,094,795,550   Rp 5,112,912,370  
0.9752  Rp 5,077,736,460   Rp 5,077,847,606   Rp 5,090,113,417   Rp 5,114,390,399   Rp 5,132,855,767  





Attachment 1. Two-Way Sensitivity Analysis toward Total inventory Cost (Scenario 3) (cont.) 
TC(T*) 
 Delay Period (M)  
TC(T*) 
 Delay Period (M)  
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0.5216  Rp 4,767,933,935   Rp 4,770,951,788  
0.0518  Rp 3,920,919,717   Rp 3,914,917,271  0.0590  Rp 3,960,499,260   Rp 3,955,924,776  0.5730  Rp 4,821,035,478   Rp 4,824,325,145  
0.0519  Rp 3,921,524,454   Rp 3,915,548,361  0.0700  Rp 4,009,386,329   Rp 4,006,034,399  0.6114  Rp 4,859,015,643   Rp 4,862,496,424  
0.0523  Rp 3,923,737,037   Rp 3,917,855,896  0.0782  Rp 4,040,798,246   Rp 4,038,049,183  0.6138  Rp 4,861,358,058   Rp 4,864,850,543  
0.0528  Rp 3,926,755,175   Rp 3,920,999,968  0.1176  Rp 4,160,214,624   Rp 4,159,093,521  0.6531  Rp 4,898,833,325   Rp 4,902,511,849  
0.0532  Rp 3,929,383,671   Rp 3,923,734,923  0.1207  Rp 4,168,132,063   Rp 4,167,095,895  0.6739  Rp 4,918,282,588   Rp 4,922,056,808  
0.0533  Rp 3,929,612,454   Rp 3,923,972,836  0.1668  Rp 4,272,701,088   Rp 4,272,637,392  0.7477  Rp 4,984,527,270   Rp 4,988,623,478  
0.0539  Rp 3,933,193,504   Rp 3,927,694,036  0.2144  Rp 4,362,570,853   Rp 4,363,194,213  0.7562  Rp 4,991,948,553   Rp 4,996,080,481  
0.0543  Rp 3,935,287,653   Rp 3,929,867,830  0.2190  Rp 4,370,488,108   Rp 4,371,167,548  0.7781  Rp 5,010,839,850   Rp 5,015,062,406  
0.0551  Rp 3,939,867,920   Rp 3,934,616,679  0.2676  Rp 4,449,530,067   Rp 4,450,739,829  0.8532  Rp 5,073,670,740   Rp 5,078,191,858  
0.0558  Rp 3,943,568,502   Rp 3,938,448,153  0.3276  Rp 4,536,368,251   Rp 4,538,112,341  0.8723  Rp 5,089,180,603   Rp 5,093,774,793  
0.0568  Rp 3,948,881,574   Rp 3,943,941,446  0.3695  Rp 4,591,786,061   Rp 4,593,851,628  0.8781  Rp 5,093,831,634   Rp 5,098,447,691  
0.0568  Rp 3,949,066,332   Rp 3,944,132,315  0.4046  Rp 4,635,473,111   Rp 4,637,783,625  0.8873  Rp 5,101,152,682   Rp 5,105,803,117  
0.0569  Rp 3,949,451,844   Rp 3,944,530,547  0.4046  Rp 4,635,473,111   Rp 4,637,783,625  0.8907  Rp 5,103,901,041   Rp 5,108,564,369  
0.0570  Rp 3,950,213,017   Rp 3,945,316,705  0.4355  Rp 4,672,352,752   Rp 4,674,865,078  0.8956  Rp 5,107,779,016   Rp 5,112,460,524  
0.0573  Rp 3,951,798,658   Rp 3,946,953,853  0.4537  Rp 4,693,288,771   Rp 4,695,913,858  0.9226  Rp 5,129,157,766   Rp 5,133,939,252  
0.0574  Rp 3,951,960,475   Rp 3,947,120,886  0.4593  Rp 4,699,694,055   Rp 4,702,353,396  0.9483  Rp 5,149,113,455   Rp 5,153,987,900  
0.0578  Rp 3,954,150,599   Rp 3,949,380,878  0.4706  Rp 4,712,461,872   Rp 4,715,189,168  0.9752  Rp 5,169,761,848   Rp 5,174,732,124  









Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.0512 4 4 4 4 4 4 4 4 4 4 4 4 
0.0518 4 4 4 4 4 4 4 4 4 4 4 4 
0.0519 4 4 4 4 4 4 4 4 4 4 4 4 
0.0523 4 4 4 4 4 4 4 4 4 4 4 4 
0.0528 4 4 4 4 4 4 4 4 4 4 4 4 
0.0532 4 4 4 4 4 4 4 4 4 4 4 4 
0.0533 4 4 4 4 4 4 4 4 4 4 4 4 
0.0539 4 4 4 4 4 4 4 4 4 4 4 4 
0.0543 4 4 4 4 4 4 4 4 4 4 4 4 
0.0551 4 4 4 4 4 4 4 4 4 4 4 4 
0.0558 4 4 4 4 4 4 4 4 4 4 4 4 
0.0568 4 4 4 4 4 4 4 4 4 4 4 4 
0.0568 4 4 4 4 4 4 4 4 4 4 4 4 
0.0569 4 4 4 4 4 4 4 4 4 4 4 4 
0.0570 4 4 4 4 4 4 4 4 4 4 4 4 
0.0573 4 4 4 4 4 4 4 4 4 4 4 4 
0.0574 4 4 4 4 4 4 4 4 4 4 4 4 
0.0578 4 4 4 4 4 4 4 4 4 4 4 4 
0.0585 4 4 4 4 4 4 4 4 4 4 4 4 
0.0590 4 4 4 4 4 4 4 4 4 4 4 4 
0.0700 4 4 4 4 4 4 4 4 4 4 4 4 
0.0782 4 4 4 4 4 4 4 4 4 4 4 4 
0.1176 4 4 4 4 4 4 4 4 4 4 4 4 
120 
 
Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.1207 4 4 4 4 4 4 4 4 4 4 4 4 
0.1668 4 4 4 4 4 5 5 5 5 5 5 5 
0.2144 5 5 5 5 5 5 5 5 5 5 5 5 
0.2190 5 5 5 5 5 5 5 5 5 5 5 5 
0.2676 5 5 5 5 5 5 5 5 5 5 5 5 
0.3276 5 5 5 5 5 5 5 5 5 5 5 6 
0.3695 5 5 5 5 5 5 5 5 5 6 6 6 
0.4046 5 5 5 5 5 5 5 6 6 6 6 6 
0.4355 5 5 5 5 5 6 6 6 6 6 6 6 
0.4537 5 5 5 5 5 6 6 6 6 6 6 6 
0.4593 5 5 5 5 5 6 6 6 6 6 6 6 
0.4706 5 5 5 5 6 6 6 6 6 6 6 6 
0.5089 5 5 6 6 6 6 6 6 6 6 6 6 
0.5216 5 5 6 6 6 6 6 6 6 6 6 6 
0.5730 6 6 6 6 6 6 6 6 6 6 7 7 
0.6114 6 6 6 6 6 6 6 6 6 7 7 7 
0.6138 6 6 6 6 6 6 6 6 6 7 7 7 
0.6531 6 6 6 6 6 6 6 6 6 7 7 7 
0.6739 6 6 6 6 6 6 6 7 7 7 7 7 
0.7477 6 6 6 6 6 7 7 7 7 7 7 7 
0.7562 6 6 6 6 6 7 7 7 7 7 7 7 
0.7781 6 6 6 6 6 7 7 7 7 7 7 7 
0.8532 6 6 6 7 7 7 7 7 7 8 8 8 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.0512 4 4 4 4 4 4 4 4 4 4 4 4 
0.0518 4 4 4 4 4 4 4 4 4 4 4 4 
0.0519 4 4 4 4 4 4 4 4 4 4 4 4 
0.0523 4 4 4 4 4 4 4 4 4 4 4 4 
0.0528 4 4 4 4 4 4 4 4 4 4 4 4 
0.0532 4 4 4 4 4 4 4 4 4 4 4 4 
0.0533 4 4 4 4 4 4 4 4 4 4 4 4 
0.0539 4 4 4 4 4 4 4 4 4 4 4 4 
0.0543 4 4 4 4 4 4 4 4 4 4 4 4 
0.0551 4 4 4 4 4 4 4 4 4 4 4 4 
0.0558 4 4 4 4 4 4 4 4 4 4 4 4 
0.0568 4 4 4 4 4 4 4 4 4 4 4 4 
0.0568 4 4 4 4 4 4 4 4 4 4 4 4 
0.0569 4 4 4 4 4 4 4 4 4 4 4 4 
0.0570 4 4 4 4 4 4 4 4 4 4 4 4 
0.0573 4 4 4 4 4 4 4 4 4 4 4 4 
0.0574 4 4 4 4 4 4 4 4 4 4 4 4 
0.0578 4 4 4 4 4 4 4 4 4 4 4 4 
0.0585 4 4 4 4 4 4 4 4 4 4 4 4 
0.0590 4 4 4 4 4 4 4 4 4 4 4 4 
0.0700 4 4 4 4 4 4 4 4 4 4 4 4 
0.0782 4 4 4 4 4 4 4 4 4 4 4 4 
0.1176 4 4 4 4 4 4 4 4 4 4 4 4 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.1207 4 4 4 4 4 4 4 4 4 4 5 5 
0.1668 5 5 5 5 5 5 5 5 5 5 5 5 
0.2144 5 5 5 5 5 5 5 5 5 5 5 5 
0.2190 5 5 5 5 5 5 5 5 5 5 5 5 
0.2676 5 5 5 5 5 6 6 6 6 6 6 6 
0.3276 6 6 6 6 6 6 6 6 6 6 6 6 
0.3695 6 6 6 6 6 6 6 6 6 6 6 7 
0.4046 6 6 6 6 6 6 6 7 7 7 7 7 
0.4355 6 6 6 6 6 7 7 7 7 7 7 7 
0.4537 6 6 6 7 7 7 7 7 7 7 7 7 
0.4593 6 6 6 7 7 7 7 7 7 7 7 7 
0.4706 6 6 6 7 7 7 7 7 7 7 7 7 
0.5089 6 7 7 7 7 7 7 7 7 7 7 8 
0.5216 6 7 7 7 7 7 7 7 7 7 7 8 
0.5730 7 7 7 7 7 7 7 7 7 8 8 8 
0.6114 7 7 7 7 7 7 8 8 8 8 8 8 
0.6138 7 7 7 7 7 8 8 8 8 8 8 8 
0.6531 7 7 7 8 8 8 8 8 8 8 8 8 
0.6739 7 7 7 8 8 8 8 8 8 8 8 9 
0.7477 7 8 8 8 8 8 8 8 8 8 9 9 
0.7562 7 8 8 8 8 8 8 8 8 8 9 9 
0.7781 8 8 8 8 8 8 8 8 8 9 9 9 
0.8532 8 8 8 8 8 9 9 9 9 9 9 10 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 
0.0062 0.0085 0.0226 0.0237 0.0287 0.0392 0.0471 0.0541 0.0564 0.0777 0.0813 0.0929 
  0.8723 6 6 7 7 7 7 7 7 7 8 8 8 
  0.8781 6 6 7 7 7 7 7 7 7 8 8 8 
  0.8873 6 6 7 7 7 7 7 7 7 8 8 8 
  0.8907 6 6 7 7 7 7 7 7 7 8 8 8 
  0.8956 6 6 7 7 7 7 7 7 7 8 8 8 
  0.9226 6 6 7 7 7 7 7 7 7 8 8 8 
  0.9483 6 6 7 7 7 7 7 7 7 8 8 8 
  0.9752 6 6 7 7 7 7 7 7 7 8 8 8 
  0.9845 6 6 7 7 7 7 7 7 8 8 8 8 
EOI 
Delay Period (M) 
0.0937 0.1096 0.1129 0.1343 0.1363 0.1461 0.1505 0.1599 0.1600 0.1691 0.1872 0.2100 
  0.8723 8 8 8 9 9 9 9 9 9 9 9 10 
  0.8781 8 8 8 9 9 9 9 9 9 9 9 10 
  0.8873 8 8 8 9 9 9 9 9 9 9 9 10 
  0.8907 8 8 8 9 9 9 9 9 9 9 9 10 
  0.8956 8 8 8 9 9 9 9 9 9 9 9 10 
  0.9226 8 8 8 9 9 9 9 9 9 9 10 10 
  0.9483 8 8 8 9 9 9 9 9 9 9 10 10 
  0.9752 8 8 9 9 9 9 9 9 9 9 10 10 





Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.0512 4 4 4 4 4 3 3 3 3 3 3 3 
0.0518 4 4 4 4 4 3 3 3 3 3 3 3 
0.0519 4 4 4 4 4 3 3 3 3 3 3 3 
0.0523 4 4 4 4 4 3 3 3 3 3 3 3 
0.0528 4 4 4 4 4 4 3 3 3 3 3 3 
0.0532 4 4 4 4 4 4 3 3 3 3 3 3 
0.0533 4 4 4 4 4 4 3 3 3 3 3 3 
0.0539 4 4 4 4 4 4 4 3 3 3 3 3 
0.0543 4 4 4 4 4 4 4 3 3 3 3 3 
0.0551 4 4 4 4 4 4 4 3 3 3 3 3 
0.0558 4 4 4 4 4 4 4 3 3 3 3 3 
0.0568 4 4 4 4 4 4 4 4 3 3 3 3 
0.0568 4 4 4 4 4 4 4 4 3 3 3 3 
0.0569 4 4 4 4 4 4 4 4 3 3 3 3 
0.0570 4 4 4 4 4 4 4 4 3 3 3 3 
0.0573 4 4 4 4 4 4 4 4 4 3 3 3 
0.0574 4 4 4 4 4 4 4 4 4 3 3 3 
0.0578 4 4 4 4 4 4 4 4 4 3 3 3 
0.0585 4 4 4 4 4 4 4 4 4 3 3 3 
0.0590 4 4 4 4 4 4 4 4 4 4 3 3 
0.0700 4 4 4 4 4 4 4 4 4 4 4 4 
0.0782 4 4 4 4 4 4 4 4 4 4 4 4 
0.1176 5 5 5 5 5 5 5 5 5 5 5 5 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.1207 5 5 5 5 5 5 5 5 5 5 5 5 
0.1668 5 5 5 5 5 5 5 6 6 6 6 6 
0.2144 6 6 6 6 6 6 6 6 6 6 6 7 
0.2190 6 6 6 6 6 6 6 6 6 6 7 7 
0.2676 6 6 6 6 6 7 7 7 7 7 7 7 
0.3276 7 7 7 7 7 7 7 8 8 8 8 8 
0.3695 7 7 7 7 7 8 8 8 8 8 8 9 
0.4046 7 7 7 8 8 8 8 8 9 9 9 9 
0.4355 7 7 8 8 8 8 8 9 9 9 9 9 
0.4537 7 8 8 8 8 8 9 9 9 9 9 10 
0.4593 7 8 8 8 8 9 9 9 9 9 9 10 
0.4706 8 8 8 8 8 9 9 9 9 9 10 10 
0.5089 8 8 8 8 8 9 9 9 10 10 10 10 
0.5216 8 8 8 8 9 9 9 9 10 10 10 10 
0.5730 8 8 9 9 9 9 10 10 10 10 10 11 
0.6114 8 9 9 9 9 10 10 10 10 11 11 11 
0.6138 9 9 9 9 9 10 10 10 10 11 11 11 
0.6531 9 9 9 9 9 10 10 11 11 11 11 12 
0.6739 9 9 9 9 10 10 10 11 11 11 11 12 
0.7477 9 9 10 10 10 11 11 11 11 12 12 12 
0.7562 9 9 10 10 10 11 11 11 12 12 12 13 
0.7781 9 10 10 10 10 11 11 12 12 12 12 13 
0.8532 10 10 10 11 11 11 12 12 12 13 13 13 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.0512 3 3 3 3 3 3 3 3 3 3 3 3 
0.0518 3 3 3 3 3 3 3 3 3 3 3 3 
0.0519 3 3 3 3 3 3 3 3 3 3 3 3 
0.0523 3 3 3 3 3 3 3 3 3 3 3 3 
0.0528 3 3 3 3 3 3 3 3 3 3 3 3 
0.0532 3 3 3 3 3 3 3 3 3 3 3 3 
0.0533 3 3 3 3 3 3 3 3 3 3 3 3 
0.0539 3 3 3 3 3 3 3 3 3 3 3 3 
0.0543 3 3 3 3 3 3 3 3 3 3 3 3 
0.0551 3 3 3 3 3 3 3 3 3 3 3 3 
0.0558 3 3 3 3 3 3 3 3 3 3 3 3 
0.0568 3 3 3 3 3 3 3 3 3 3 3 3 
0.0568 3 3 3 3 3 3 3 3 3 3 3 3 
0.0569 3 3 3 3 3 3 3 3 3 3 3 3 
0.0570 3 3 3 3 3 3 3 3 3 3 3 3 
0.0573 3 3 3 3 3 3 3 3 3 3 3 3 
0.0574 3 3 3 3 3 3 3 3 3 3 3 3 
0.0578 3 3 3 3 3 3 3 3 3 3 3 3 
0.0585 3 3 3 3 3 3 3 3 3 3 3 3 
0.0590 3 3 3 3 3 3 3 3 3 3 3 3 
0.0700 4 4 4 4 4 4 4 4 4 4 4 4 
0.0782 4 4 4 4 4 4 4 4 4 4 4 4 
0.1176 5 5 5 5 5 5 5 5 5 5 5 5 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 














0.1207 5 5 5 5 5 5 5 5 5 5 5 5 
0.1668 6 6 6 6 6 6 6 6 6 6 6 6 
0.2144 7 7 7 7 7 7 7 7 7 7 7 8 
0.2190 7 7 7 7 7 7 7 7 7 7 7 8 
0.2676 7 8 8 8 8 8 8 8 8 8 8 9 
0.3276 8 8 8 9 9 9 9 9 9 9 9 10 
0.3695 9 9 9 9 9 9 10 10 10 10 10 10 
0.4046 9 9 9 10 10 10 10 10 10 10 10 11 
0.4355 9 10 10 10 10 10 10 11 11 11 11 11 
0.4537 10 10 10 10 10 10 11 11 11 11 11 11 
0.4593 10 10 10 10 10 10 11 11 11 11 11 11 
0.4706 10 10 10 10 10 11 11 11 11 11 11 12 
0.5089 10 11 11 11 11 11 11 11 12 12 12 12 
0.5216 10 11 11 11 11 11 11 12 12 12 12 12 
0.5730 11 11 11 11 12 12 12 12 12 12 13 13 
0.6114 11 12 12 12 12 12 12 13 13 13 13 13 
0.6138 11 12 12 12 12 12 12 13 13 13 13 13 
0.6531 12 12 12 12 12 13 13 13 13 13 13 14 
0.6739 12 12 12 12 13 13 13 13 13 14 14 14 
0.7477 12 13 13 13 13 13 14 14 14 14 14 15 
0.7562 13 13 13 13 13 14 14 14 14 14 15 15 
0.7781 13 13 13 13 14 14 14 14 14 15 15 15 
0.8532 13 14 14 14 14 14 15 15 15 15 15 16 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 
0.2363 0.2456 0.2768 0.2931 0.3031 0.3680 0.3824 0.4217 0.4404 0.4701 0.4936 0.5432 
  0.8723 10 10 10 11 11 12 12 12 12 13 13 13 
  0.8781 10 10 11 11 11 12 12 12 12 13 13 13 
  0.8873 10 10 11 11 11 12 12 12 12 13 13 14 
  0.8907 10 10 11 11 11 12 12 12 13 13 13 14 
  0.8956 10 10 11 11 11 12 12 12 13 13 13 14 
  0.9226 10 10 11 11 11 12 12 13 13 13 13 14 
  0.9483 10 10 11 11 11 12 12 13 13 13 13 14 
  0.9752 10 11 11 11 11 12 12 13 13 13 14 14 
  0.9845 11 11 11 11 11 12 12 13 13 13 14 14 
EOI 
Delay Period (M) 
0.5435 0.5842 0.5972 0.6126 0.6399 0.6634 0.7015 0.7314 0.7514 0.7611 0.7853 0.8359 
  0.8723 13 14 14 14 14 15 15 15 15 15 16 16 
  0.8781 13 14 14 14 14 15 15 15 15 15 16 16 
  0.8873 14 14 14 14 14 15 15 15 15 16 16 16 
  0.8907 14 14 14 14 15 15 15 15 16 16 16 16 
  0.8956 14 14 14 14 15 15 15 15 16 16 16 16 
  0.9226 14 14 14 15 15 15 15 16 16 16 16 17 
  0.9483 14 14 15 15 15 15 16 16 16 16 16 17 
  0.9752 14 15 15 15 15 15 16 16 16 16 17 17 





Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 
EOI 
Delay Period (M) 




























0.1207 5 5 5 
0.0518 3 3 3 2 2 2 2 0.1668 6 6 7 
0.0519 3 3 3 2 2 2 2 0.2144 8 8 8 
0.0523 3 3 3 3 2 2 2 0.2190 8 8 8 
0.0528 3 3 3 3 2 2 2 0.2676 9 9 9 
0.0532 3 3 3 3 2 2 2 0.3276 10 10 10 
0.0533 3 3 3 3 2 2 2 0.3695 10 10 10 
0.0539 3 3 3 3 3 2 2 0.4046 11 11 11 
0.0543 3 3 3 3 3 2 2 0.4355 11 11 11 
0.0551 3 3 3 3 3 2 2 0.4537 11 11 12 
0.0558 3 3 3 3 3 3 3 0.4593 11 11 12 
0.0568 3 3 3 3 3 3 3 0.4706 12 12 12 
0.0568 3 3 3 3 3 3 3 0.5089 12 12 12 
0.0569 3 3 3 3 3 3 3 0.5216 12 12 12 
0.0570 3 3 3 3 3 3 3 0.5730 13 13 13 
0.0573 3 3 3 3 3 3 3 0.6114 13 13 13 
0.0574 3 3 3 3 3 3 3 0.6138 13 13 14 
0.0578 3 3 3 3 3 3 3 0.6531 14 14 14 
0.0585 3 3 3 3 3 3 3 0.6739 14 14 14 
0.0590 3 3 3 3 3 3 3 0.7477 15 15 15 
0.0700 4 4 4 3 3 3 3 0.7562 15 15 15 
0.0782 4 4 4 4 4 4 4 0.7781 15 15 15 
0.1176 5 5 5 5 5 5 5 0.8532 16 16 16 
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Attachment 2. Two-Way Sensitivity Analysis toward Economic Order Interval (Scenario 3) (cont.) 
EOI 
Delay Period (M) 
EOI 
Delay Period (M) 














0.1207 5 5 5 5   0.8723 16 16 16 17 17 17 17 
0.1668 7 7 7 7   0.8781 16 16 16 17 17 17 17 
0.2144 8 8 8 8   0.8873 16 16 16 17 17 17 18 
0.2190 8 8 8 8   0.8907 16 16 16 17 17 17 18 
0.2676 9 9 9 9   0.8956 16 16 16 17 17 18 18 
0.3276 10 10 10 10   0.9226 17 17 17 17 17 18 18 
0.3695 10 11 11 11   0.9483 17 17 17 17 18 18 18 
0.4046 11 11 11 12   0.9752 17 17 17 18 18 18 18 
0.4355 11 12 12 12   0.9845 17 17 17 18 18 18 18 
0.4537 12 12 12 12          
0.4593 12 12 12 12          
0.4706 12 12 12 12          
0.5089 12 13 13 13          
0.5216 13 13 13 13          
0.5730 13 13 14 14          
0.6114 14 14 14 14          
0.6138 14 14 14 14          
0.6531 14 14 15 15          
0.6739 14 15 15 15          
0.7477 15 15 16 16          
0.7562 15 16 16 16          
0.7781 16 16 16 16          
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